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SUMMARY
This thesis describes an investigation into the mouse-protecting nucleotide 
sequences o f defective interfering (Dl) Semliki Forest virus (SFV) RNA was 
extracted from tissue culture preparations o f Dl SFV and reverse transcribed 
Putative Dl SFV cDNA was amplified by the polymerase chain reaction using 
primers specific for the termini o f the virion RNA A number of molecular clones 
were constructed from the products o f amplification and the nucleotide sequences 
o f two o f these clones were determined (pSFVDI-6 2146 nts and pSFVDI-19 
1244 nts) Both pSFVDI-6 and pSFVDI-19 were derived from three non­
contiguous regions o f  the SFV genome comprising the 5* and 3' termini and part of 
the nsP2 coding region RNA transcribed from these clones was transfected into 
SFV-iniected BHK-21 cells to produce genetically homogeneous Dl SFV 
preparations These preparations were stable on serial passage and interfered with 
virus multiplication m  vitro The transfection technique was also used in a 
preliminary investigation of the regulatory elements of the SFV genome A 388- 
nucleotide region within the nsP2 gene o f SFV was tentatively defined as 
containing all or part o f a packaging signal since Dl SFV clones lacking this region 
were not propagated as virions
To determine the biological activity o f the cloned Dl SFV preparations in vivo they 
were mixed with 10 LD*, SFV and inoculated into adult mice by the intranasal 
route The Dl SFV preparation derived from pSFVDI-19 typically conferred 75% 
protection against the lethal encephalitis that normally follows infection with SFV. 
whereas the Dl SFV preparation derived from pSFVDI-6 was non-protecting 
However, it should be noted that the concentration o f Dl SFV in these cloned 
preparations was not standardised Modulation of infection in vivo was 
independent o f the antigenic load and mice were susceptible to subsequent lethal 
challenge A preliminary experiment suggested that propagation o f D l SFV 
genomes was cell-specific because genomes derived from pSFVDI-19. but not 
pSFVDI-6. could be detected in mouse brain tissue following intracerebral 
coinoculation o f SFV with the cloned Dl SFV preparations
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1I. SEMLIKI FOREST VIRUS
(a) Classification
Semliki Forest virus (SFV) was first described by Smithbum and Haddow (1944) 
Originally it was classified as an arbovirus because it infects vertebrates and is 
transmitted by a mosquito vector It has since been classified in the genus 
alphavirus (formerly known as the group A arboviruses), o f the family Togaviridae 
(Matthews. 1982)
The togavirus family consists o f animal viruses which are enveloped and possess a 
single RNA genome o f positive polarity logs viruses therefore belong to group IV 
o f the Baltimore classification o f  viruses (Baltimore. 1971) Besides the 
alphaviruses, this family includes the genera pestivirus (eg  hog cholera), 
artenvirus (e g equine arteritis virus) and rubivirus (e g rubella virus)
To date, about 2S alphaviruses have been identified, many o f which are important 
veterinary and human pathogens (Chamberlain, 1980) Alphaviruses were originally 
grouped according to serological data (('alisher and Karabatsos. 1988) More 
recently, computer analysis o f protein sequences has been used to construct 
phylogenetic trees l>evinson el a!  (1990) used such an analysis to divide several 
alphaviruscs into three subgroups the Semliki Forest virus subgroup (SFV. 
O’nyong-nyong virus and Ross River virus), the eastern encephalitis subgroup 
(eastern equine encephalitis virus and Venezuelan equine encephalitis virus) and the 
Sindbis virus subgroup
2(b) Epidemiology
SFV was first isolated from female Andes abnormal is mosquitoes caught in 
Bundinyama. western Uganda (Smithbum and Haddow. 1944) Serological studies 
have shown the vims to  be geographically dispersed (Calisher and Karabatsos,
1988), and analysis o f phylogenetic trees suggested that alpha viruses originated in 
the New World (Levinson el a l , 1990)
SFV has been isolated from mice, birds and mosquitoes, and neutralising antibodies 
have been found in humans (Chamberlain, 1980) Willems el a t (1979) reported a 
case o f a laboratory technician developing a lethal encephalitis following infection 
with SFV and in 1990, Mathiot el aI identified SFV as responsible for several 
cases o f febrile illness in humans in Central African Republic However, no other 
cases o f clinical illness in humans following infection with SFV have been reported 
to date
(c) Pathogenesis
(!) Progress o f  infeciitm
SFV was first identified from the ability of mosquito extracts to cause a lethal 
encephalitis in mice after intracerebral inoculation (Smithbum and Haddow. 1944) 
The disease was characterised by a roughening o f  the coat followed by hind limb 
paralysis, muscular twitchings and convulsions The original virus isolate was 
serially passaged in mouse brain Early passages, from which most laboratory 
strains are derived, caused death after six days After about 40 passages, the mean
3time o f death was 2 days Hence the virus was highly neurotropic for the central 
nervous system (CNS) Inoculation by the subcutaneous or intraperitoneal routes 
delayed the onset o f  symptoms by one to two days, but there was no difference in 
the progress o f the disease SFV was shown to be lethal for rabbits, guinea-pigs 
and rhesus monkeys after intracerebral inoculation (confirmed by Bradish el a! . 
1971).
Seamer el a l (1967) found that following peripheral inoculation. SFV multiplied in 
the spleen, liver, lymph nodes and CNS However, histopathological lesions were 
only present in the CNS Pathak and Webb (1974) used electron microscopy to 
study the mechanism by which SFV enters the CNS They concluded that the virus 
was transported across the blood-brain barrier either in coated vesicles or by 
actively migrating leukocytes
To date, no receptor for SFV expressed on neural cells has been identified 
However. Ubol and Griffin (1991) used an ami-idiotypic antibody to identify a 
putative Sindbis virus receptor on mouse neural cells This receptor was a protein 
that was also detected in murine tissue culture cells but rarely in human cell lines 
In addition, the protein was regulated in the development o f the nervous system It 
was concluded that such a receptor may contribute to the age-dependent 
susceptibility o f mice to fatal encephalitis induced by alpha viruses
00 yimlence
A number o f studies have attempted to determine the properties o f  SFV 
responsible for virulence Bradish el a! (1971) studied the virulence of several
4strains o f SFV inoculated by the intraperitoneal. respiratory or intracerebral routes 
in different hosts Suckling mice were susceptible to all strains, while adult mice 
were only killed by so-defined virulent strains The transition to non-susceptibility 
to a virulent strains occurred at about 16 days o f  age. after which the virus 
conferred protection to subsequent challenge (Bradish el a/ . 1972) Pusztai el a/ 
(1971) showed that after intraperitoneal inoculation o f weanling mice with virulent 
or avirulent strains o f SFV (V I3 and A7), a viraemia was induced followed by 
brain invasion The initial stages o f  the disease were identical for both virulent and 
avirulent strains (confirmed by Bradish and Allner. 1972) However. V I3 was 
detected in the brain 24 hours before A7 and titres increased to death, while titres 
o f  A7 reached a peak and then declined
Histopathological lesions have been observed in the CNS following infection of 
adult mice with both virulent and avirulent strains o f SFV However, the cellular 
effects are different for the two strains F.lectron microscopic studies have shown 
that following infection of adult mice with the A7(74) strain there is no virus 
maturation and viral nucleocapsid material accumulates in neurons The infection 
results in a subacute demydmating memngoencephalomyditis with little neuronal 
destruction or infection of oligodendrocytes and is followed by remydination and 
complete recovery (Pathak el a ! , 1976, Pathak and Webb. 1983. 1988. Khalili- 
Shira/i el a t . 1988. Fazakerley and Buchmeier. 1992) In contrast, lethality of 
virulent strains is rdated to necrosis o f neurons and oligodendrocytes (Atkins and 
Sheahan. 1982, Atkins el a l , 1985. 1990. Smyth el a t . 1990) In addition, the 
avirulent A7 strain has been shown to induce abortion following peripheral 
infection o f pregnant mice (Atkins el a / .  1982) Ter at «»genesis was shown
5subsequently to result from virus infection o f cells originating in the mesenchyma 
(Mabruk el a l , 1988. 1989)
One feature o f infection by several neurotropic viruses, including Russian spring- 
summer encephalitis. St Louis encephalitis and Denguc-2 viruses, is the induction 
o f smooth membrane proliferation in the CNS (Murphy. 1980) Electron 
microscopic studies have shown that acute encephalitis o f adult mice resulting from 
infection with the virulent L10 strain o f SFV is also associated with the 
development o f  numerous membrane vesicles, from which mature virus particles 
bud In contrast, infection o f adult mice with the A7(74) strain does not result in 
significant membrane proliferation and mature virus particles have not been 
detected in the brain (Pathak el a l . 1976, Pathak and Webb. 1978) This 
association between virulence and membrane proliferation has been confirmed by 
studies in which adult mice were treated with gold sodium thiomalate (GSTM) 
before infection with a virulent SFV Virus titres in the brain were shown to be 
significantly increased and the infection was lethal (Bradish el a l . 1975, Mehta and 
Webb, 1987) Subsequent studies showed that GSTM induces membrane 
proliferation and depresses peritoneal macrophage function (Mehta and Webb. 
1990. Mehta el a l . 1990) In addition, it has been suggested that the lethality of 
■virulent SFV for neonatal mice is associated with membrane proliferation In 
contrast to adult mice, the brain cells o f neonatal mice are still developing and there 
may be sufficient membrane proliferation for virus maturation (Mehta el a! , 1990)
6fill) ( 'NS Jemyelmalion
Avirulenl SFV has been used as a model for investigating demyelinating virus 
diseases o f humans, and in particular, multiple sclerosis (Atkins el a l , 1990. 
reviewed in Fazakerley and Buchmeier. 1993) A number o f studies have suggested 
that demyelination by a virulent SFV is immune-mediated Berger (1980) showed 
that following infection with the A7(74) strain, demyelination was more severe in 
immunocompetent mice than in nude mice This supported previous work that 
suggested demyelination was T-cell dependent (Jagelman el a t , 1978) In addition. 
Jenkins el a l (1988) showed that infection o f T-cell deficient nude mice with the 
■virulent A7(74) strain did not result in optic nerve demyelination Fazakerley and 
Webb (1987a) showed that adoptive transfer of syngeneic spleen cells to A7(74)- 
infected athymic mice restored the lesions of demyelination in the CNS However, 
this did not occur following peripheral transfer of anti-SFV immune serum and 
demyelination could be prevented by total body irradiation (Fazakerley and Webb. 
1987b) Fazakerley and Buchmeier (1993) suggested that demyelination is 
mediated through a T-cell response to viral determinants on the cell surface or to 
an autoantigen
flv) The molecular basis o f  virulence
In an attempt to determine the molecular basis of virulence. Barrett el al (1980) 
isolated and characterised a number of mutants o f SFV (LIO virulent strain) 
showing altered virulence in weanling mice l-osa o f  neurovirulence was shown 
subsequently to be associated with a loss of the ability either to enter the brain or 
to damage neurons (Atkins and Sheahan. 1982) Two mutants (M9 and M l36) had
7similar host range and molecular properties to the avirulent A7 strain (Atkins, 
1983) Subsequently, Heame el aI (1987) isolated four temperature-sensitive 
mutants o f the A7 strain that had altered pathogenicity for mouse embryos These 
mutants had defects in RNA synthesis that were more extreme than that expressed 
by the A7 strain (Woodward and Smith, 1979)
Recently, investigation of the molecular basis of alphavirus pathogenesis has been 
facilitated by the construction o f infectious clones (SFV Liljestròm el al., 1991, 
Sindbis Rice el a/., 1987) Glasgow el aI (1991) showed that virus derived from 
the SFV-derived clone had similar pathogenic properties to the virulent L10 strain 
Two mutations in the p62 envelope protein region (p62 is a precursor of the E2 
and E3 glycoproteins see section Id) reduced the rate o f  multiplication of the virus 
in mouse brain and extended the mean time o f death following intranasal 
inoculation o f 40-day-old mice Similar work with Sindbis virus has shown that 
defined mutations affecting pathogenesis occur within the genes encoding the 
membrane glycoproteins El and E2 (l.ustig el a t , 1988, Polo el a l . 1988, Polo 
and Johnston, 1990, Tucker and Griffin, 1991),
(d) Structure
Figure I I shows a schematic diagram of SFV SFV is an enveloped virus with an 
icosahedral nucleocapsid (Kiiriainen and SOderlund. 1978) The nucleocapsid 
contains a single molecule o f positive-stranded RNA o f sedimentation coefficient 
42S (Friedman el a l , 1966) Electron microscopic studies have shown that the 
nucleocapsid is surrounded by a lipid bilayer with an average radius o f  23 nm The 
lipid membrane contains 80 spike proteins extending to an outer radius of about
SEMLIKI FOREST VIRUS
Figure l . l  Schematic diagram o f a Scmliki Forest virus panicle
The diagram o f  SFV is reproduced from Branden and Tooze (1991). The panicle 
is about 64 nm in diameter A single 42S RNA molecule is contained within a T -4 
icosahedral nucleocapsid that composes a single capsid protein The nudeocapsid 
is surrounded by a lipid bilayer o f host-cell ongin 240 spike protein structures are 
arranged as trimers in the lipid membrane and are composed o f the E l. E2 and E3 
structural proteins
932 nm The spikes are organised as a lattice with a triangulation number T -  4 
(Vogel el a l ,  1986. Fuller. 1987)
The nucleocapsid core consists o f capsid protein with a molecular weight (Mr) o f 
30,000 (Soderlund el a ! , 1979) The capsid protein contains 267 amino acids and 
has clusters o f  basic amino acids and prolines in the N-terminal third o f  the 
polypeptide chain which are suspected to  be involved in binding to the 42S RNA 
(Garoff el a l , 1980a, b) Biochemical studies have shown that each spike protein 
consists o f  two glycoproteins that span the lipid bilayer (E l. Mr«49,000 and E2. 
Mrm5 1,000) and a third (E3, Mr"  10,000) that is associated with the external 
domains o f  E l and E2 At present it is not known how E3 is bound to the spike 
protein The viral membrane can be solubilised with nonionic detergents into E2EI 
heterodimeric structures This and other studies have suggested that the SFV spike 
is organised as a trimer o f the E2EI heterodimer (Simons el a l . 1973. Ziemiecki 
and Garoff. 1978, Wahlberg el a l , 1989, Anthony and Brown. 1991. Levy-Mintz 
and Kielian, 1991. Wahlberg el a l . 1992)
The EI and E2 glycoproteins are organised in the lipid bilayer with the caiboxy (C) 
-terminus on the inside The haemagglutinating activity o f the virus is a (unction of 
the El subunit (Ghanas el a l , 1982) and E2 has the determinant for neutralisation 
(Boere el a l . 1983) Two arginine residues at the ('-terminus o f  El and 31 ammo 
acid residues at the ('-terminus of E2 are located on the internal side o f the 
membrane The interaction o f the spike protein with the nucleocapsid is therefore 
thought to occur through the ('-terminus o f  E2 (Garoff el a l . 1980a) Recently. 
Barth el a! (1992) showed that the ('-terminal peptide o f SFV had no major role 
to play in the multiplication o f the vims in cells of vertebrate origin
10
A number o f studies have provided biochemical evidence for spike protein- 
nudeocapsid interactions of SFV and Sindbis vim i (SFV Garoff and Simons. 
1974, Melenius and Kartenbeck. 1980, Sindbis reviewed in Schlesinger and 
Schlesinger. 1986) The work o f Vaux el aJ (1988) and Kail el a i (1991) showed 
by means of anti-idiotypic antibodies that the ('-terminal domain o f E2 has 
structural complementarity to the nucleocapsid and that the ('-terminal 8 amino 
acids o f E2 were a signal for nucleocapsid interaction However, Suomalainen and 
(iaroff (1992) have since demonstrated that the anti-E2 antibody used in this work 
was not specific for nucleocapsid protein as claimed, but recognised a component 
o f  the viral replication machinery More reliable evidence for spike protein- 
nucleocapsid interaction was provided by Metsikko and Garoff (1990), who 
showed that synthetic peptides comprising the ('-terminal domain o f E2 bound 
efficiently to nudeocapsids in vitro Furthermore, oligomers of these peptides 
interacted in preference to monomers, suggesting that the interaction with the viral 
nucleocapsid occurs through complexes o f  the E2 protein
(r)  Genome structure
(!) Primary structure
Figure I 2a shows a diagram of the protein-coding regions o f the SFV genome 
The 42S RNA is 11,442 nucleotides in length (Mr-  3 95 x I06 ) and has a base 
composition o f 26 7% A, 20 1% U, 27% G and 26 2% C (Garoff el al., 1980a, 
1980b, Riedel el a/., 1982, Takkinen, 1986) At the 5’ terminus is a 7-methyl 
guano sine cap structure, which has the same nucleotide sequence as that for the
I l
Figure 1.2 Primary and secondary structures o f SFV RNA
(a) shows the protein coding regions of the 42S RNA (b) shows a schematic 
diagram o f the panhandle structure o f the 42S RNA observed by electron 
microscopy (c) is reproduced from Berben-Bloemheuvel (1992) and shows the 
proposed secondary structure model for the 5' untranslated regions o f the 42S and 
26S RN As o f SFV
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Sindbis virus genome (SFV Pettersson el a i., 1980, Sindbis Hefti el a l , 1976, 
Dubin el a i , 1977). At the 3' terminus o f  SFV RNA and other alphavirus genomes 
is a poly( A) tract o f approximately 80 nucleotides (Armstrong el a i . 1972, Eaton 
and Faulkner. 1972, Clegg and Kennedy. 1974) The 50 nucleotides at the 3* 
terminus o f SFV RNA have an 80% A + U content It has been suggested that this 
region may serve as a polyadenylation signal (Ou el a! , 1982b)
The 85 nucleotides at the 5' terminus and the 264 nucleotides at the 3' terminus of 
the SFV genome are not translated (CiarofT el a i . 1980b, Takkinen, 1986) There 
is an open reading frame coding for a 2431 amino acid polyprotein which extends 
from an AUG codon at nucleotides 86-88 to a UAA termination codon at 
nucleotides 7379-7381 Non-structural proteins (nsPI-4) are translated from this 
region (see section Ig-v) Structural proteins are translated from 26S RNA, which 
is derived from the 3' 4074 nucleotides o f  the 42S RNA in the infected cell (see 
section Ig-vtf, Takkinen. 1986) There is a 13-nucleotide overlap o f the 26S RNA 
with the 42S genome and 5 1 nucleotides at the 5' terminus o f the 26S RNA are not 
translated The structural proteins are translated in a different reading frame to that 
used for translation o f the non-structural proteins (Riedel el a i . 1982. Takkinen. 
1986)
0 0  Secondary structure
Electron microscopic studies of Sindbis virus and SFV RNAs showed that the 
molecules can circularise and form panhandle structures (Figure I 2b, Hsu el a i . 
1974, Kennedy. 1976, Frey el a i , 1979) Ou el ai (1983) suggested that the base- 
pairing o f the panhandle occurred between complementary regions o f  10
13
nucleotides located 190 nucleotides within the 5' terminus and 241 nucleotides 
within the 3' terminus The extreme termini o f the RNA were not suspected to be 
involved in base-pairing themselves
A number o f  regions o f alphavirus RNAs have been implicated as important to the 
regulation o f replication Ou el a l  (1983) suggested that stem-loop structures can 
be formed from about the first 40 nucleotides o f several alphavirus genomes and 
they showed that a 5 1 nucleotide region was conserved at the 5' terminus o f the 
26S RNA These regions were suspected to have a role in the regulation o f RNA 
transcription In addition. Ou el a/  (1982a) suggested that a 21 nucleotide region 
at the junction between the 26S RNA and the non-structural coding sequences was 
required for the initiation o f  transcription o f the 26S RNA Although these 
conclusions were not based on experimental evidence. Levis el a l  (1990) showed 
that this region could direct the transcription in the infected cell of subgenomic 
RNA from a defective interfering Sindbis virus genome Konings el a l (1987) 
analysed leader sequences from 50 eukaryotic mRNAs, including SFV RNA, and 
showed that the majority had a common conformation at the 5* region 
Expérimental data have suggested that such regions arc important for translation 
from the correct start codon and for regulation o f viral protein synthesis in the 
infected cell (van Duijn et a l ,  1988, Berben-Bloemheuvelt-f a l , 1992) Figure I 2c 
shows the computer-predicted secondary structure model proposed by Berben- 
Blocmhcuvcl el al (1992) for the 5* termini o f the 42S and 26S RNAs In this 
model the cap structure o f  the 42S RNA is masked and may impede translation in 
the infected cell, whereas the 26S RNA cap is free to interact with cap-binding 
protein This may explain why the 26S RNA is able to escape the shut-off o f  host 
protein synthesis (sec section I g -III)
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(0  Growth in vitro
SFV grows in a wide variety o f cell types, including several mammalian, human 
and mosquito lines, and is readily assayed by plaque formation (Henderson and 
Taylor, I960) In addition, it grows over a wide temperature range o f 20-40°C 
(Burge and Pfcfferkom, 1966) For these reasons, and because it is relatively non- 
pathogenic for humans, SFV has been used extensively as a model for studying the 
multiplication o f enveloped RNA viruses
Early studies on the growth o f SFV in chick embryo fibroblasts (CEF) showed that 
the virus replicated entirely in the cytoplasm (Taylor. 1965. Achcson and Tamm. 
1967), At about 3 hours after infection o f  CEF■ at 37°C, the rate o f production of 
SFV in the culture medium increased exponentially to a maximum o f 200 plaque- 
forming units/cell/hour at 5-9 hours after infection Cytopathic changes were 
observed 6 hours after infection and cells were rounded and detaching from the 
surface of the growth vessel by 12 hours The maximum cytopathic effect 
coincided with the cessation o f virus production Electron microscopic studies 
showed the appearance o f  unique membranous structures, or cytopathic vacuoles 
(CPV), following infection o f CEFs and other cell lines with SFV (Acheson and 
Tamm, 1967. Erlandson e l at., 1967, Friedman and Berezesky, 1967, Grimley el 
a/., 1968. Friedman el a / ,  1972). Two morphologically distinct CPVs were 
identified The first was produced 1-2 hours after infection (CPV-I) and the second 
(CPV-II) was produced late in the infectious cycle Grimley el a l  (1968) showed 
that CPV-Is were loci o f RNA synthesis and more recently. Froshauer el aI (1988) 
and Pertnen and Kaariainen (1991) have shown that they are endosomes and 
lysosomes associated with the replicative proteins nsP3 and nsP4
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While the growth of 8FV and other alphaviruses in vertebrate cell lines results in 
cell lysis, infection of mosquito cell lines is often persistent with little or no 
cytopathic effect (Davey el a l , 1973, Iganshi el a / . 1977, Tooker and Kennedy 
1981) The nature of the host cell components that influence the growth of 
alphaviruses in vertebrate and invertebrate cells has yet to be elucidated, but Baric 
el a t (1983) suggested that the growth of Sindbis virus in these cell lines required 
host cell transcription and presumably protein synthesis
( l)  Infectious cycle
0) Overview
Figure I 3 shows a schematic diagram of the infectious cycle o f SFV Each stage 
of the cycle is described in detail below
(10 Hindiny and endtuylosis
SFV binds to a receptor on the surface of cells through its spike proteins and is 
internalised by endocytosis in coated vesicles (Helenius el a i . 1980. Marsh el a l . 
1983. H a s e r /o / ,  1989)
At present it is not known which component o f the host cell membrane is required 
for the attachment of alphavtrus particles Alpha viruses can infect a wide range of 
cell types, both vertebrate and invertebrate, and must therefore recognise either 
different receptors or a receptor that is ubiquitous Helenius el a! (1978) showed
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Key NC nucleocapsid. PM r  plasma membrane. ER endoplasmic reticulum 
F ig u re  I J  The infectious cycle o f  SFV (adapted from Ciaroff el a l . 1982)
The virus binds to the host cell receptors through its spike proteins and enters the 
cell by endocytosis The virus is transported to endosomcs in coated pits where the 
acidic pH results in a conformational change in the spike proteins This induces 
fusion between the viral and endosomaJ membranes and the release o f the 
nucleocapsid into the cytoplasm where it is uncoated The 42S RNA acts as 
messenger for the translation o f viral replicase proteins which transcribe new 
genomes and subgenomic 26S RNA The 26S RNA encodes the structural proteins 
o f  the virus The nucleocapsid assembles in the cytoplasm and the spike proteins 
become inserted in the membrane o f the rough endoplasmic reticulum and are 
transported through the Ciolgi apparatus to the plasma membrane o f the cell 
Finally the spike proteins are incorporated into the viral envelope and the mature 
virion is released by budding at the cell surface
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that SFV could bind to antigens o f the major histocompatibility complex of human 
and murine cells However, studies by Old-Hone el al (1980) showed that infection 
by SFV could still occur in the absence o f these antigens Baby hamster kidney 
(BHK)-2I cells have been shown to bind approximately 5 x 10* SFV particles/cell 
at 4°C under saturating conditions (Fries and Helenius, 1979) Helenius el al 
(1980) showed that SFV binds preferentially to microvilli on BHK cells but the 
nature o f the receptor was not determined Recently. Wang el al (1992) obtained a 
monoclonal antibody that blocked the attachment of Sindbis vims to BHK-21 cells 
and partly blocked attachment to mosquito cells The antibody recognised a cell 
surface protein that bound to basement membrane laminin and was highly 
conserved among mammals They suggested that the ubiquity of this receptor was 
responsible for the wide host range o f Sindbis vims
(in) M embrane fusion and entry into the cytoplasm
Following internalisation. SFV is transported in coated vesicles to the endosomes 
where the acidic pH induces a conformational change in the spike proteins This 
results in fusion between the viral and endosomal membranes and precedes entry of 
the nucleocapsid into the cytoplasm (White and Helenius. 1980. Helenius el a! , 
1982. Kielian and Helenius. I98S, Wahlberg and Garoff 1992)
Fusion o f SFV particles to the host membrane is mediated through the EI subunit 
o f the spike proteins (Omar and Koblet, 1988. Levy-Mintz and Kielian. 1991) This 
fusion reaction is known to require the presence of cholesterol in the target 
membrane (Kielian and Helemus. 1984. Phalen and Kielian. 1991) Wahlberg and 
Garoff (1992) showed that the E2EI heterodimeric association of the spike protein
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(see section Id) is destabilised soon after the vims enters the endocytic pathway 
Exposure o f the spike protein to  mildly acidic pH causes the El subunit to 
dissociate from the E2 protein and form a homotrimeric complex (Wahlberg el u/ 
1992) Vims penetration and fusion processes are inhibited by a monoclonal 
antibody directed specifically to this trimeric form of E l. which is suspected 
therefore to represent the SFV fusion protein (Wahlberg and Garoflf. 1992. 
Wahlberg el a i ,  1992)
Electron microscopic studies have shown that nucleocapsids appear on the 
cytoplasmic side of the endosomal membrane immediately after fusion These 
rapidly disappear from view, suggesting that they are disassembled as soon as they 
enter the cytoplasm (Helenius. 1984) Host cell protein synthesis is shut oft'about 4 
hours after infection with SFV The capsid protein is suspected to be important in 
this process, but the precise mechanisms involved have not been determined (van 
Steege/o / . 1984. Elgizoli el a t . 1989)
(iv) 11'nettaliny
The passage of the nucleocapsid through acidic endosomes is not thought to be 
important to the uncoating process (Stubbs el a ! , 1991) Uncoating of Sindbis 
vims has been shown to occur through association with ribosomes (Wcngler and 
Wengler. 1984, Wengler el a i ,  1984) Recently. Singh and Helenius (1992) 
showed that a similar association occurs with the SFV nucleocapsid Ribosomes 
were shown to bind to capsid proteins and release them from the nucleocapsid in 
an irreversible, non-cataiytic process The precise interaction o f  the capsid protein 
with ribosomal RNA is not known at present, but Choi el at (1991) have
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suggested that the interaction may be mediated through the amino terminal 
segment of the capsid protein, which is exposed on the surface o f the nucleocapsid
(v) Synthesis and  function o f  the non-structural proteins
Following uncoating, the 42S RNA is released into the cytoplasm where it acts as 
messenger for the translation o f non-structural (ns) proteins The 5' two-thirds o f 
the genome is translated as a polyprotein (nsPI234. sec figure I 2a) which is 
cleaved proteolytically to yield four mature proteins (nsPI-nsP4 Mr » 60,000. 
89,000, 52,000, 69,000 respectively) All four proteins are required for replication 
o f  the 42S RNA and are thought to become associated as a replication complex in 
the infected cell (Takkinen, 1986, Kaanainen el a l . 1987. Barton et a l , 1991, 
1-emm and Rice. 1993) A number of studies have revealed short-lived intermediate 
polypeptides in infected cells These studies suggested that the nsPI234 
polyprotein is processed through two different pathways to yield either nsPI23 + 
nsP4 or nsPI2 + nsP34 precursors (Lachmi and kaâriâinen. 1977, Lehtovaara et 
a l , 1980. Takkinen et a l , 1990. 1991)
A number of recent studies on Sindbis virus and SFV have suggested functions for 
the four non-structural proteins produced in the infected cell nsPI has been 
implicated in the synthesis o f negative-strand RNA (see section Ig-vl) In addition 
it has been suggested to be involved in the méthylation and capping o f positive- 
strand RNA (Mi et a l ,  1989. Wang el a l , 1991) nsP2 has two enzymatic 
activities The N-terminal half is thought to function as a helicase and the C- 
terminal half as an autoprotease (Ding and Schlesinger. 1989, Hardy and Strauss,
1989) In addition. nsP2 possesses information that directs itself to the nucleus of
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the infected cell The function of n*P2 in the nucleus is not known, but it has been 
suggested that it may serve to inhibit host cell DNA and RNA synthesis (Pertncn el
of.. 1990)
nsP3 is a phosphoprotein with phosphorylated serine and threonine residues and is 
associated with the cytopathic vesicles described in section I f  (Froshauer el a! . 
1988. Penmen el a t ,  1988, Peranen. 1991, Peranen and Kaanaincn. 1991) 
However, the function o f  nsP3 has no1, been determined, although Hahn el al 
(1989) demonstrated that it was essential for RNA synthesis Finally. nsP4 is 
thought to function in the initiation and elongation processes o f RNA synthesis and 
possesses autoprotease activity (Sawicki el a l ,  1990, Takkinen el a l . 1990) For 
SFV and Sindbis virus, nsP4 is produced in lower amounts in the infected cell than 
nsPI, 2 or 3 (Kerinen and Ruohenon. 1983, Li and Rice. 1989)
(vi) Synthesis o f  42S and 26S RNAs
The nonstructural proteins translated from the 42S RNA serve as an RNA- 
dependent RNA polymerase for the synthesis of new genomes and the subgenomic 
26S RNA The 42S RNA is a template for the production o f  minus-strand 42S. 
which in turn is a template for the synthesis o f new plus-strand 42S RNA The 26S 
RNA is transcribed from an internal initiation site on the negative-strand 42S RNA 
(Kaantmcn and Soderfund. 1978, Pettersson el a t ,  1980. Sawicki and Sawicki. 
1980, Sawicki el a l . 1981. Riedel el a l . 1982) The rate of synthesis o f plus and 
minus-strand RNAs increases dunng the first 3 hours post-infection, after which 
the synthesis of minus-strand RNA ceases The synthesis o f  42S and 26S RNAs
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continues at a constant rate throughout the infectious cycle (Bruton and Kennedy. 
1975. Sawicki and Sawicki, 1980)
A number o f temperature-sensitive mutants o f Sindbis virus have been obtained 
which fail to shut off the synthesis o f  minus strand RNA (Sawicki el al., 1981. 
Sawicki and Sawicki, 1986) Sawicki el a l (1990) showed that a single base 
change in the nsP4 gene was responsible for the phenotype o f  three such mutants 
and suggested that a domain o f nsP4 functions to ensure that the minus strand is 
the preferred template o f  the replication complex
(vii) Synthesis o f  structural proteins
All the structural proteins o f  SFV are synthesised from the 26S RNA as a 
polyprotein precursor from a single initiation site The polyprotein is synthesised in 
the order C'-p62-6K-EI (Mr » 33,000, 62,000, 6,000, 50,000 respectively) and 
individual proteins are released from the precursor by post-translational cleavage 
(Clegg and Kennedy. 1975, Garoff et a l , 1980b) The 26S RNA is suspected to be 
translated more efficiently than the 42S RNA This may be a result of differences in 
the untranslated regions o f these RNAs (Berben-Bloemheuvel e ta ! . 1992)
The capsid protan is synthesised in the cytoplasm and is released from the nascent 
polypeptide by autoproteolysis (Melançon and Garoff. 1987) This event reveals 
the N-terminal sequence of the p62 polypeptide which targets the p62-6K-EI 
polypeptide to the endoplasmic reticulum (ER) All but the ('-terminus and 
membrane anchor sequences are translocated across the ER membrane (Garoff et 
a ! , 1978) Recent studies have shown that the signal sequence o f p62 consists o f a
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16-amino acid peptide at the N-terminus o f  the polypeptide (Garoff el a l , 1990) 
The p62 signal sequence is glycosylated in the lumen of the ER before the entire 
p62 sequence has been synthesised, suggesting it is not important for the 
completion o f chain translocation (Garoff el a l , 1990)
The C-terminus o f  p62, which remains on the cytoplasmic side of the ER, contains 
a second signal sequence that is involved in the translocation of the 6K polypeptide 
and is cleaved by a signal peptidase Translocation o f 6K continues until the anchor 
sequence becomes inserted into the ER membrane (LiljestrOm and Garoff. 1991 a) 
The translocation o f the El polypeptide proceeds in a similar manner, with the C- 
terminus o f  6K serving as a signal sequence which is cleaved by a signal peptidase 
(Melan^on and Garoff. 1986. LiljestrOm and Garoff. 1991 a)
(vill) h  ate o f  the structural proteins
Within the ER the p62 precursor becomes associated as a heterodimer with El 
through its E3 domain (Wahlberg el a l , 1989, Lobigs el a l , 1990) This 
heterodimeric complex is transported via the Golgi network to the plasma 
membrane o f  the infected cdl (Green el a l , 1981. dc Curtis and Simons. 1988) 
The 6K protein also associates with the p62EI complex in the ER and is 
transported to the plasma membrane However, the precise role of 6K in virion 
maturation is unclear Deletion o f  6K from the SFV genome does not prevent 
transport o f  the p62EI complex to the plasma membrane but does result in a 
significant reduction of virus release (LiljestrOm el a l , 1991, Lusa el a l , 1991)
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Before the p62E 1 heterodimer reaches the plasma membrane, the p62 component 
is proteolytically cleaved to yield the E2 and E3 proteins that are present in the 
mature virion (de Curtis and Simons, 1988, Wahlberg el al., 1989) In mosquito 
cells, this cleavage has been shown to occur before entry into the ER However, 
the significance o f  this is not known at present (Naim and Koblet, 1990) Salminen 
el a t (1992) showed that a mutation in the p62 cleavage site prevented maturation 
o f the protein This did not affect virus release but virions were non-infectious 
They concluded that p62 cleavage is required for virus uptake into cells and for 
promoting membrane fusion in the endosomes The El moiety is also modified 
after transport through the Golgi network to a pH-sensitive form (Kielian el a l ,
1990) This mature form o f  El permits membrane fusion following entry o f the 
virus into acidic lysosomes (see section Ig-ii)
(ix) Assembly and release
Assembly o f virion particles requires the association o f genomic RNA with capsid 
protein and subsequent interaction o f the nucleocapsid with the spike glycoproteins 
embedded in the plasma membrane o f the infected cell The 42S RNA but not the 
26S RNA is encapsidated. suggesting that a specific interaction occurs between the 
5' two-thirds o f the genome and the capsid protein (Ulmanen el a l , 1976) 
However, the precise nature of this interaction has not been determined Studies 
with Sindbis virus showed that the capsid protein can interact with different RNAs 
to form stable nucleocapsid structures, suggesting that a specific packaging signal 
is not necessarily required for encapsidation in the infected cell (Wengler el a l , 
1982, Wengler, 1987) However. Weiss el al (1989) identified a 500-nucleotide 
domain within the nsPI gene that bound efficiently to capsid protein In vitro In
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addition, deletion o f this domain from a defective interfering genome prevented its 
encapsidation in the infected cell, suggesting that a packaging signal is needed for 
nucleocapsid formation To date, no such signal has been identified for SFV
SFV and other alpha viruses mature by budding at the cell surface (Achcson and 
Tamm, 1967, F.rlandson el a/.. 1967) In this process, the nucleocapsid is 
surrounded by a lipid bilayer envelope containing the viral spike proteins Recent 
evidence suggests that budding is driven by a specific interaction of the membrane- 
bound spike proteins with the nucleocapsid (see section Id. Suomalainen el a l . 
1992) Zhao and Garoflf (1992) showed that membrane-bound spike proteins 
degrade rapidly in the absence of nucleocapsid. suggesting an efficient mechanism 
exists to capture nucleocapsids into budding complexes However, the nature o f 
this mechanism has yet to  be determined
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2. DEFECTIVE INTERFERING VIRUSES
(a) Overview
Defective interfering (Dl) viruses have been described for all viruses studied It is 
beyond the scope o f this thesis to describe them all and the remainder of this 
introduction will focus mainly on the Dl panicles o f alpha viruses, with reference to 
other viruses where appropriate A number o f  reviews are available on aspects o f 
Dl viruses that are not considered here (Lazzarini el a l . 1981, Perrault. 1981, 
Holland. 1985, 1990. Barrett and Dimmock. 1986, Nayak el a l . 1989, Dimmock. 
1991. Roux el a l . 1991)
(i) Definition
Von Magnus (1954) first described the generation o f non-infectious or 'incomplete' 
virus panicles by serial passage o f high multiplicities o f  influenza virus in fenilised 
hens eggs Following these first observations, evidence accumulated in a number of 
animal and tissue culture systems for a distinct type o f non-infectious virus panicle 
that could interfere with the intracellular replication o f homologous virus Based on 
this evidence. Huang and Baltimore (1970) defined 'defective interfering' or 'Dl' 
panicles as responsible for the interference phenomenon They also described the 
non-defective homologous virions as 'standard virus', these are the terms that will 
be used predominantly in this thesis
It should be noted that the term 'defective' can apply to  any virus that lacks some 
function essential to autonomous replication and a defective vims does not
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necessarily have the capacity to interfere with standard virus propagation In 
addition, 'interference' with standard virus propagation is not a property exclusive 
to Dl viruses For example, satellite RNAs o f plant viruses are capable of 
modulating disease but share little sequence homology with the standard virus 
genome and thus differ from DI genomes (Francki, 1985)
The distinguishing properties o f  Dl panicles are summarised below (adapted from 
Barrett and Dimmock, 1986):-
♦ Incapable o f autonomous replication, i e are defective
♦ Reduce the yield o f standard virus following coinfection, i e are interfering •
♦ Possess a deleted form o f  the standard virus genome
♦ Require a functional nucleic acid for interference
♦ Are antigenically identical to  standard virus
♦ Are enhanced after coinfection with standard virus
♦ This depends on the ratio o f standard to Dl virus used in coinfection with excess 
standard virus there is no reduction in standard virus titres
0 0  Significance o f  1)1 particles
Most animal viruses have been shown to have associated Dl viruses In addition. 
Dl viruses have been described for plant viruses (Li et a t , 1989) The ubiquity of 
Dl viruses suggests they have a role in natural infection and confer some 
evolutionary advantage to the standard virus Huang and Baltimore (1970) first 
suggested that Dl virus may be important to persistence o f viral diseases but the
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difficulty in isolating Dl virus from naturally occurring infections has impeded the 
resolution o f this hypothesis
Whatever the natural role o f Dl viruses, their ability to interfere with standard virus 
propagation suggests a use as antiviral agents This concept is supported by the 
fact that Dl viruses are ubiquitous, non-infectious and possess the same structural 
proteins and therefore have the same cellular tropisms and immunology as standard 
virus The potential of Dl viruses as antiviral agents has not yet been fully realised, 
but as will be described below, a number o f investigations have shown that Dl 
viruses can modulate the progress o f viral disease in experimental infections
Dl viruses have also been used extensively to study the molecular biology o f 
viruses Dl virus genomes are generally a small fraction of the standard genome 
size and their regulatory elements reside in a relatively short length o f  nucleic acid 
This has facilitated the identification o f viral regulatory elements in a number o f 
systems, including Sindbis virus and mouse hepatitis virus (see section 2c).
(b ) D l p a r t ic le  s tru c tu re
(!) Structure
Most Dl genomes are unable to  encode structural proteins and are therefore 
dependent on the standard genome for the provision o f these Dl particles are 
therefore considered as containing the same structural proteins as standard virus 
and bang antigemcally indistinguishable from standard virus It is conceivable for a
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Dl genome to encode truncated structural proteins that are incorporated into the 
nucleocapsid. but there is no evidence for this
The buoyant density o f Dl alphavirus particles on a caesium chloride gradient is 
generally greater than standard virions (Shenk and Stollar, 1973; Bruton and 
Kennedy, 1976). It was suspected that this was a consequence o f virions packaging 
multiple copies o f  Dl genomes or the Dl SFV particles packaged single copies but 
had more compact nucleocapsids The latter conclusion is supported by evidence 
that Dl SFV has single-hit u v -inactivation kinetics (Barrett e la l , 1981)
Electron microscopic studies have shown that particles of Dl alphavirus are on 
average smaller than those o f standard virus Following serial passage o f Sindbis 
virus in BHK cells, Johnston el a /  (1975) described the appearance o f particles 
that were 37 nm in diameter compared with 50 nm for standard virions Although 
the appearance o f these smaller particles correlated with a decrease in virus titre, 
the larger particles were also suspected to have interfering activity Later studies by 
Barrett el a l (1984b) showed that Dl particles of SFV had an average diameter of 
47 nm compared with 56 nm for standard virus particles
The only Dl particles that differ obviously in size from standard particles are those 
o f  the rhabdovirus. vesicular stomatitis virus (VSV) Electron microscopic studies 
showed Dl VSV as shorter rods than standard virus particles (Hackett, 1964) and 
later studies showed that the Dl particle size was determined by the size o f the 
packaged genome (Holland el ai., 1976)
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00 Separation o f 1)1 particles from infectious virus
Because o f  the similarity in size o f  the particles o f Dl alphavirus and standard virus, 
separation o f  the two has proved difficult Bruton and Kennedy (1976) could 
separate Dl SFV from standard virus on a caesium chloride gradient, but biological 
activity was destroyed Attempts to separate Dl SFV from standard virus whilst 
retaining biological activity using metrizamide or sucrose density gradient 
centrifugation were unsuccessful (KaariAinen el a i, 1981, Barrett el a!., 1984a) 
Fortunately the u v -target size o f Dl SFV genomes is smaller than that o f standard 
virus enabling infectivity to be removed from Dl virus preparations without 
destroying the biological activity o f the Dl genome (Dimmock and Kennedy. 
1978) The Dl particles o f  VSV, being smaller than those o f standard virus, can be 
separated by sucrose density gradient centrifugation (Huang et al , 1966)
Recently a novel system has been developed to enable Dl VSV to be propagated in 
the absence o f  helper standard virus cDNA clones o f each o f the five VSV genes 
and a Dl VSV genome were transfected simultaneously into BHK-21 cells 
harbouring a vaccinia recombinant that expressed T7 RNA polymerase 
cytoplasmically Transcription o f these clones was mediated within the cells 
through T7 promoters incorporated at the V termini The 3* termini o f  the 
transcripts were generated through autolytic cleavage by a ribozyme that was 
incorporated downstream o f the viral cDNA The Dl RNA transcripts that were 
generated were replicated and encapsidated by proteins expressed from the cloned 
virus genes and mature Dl particles were obtained in the culture medium (Pattnaik 
and Wertz. 1990. 1991. Pattnaik el a i . 1992) With the genomes o f SFV now 
cloned, it may be possible to develop a similar system for the production o f helper-
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free D1 SFV preparations and avoid the need for u.v -irradiation to remove 
infectivity
(c) Dl virus genomes
(i) Semhki horesl virus
In early studies. DI SFV generated after nine serial undiluted passages o f SFV in 
BHK-21 cells was shown to contain two positive-strand RNA species that were 
approximately 20% (about 2 kb) o f  the standard RNA size (Bruton and Kennedy. 
1976) Further work by Bruton e i a l (1976) showed that these RNAs shared 
extensive sequence homology and were not derived from the nucleotide sequences 
o f the 26S RNA o f SFV In addition, both RNAs were capped and polyadenylated 
but were not able to serve as mRN As Subsequent oligonucleotide mapping studies 
by Kennedy (1976) showed that both RNAs were derived from the 5* two-thirds 
and the terminal sequences o f the 42S RNA
In similar work. Pettersaon (1981) serially passaged SFV in BHK-21 cells and after 
11 passages isolated Dl RNA species o f about 2 kb from the cytoplasm o f infected 
cells This RNA was polyadenylated and oligonucleotide mapping showed that the 
5'-terminal cap structures were heterogeneous and different from the 42S RNA 
Subsequently, this Dl RNA and one isolated from virus particles derived from the 
fourth passage were found to contain repeated sequences (Ktttrittinen el a l , 1981) 
A more detailed analysis o f the Dl RNAs isolated by Pettersson was made through 
molecular cloning and sequencing o f  cDNA (Soderlund el a l . 1981. I^htovaara el 
a l , 1981, 1982) Figure I 4 shows the derivation of two o f these RNAs (Dl 301
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(b)
Figure 1.4 Comparison of DI 301 and Dl 309 with SFV RNA
SFV RNA and the Dl SFV RNAs (I ehtovaara el a/.. 1981, 1982) are represented 
as linear sequence blocks Dl 301 and Dl 309 have been simplified to show only 
extensive regions o f homology with SFV RNA, which are labelled a-c in (a) and d- 
g in (b) Because some regions o f  homology overlap, only the nucleotides at the 3' 
termini of each region of the Dl RNAs are numbered The dashed lines represent 
the nucleotide sequences at the 5’ termini o f  the Dl RNAs that have not been 
determined In (a) the two regions labelled b* are deleted forms of region b. 
lacking the 6« nucleotides which correspond to nucleotides 2858 to 2917 o f the 
SFV genome
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and Dl 309) from SFV RNA, and has been updated to include the regions o f SFV 
RNA which had not been sequenced at the time The nucleotide sequences o f Dl 
301 and Dl 309 were determined from cDNA clones, both o f which lacked the 5’ 
termini (200-300 nucleotides) o f the respective RNAs The nucleotide sequence 
just within the 5' terminus o f Dl 309 was determined from direct sequencing of 
primer-extended cDNA Dl 301 contains three copies of regions derived from the 
5' terminal sequences and the nsP2 gene o f SFV and a region derived from the 3' 
terminus o f SFV RNA Dl 309 has a more complex structure than Dl 301, 
although it was derived from similar regions o f SFV RNA. In addition to the 
regions derived from the terminal sequences and the nsP2 gene o f  SFV there is a 
short sequence o f 59 nucleotides derived from the upstream sequences o f the SFV 
3' untranslated region that is represented twice in Dl 309 (labelled T ' in Figure 
I 4b) Analysis of the termini o f a number of other Dl RNAs showed that all 
retained regions derived from the 3' terminus o f SFV RNA
By definition Dl genomes must possess the information required for replication and 
for packaging into virions and the information for interference and amplification 
To investigate the functional regions o f Dl 301, Jalenko and Soderlund (1985) 
cloned the internal regions comprising the repeating units into an SV40 vector 
This clone (svDI 301) lacked about 200 nucleotides from the 5' terminus and 70 
nucleotides from the 3' terminus o f Dl 301 svDI 301 RNA was expressed by 
infection o f  monkey kidney cells Following superinfection with SFV the RNA was 
not replicated but the packaging efficiency of SFV RNA was reduced by about 
50% They concluded that the repeating units o f  Dl 301, which derived from the 
5'-terminal sequences and the nsP2 gene of SFV (regions 'a' and V  in Figure I 4a),
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were involved in encapsulation and the terminal sequences o f Dl 301 were required 
for replication
00  SinJbis virus
Dl RNAs o f  Sindbis virus are similar in structure to those o f SFV Early studies 
showed that Dl RNAs of 20-50% o f the standard genome size were generated by 
high-muhiplicity passaging o f  Sindbis virus in BHK or CEF cells (Johnston el a i , 
1975. Guild and Stollar, 1975, 1977, Guild el o f , 1977, Dohner el a l , 1979) 
These RNAs were positive-stranded, polyadenylated and hybridisation studies 
showed they were composed o f  Sindbis virus RN A
Dl RNAs o f  Sindbis virus were later characterised by molecular cloning and 
sequencing (Monroe el a t , 1982. Monroe and Schlesinger. 1983. 1984) Figure 
I 5a shows the derivation o f  one such Dl RNA (SSOI) from the standard genome 
Like the structure o f the Dl SFV genomes described by I^htovaara el a t (1982). 
this Dl RNA contains sequences derived mainly from the 5' terminus o f the 
standard genome which are repeated and rearranged One feature of this Dl RNA 
and of other Dl RNAs of Sindbis virus produced by serial passaging in CEF cells is 
a sequence covalently linked to  the 5' terminus which is homologous to nucleotides 
10-70 o f  s rat tRNA“*’ sequence, differing by only 2 nucleotides (Figure I 5b) This 
sequence was not associated with Dl RNAs produced after passaging in BHK cells 
(Monroe and Schlesinger. 1984) The significance o f  the colinear tRNA“*’ 
sequence is not known, but Tsiang el a i (1985) showed that it did not confer a 
competitive advantage over Dl RNAs without the sequence
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Figure 1.5 Structure o f Dl Sindbis virus RNA
(a ) is reproduced from Monroe and Schlesinger (1984) and shows the derivation of 
the Dl RNA o f  Sindbis virus (SSOI) from the standard virus RNA SS01 RNA is 
represented as linear sequence blocks with the hatched area at the 5' terminus 
denoting cellular tRNA“’’
(b )  is reproduced from Monroe and Schlesinger (1983) and shows the structure of 
the tRNA“* at the V terminus o f two Dl RNAs o f  Sindbis virus • denotes the two 
nucleotide differences with the rat iRNA“* sequence
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In an attempt to define regulatory elements o f  Sindbis virus RNA. Levis el al 
(1986) deleted various regions of a clone of Dl Sindbis virus and studied the 
effects this had on replication and packaging They found that only 162 nucleotides 
derived from the 5' terminus and 19 nucleotides from the 3' terminus o f the Sindbis 
virus genome were required for replication and packaging These results were 
supported by Levis el a l (1987) who replaced the internal sequences o f a Dl 
genome of Sindbis virus with the gene for chloramphenicol acetyl transferase 
(CAT) The termini of the Dl genome supported the expression o f  CAT in infected 
cells and the recombinant genome was replicated and packaged by helper Sindbis 
virus Further analyses by Tsiang e l a l  (1988) showed that deletion of II 
nucleotides from the 5' terminus of a clone of Dl Sindbis virus (corresponding to 
nucleotides 16-26 o f Sindbis virus RNA) prevented transcripts from being 
propagated as virions It was suspected that the stem-loop structure in this region, 
thought to be required for replication (Ou el a l , 1983), had been disrupted
Weiss el al (1989) used capsid protein-binding studies to identify a region of 
Sindbis virus RNA from nucleotides 746-1226 (within the nsPI gene) that was 
required for encapsidation A Dl RNA that lacked this region was not detected on 
passaging, suggesting it was not packaged into virions These results appear to 
conflict with the data provided by Levis el a l (1986) who suggested that only the 
terminal sequences of the Sindbis virus genome were required for propagation of 
Dl RNA as virions The work of Weiss el al (1989) is probably more reliable 
because the assay used by Levis el a! (1986) for analysing the effects of deletion 
did not distinguish between replication and propagation as virions Furthermore, a 
clone containing only the terminal regions of the Sindbis virus genome was not
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amplified on passaging, although it was suspected that this was too small to be 
packaged efficiently into virions
Oil) <)lher posilive-stranJ HNA viruses
Apart from SFV and Sindbis virus, the only other positive-strand RNA viruses for 
which Dl genomes have been characterised by sequencing are poliovirus and 
mouse hepatitis virus (MHV)
Early hybridisation studies on Dl RNAs o f poliovirus showed that only about 15% 
o f  the standard genome was deleted (Cole and Baltimore. 1973) In later studies. 
Dl RNAs derived from the Sabin and Mohoney strains o f poliovirus type I were 
shown to lack the genome region encoding the capsid protein (Nomoto el a t , 
1979. Kajigaya el a / .  1985) Unlike the Dl genomes of other positive-strand 
viruses, these retained the reading frame used by the standard virus genome (Kuge 
el a l . 1986. Omata el a t . 1986)
Recently, the Dl genomes o f  MHV (a corona virus) have been investigated Makino 
el a l (1985) isolated a number o f different Dl MHV particles produced by high 
multiplicity passaging o f  MHV in tissue culture One type o f Dl RNA was almost 
genomic size and contained small multiple deletions throughout most o f  the 
standard genome The regions o f the standard genome that encoded the 
polymerase gene, located at the 5' terminus, and a structural protein, located at the 
.V terminus, were retained This Dl RNA could replicate in the absence o f  helper 
virus and was weakly interfering (Makino el a t . 1988) A second type o f Dl RNA 
o f  2 3 kb was also isolated that retained the termini o f the standard genome and a
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region derived from the polymerase gene (gene I) A similar DI RNA o f 5.5 kb 
(Dl-a) was isolated by van der Most r ia l  ( 1991 ) Unlike the 1)1 genomes o f  SFV 
described by Lehtovaara rt al (1982). these did not possess sequence repeats or 
rearrangements In addition, de (»root rl a l (1992) showed that the three regions 
o f  Dl-a which were derived from the termini and polymerase gene of the MHV 
genome were (used in-frame Frameshift mutations reduced the accumulation of 
the Dl RNA. which was ultimately competed out by mutant Dl RNA with a 
restored reading frame
Dl RNAs o f MHV, like those o f Sindbis virus, have been used to identity 
regulatory elements within the standard genome These studies have shown that the 
3* terminus o f  the polymerase gene is required for encapsidation and the terminal 
regions of the standard virus genome for replication (Makino rl a l 1990. van der 
Most. 1991).
(tv) NrftuUvt-strand RNA viruses
O f the Dl genomes o f negative-strand RNA viruses, those o f  VSV and influcn/a 
virus are the best studied, and are considered here because o f  their importance in 
vivo. Little is known about the Dl genome structure o f other negative-strand 
viruses
The Dl genomes o f VSV are typically 10 to 60% o f  the standard genome length 
(reviewed in Perrault. I9 g |)  A mixture o f  positive and negative sense Dl RNAs 
may be packaged in the same particles, although the negative strands tend to be in 
excess in a given population (Roy el a l . 1973. Perrault and I-eavitt. 1977)
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Although it it difficult to generalise on the genome structure o f Dl viruses, 
sequencing studies of Dl VSV have revealed two common types Most Dl VSV 
genomes have short-stem or panhandle structure, in which the 5’ terminus o f the 
standard genome it retained and the 3* terminus it replaced by sequences 
complementary to the 5' terminus The stem o f the panhandle structure can range 
from 45 to 200 nucleotides in length (Schubert el a l , 1979, Kolakofsky. 1982) In 
the second common type o f  Dl VSV genome the 3' half of the genome is entirely 
complementary to the 5* half and hairpin or 'snapback' structures are formed 
(lazzarini el a l , 1975, Perrault. 1976) Other rare Dl VSV genomes have also 
been described which comprise single or multiple internal deletions and retain the 
termini o f the standard genome (Kolakofsky. 1982, Kang el a l . 1985. Rud el a ! , 
1986)
About 5 Dl genomes o f  influenza virus have now been analysed by sequencing and 
about 30 by hybridisation and oligonucleotide mapping studies (reviewed in Nayak 
el a t , 1989) Unlike the Dl genomes of VSV, those o f influenza virus are derived 
solely from the negative-stranded RNA In addition, the termini o f the standard 
genome are retained and no snapback-type molecules have been found Most Dl 
genomes o f influenza virus are derived from the polymerase genes by single or 
multiple deletion events In addition, some Dl genomes have internal sequences 
derived in part through interscgmental genome rearrangements (lazzanni el a i ,  
1981. Nayak el a l . 1989)
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(d) ( irn rn tio n  and amplification of DI RNA
0) ( rtneraHtm and evoJulion o f  1)1 RNA
Generation is defined as the initial event by which a Dl genome is created The 
precise mechanisms which produce Dl genomes from the standard genome have 
not been determined but they presumably involve replication errors by the viral 
polymerase The genome structures o f Dl virus permit speculation on such 
mechanisms, but this may be misleading because only those genomes that are 
amplified can be investigated Studies of Dl alphavtrus during serial passage have 
shown that the genome size decreases with passage number (Johnston el a l , 197$, 
Guild el a/., 1977, Stark and Kennedy. 1978) This was thought to be a 
consequence of sequential deletion steps involving template jumping by the viral 
replicase, with smaller Dl genomes being generated from larger ones It was 
suspected that smaller Dl genomes were replicated more frequently, thus 
competing out the larger Dl genomes and becoming the predominant Dl RNA 
species in the population (Kennedy. 1976, Stark and Kennedy. 1978) However. 
Kaariftinen et a l (1981) showed that the average size o f DI SFV RNAs could 
increase on passage, presumably through duplication o f parts o f  the genome In 
addition, the sequence repeats and rearrangements o f the Dl SFV genomes 
described by l^htovaara (1981. 1982) suggest a more complex mechanism for Dl 
genome generation than a series o f deletion steps
Clearly the replicase complex o f  RNA viruses has a limited fidelity for replicating 
the standard genome There is no evidence of preferred breakage points in the 
standard genome but it has been suggested that the replicase complex may be able
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to copy non-contiguous regions o f the template genomes which have become 
juxtaposed by RNA folding (reviewed in Perrault. 1981 and Holland. 1985) How 
repeated regions are incorporated into Dl genomes is not known but it is possible 
that they derive from recombinational events between the Dl genome and the 
standard or other Dl genomes
Makino and Lai (1989) suggested that the leader sequence o f the MHV genome is 
involved in replication o f Dl RNA They showed that following transfection o f Dl 
RNA into MHV-infected cells, the leader sequence o f  the Dl RNA switched to the 
viral RNA after a single round o f replication They proposed that the generation of 
Dl RNA may be triggered by the binding o f free leader sequences derived from 
standard viral RNA to different sites within the template
00 Ampiificalum o f  1)1 RNA
Once a Dl genome has been generated i1 can only become established in a virus 
population if it confers a selective advantage that enables it to be amplified relative 
to other viral RNAs Dl genomes are smaller than the standard virus genome and 
are presumably replicated more frequently in the infected cell as a consequence 
However, this property alone does not explain the observations o f KaanAincn el al 
(1981) that smaller Dl genomes can be competed out by larger ones It is possible 
that amplification is achieved through the possession of multiple recognition sites 
for viral regulatory proteins, as described by Lehtovaara el a t (1981, 1982) for Dl 
SFV. but there is no evidence that such genomes are selected in preference to ones 
with only single recognition sites It is likely that amplification is a multi-factorial 
process and the precise mechanisms involved remain to be determined
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OH) huffed of host cell on 1)1 RNA ¡generalton and ampli fication
Stark and Kennedy (1978) showed that Dl SFV is generated and amplified at 
different rates in different cell types Dl panicles were produced after only a few 
passages o f standard virus in mouse 3T3, rat NRK and CEF cells, whereas in 
HeLa-H cells. Dl SFV was not detected after 200 passages However, Dl virus 
could be propagated in all cell types In addition. Steacie and Eaton (1984) showed 
that some preparations o f Dl SFV generated in mosquito cells were not propagated 
in CEF cells Clearly the generation, amplification and propagation o f  Dl viruses 
depends in part on host cell components In a number o f HeLa cell types Dl SFV 
is not propagated It has been suggested that in this situation, replication o f viral 
RNA involves particular sequences that are recognised by the viral-host replicase 
complex and are absent from the Dl genome (Dimmock. 1991) This implies that 
Dl virus propagation in different cell lines is also dependent in part on the sequence 
o f the Dl genome
(e) Interference in vitro
By definition, interference results in a reduction in the yield o f  standard virus 
Interference is an intracellular event that involves an interaction o f the Dl genome 
with the replication cycle o f the standard virus In addition, the degree of 
interference by a Dl virus is greatest against the homologous virus from which it 
was derived (Huang, 1973, Barrett and Dimmock. I984d)
Theoretically, interference can occur at any stage o f the infectious cycle and the 
wide variety o f  Dl genomes that have been isolated may be a reflection o f this In
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coinfected cultures, interference can be influenced by the host cell It is dependent 
on the ratio o f Dl to standard virus in the inoculum and with excess standard virus 
no interference takes place (Perrault and Holland. 1972, Barrett el a l , 1981, 
Debnath el a! , 1991) In addition. Dl virus preparations generated by serial 
undiluted passage are heterogeneous (KiAritinen el a l ,  1981. Barrett el a / .  
1984a) For these reasons the resolution o f the precise mechanisms involved in 
interference has proved difficult However, a number o f mechanisms have been 
proposed, some of which are described bdow
(!) A ¡phuvint.ses
A number of studies have shown that coinfection o f cell cultures with Dl particles 
and standard virus results in a reduction in the levels o f 42S and 26S viral RNAs 
(Weiss and Schlesmger. 1973, Johnston el al., 1975, Bruton el a l , 1976, Guild el 
a l , 1977) The synthesis o f both positive and negative-strand RNA is inhibited and 
the total amounts of viral RNA reduced (Guild and Stollar. 1975, Barrett el a l , 
1981) In addition, a reduction in the number of cytopathic vacuoles associated 
with the viral replication complex has been observed (Levin el a t ,  1973) 
Interference by Dl alphaviruses is therefore thought to occur at the level o f RNA 
synthesis Barrett and Dimmock (1985) showed that Dl SFV could inhibit virus- 
specified RNA and polypeptide synthesis and inhibit the shut-off o f host protein 
synthesis in coinfected cells The specific effects on cellular and viral polypeptide 
synthesis differed according to the preparation o f Dl virus that was used However. 
Jalenko and Soderlund (1985) showed that viral RNA synthesis was unaffected by 
a cloned preparation of Dl RNA (svDI 301 see section 2b-/) and interference
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occurred at the level o f encapsidation Clearly, different Dl genomes of 
alphaviruses can interfere through different mechanisms
Some DI alphavirus genomes can function as messenger RNAs in the infected cell, 
but there is no evidence for translation products being involved in interference 
(Weiss and Schlesinger. 1973, Guild and Stollar, 1975) In addition, some Dl 
genomes do not have open reading frames and therefore must interfere solely at the 
level o f  the RNA (l.ehtovaara el a ! , 1981, 1982. M onroe and Schlesinger. 1984)
More generally, interference occurs through the competition for a limiting amount 
o f  standard viral nonstructural and structural proteins The competitive ability o f a 
Dl genome may be enhanced by the possession o f  multiple recognition sites for 
regulatory proteins, which have been described for the Dl genomes o f SFV 
(l.ehtovaara el a / .  1981, 1982) and some DNA viruses (reviewed in Perrault, 
1981) However, there is no direct evidence that such repeated sequences can 
enhance levels o f interference
0 0  Negative-stranJ RNA viruses
A number of mechanisms have been proposed for interference by the different 
types o f  DI VSV genomes (see section 2b-/v, reviewed in Holland. 1985. 1990) In 
the short-stem genomes the .V-terminal sequences o f  the standard viral RNA that 
contain the transcriptase recognition site are replaced by the 5'-terminal sequences 
o f the standard RNA containing the replicase initiation site These genomes 
cannot therefore be transcribed into RNA and like the snap-back Dl genomes
possess repli case initiation sites in both RNA and RNA sequences The replicative 
advantage o f  these genomes is suspected to be attributable to these features
The Dl genomes o f  influenza virus are generally derived by internal deletion of the 
standard genome Some o f these genomes are translated in the infected cell and it 
has been suggested that interference may be mediated in part through translation 
products, although there is no direct evidence for this (Penn and Mahy, 1985. 
N a y a k e la /,  1989)
( 0  M o d u la t io n  o f  in fe c tio n  in vivo
(0  Overview
A number o f  studies have shown that Dl viruses can modulate infection in vivo 
after co-administration with standard virus The degree of modulation can range 
from prevention o f  a normally lethal infection (protection) to a delay in the onset of 
disease signs Modulation of infection in vivo by Dl virus has been observed for a 
number o f  virus systems, the most extensively studied of which are VSV, SFV and 
influenza virus In both the VSV and SFV systems. Dl virus interferes with virus 
multiplication in the brain In contrast, modulation o f infection by Dl influenza 
virus is mediated through cell-specific interactions with the immune system Dl 
influenza virus has no effect on virus multiplication in the lungs but interferes with 
standard virus in lymphocytes to prevent a lethal immune pathology (Dimmock el 
a l . 1986. M organ and Dimmock. 1992) It is therefore not pertinent to discuss the 
influenza virus system in detail here For reviews on these and other Dl virus
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systems the reader should consult Barrett and Dimmock (1986). Dimmock (1991) 
and Roux el a i (1991).
fit) VSV
Doyle and Holland (1973) first demonstrated that a normally lethal infection by 
intracerebral inoculation o f  adult mice with VSV could be prevented by 
administration o f Dl VSV At least I010 Dl particles were required for protection 
and this was only effective against a small dose o f  standard virus Further studies 
showed that protection was specific for homologous virus and was not a 
consequence o f interferon induction (Holland and Doyle. 1973) While these 
studies failed to detect Dl virus in the brains of protected adult mice. Holland and 
Villarreal (1975) indirectly demonstrated the presence o f Dl VSV in the brains of 
newborn mice by using an m  vitro amplification step In later studies. Cave el al 
(1984, 1985) used northern blot analysis to detect Dl VSV RNA in the brains of 
adult mice which had been inoculated by the intranasal route For this, a nick- 
translated clone o f a Dl VSV genome was used as probe These studies also 
showed that the ratio o f  Dl to standard virus was an important determinant of 
protection Protection was achieved after intranasal coinoculation of a I 100 ratio 
o f Dl standard virus while a I I ratio did not protect
The possibility that protection by Dl VSV was immune-mediated was investigated 
by Crick and Brown (1977) They showed that acetyl ethyleneimine-inactivated Dl 
VSV could protect mice against a lethal dose o f  VSV. suggesting that host 
responses were involved in protection In addition, protection was observed against 
heterologous strains o f  VSV. rabies and a neurotropic strain of foot-and-mouth
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disease However. Jones and Holland (1980) and Fultx el a t (1982) showed that 
u v -irradiated Dl VSV did not protect against a lethal dose o f standard virus and 
protection therefore required a biologically active Dl genome These conflicting 
results may have been due in part to differences in the Dl preparations and mouse 
strains that were used
(in) Semhki Forest virus
Dimmock and Kennedy (1978) first demonstrated that Dl SFV generated in tissue 
culture could protect adult mice against a normally lethal dose of SFV inoculated 
by the intranasal route The Dl SFV preparation used typically conferred ->50% 
protection when administered simultaneously with standard virus and reduced brain 
titres by lO’-fold In mice which did not survive, the infection followed its normal 
course The greatest degree o f protection against 10 LDM (6,000 p f  u ) was 
observed with a ratio of at least 67 'p .f u -equivalents' Dl SFV to I p f  u standard 
virus Protection was not mediated through interferon induction or stimulation of 
the host immune system and was suspected to be a consequence o f intracellular 
interference by the Dl genome with virus multiplication Subsequent studies by 
Crouch e i a / ( 1982) and Barrett el aJ { 1984c) demonstrated the complete absence 
o f  histopathological lesions in the brain tissue of protected mice In addition, there 
was no evidence o f immune cell infiltration, further suggesting that protection by 
Dl SFV was not immune-mediated
Barrett and Dimmock (1984c) described a number o f  factors important to the 
modulation o f  infection m  vivo by Dl SFV Protection was influenced by the strain 
o f mouse used, and was not observed in C,H-He/Mg mice, although this may have
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been a consequence o f needing a higher titre o f  SFV for a lethal dose The quantity 
o f Dl virus and SFV in the inoculum were also crucial to  the protecting effect 
Doubling the concentration of SFV or halving the concentration o f  Dl virus 
resulted in a significant reduction in protection
In subsequent studies by Barrett and associates, a comparison was drawn between 
two mouse-protecting Dl SFV preparations (pi3a and p4). which had been 
generated by serial undiluted passage o f  SFV in BHK-21 cells (pi3a was derived 
from the preparation used by Dimmock and Kennedy. 1978) In all these 
experiments levels o f  SFV antigen were standardised by haemagglutination litres 
and u v -irradiated SFV was used to control for possible immunological effects and 
blockage o f SFV receptors by Dl virus Following intranasal inoculation into adult 
mice, both p i3a  and p4 conferred about 60% protection against 10 LDW SFV 
However, mice protected with pi3a were resistant to challenge with 100 LD*, 
SFV at 2 1 days after the initial inoculation and mice protected with p4 were totally 
susceptible (Barrett and Dimmock, 1984b. Barrett el a / .  1984c) Neutralising 
antibodies in serum were detected in 75% o f mice treated with pi 3a but only 30% 
o f  mice treated with p4 However, there was no evidence that the levels of 
circulating antibody were sufficient for protection Following coinoculation with 
encephalomyocarditis virus (EMC), which is sensitive to interferon, no modulation 
o f  EMC infection was observed, suggesting that protection by Dl SFV was not 
mediated through non-adaptive immune responses (Barrett and Dimmock. 1984b)
A comparison o f the growth curves o f  SFV in mice treated with SFV. pi 3a or p4 
was investigated by Barrett el al (1984c) Following intrananal inoculation of adult 
mice with SFV. virus was detected in the brain and olfactory lobes I day post­
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infection (p i ) and titres rose until death (4-5 days p i ), reaching titres o f I0 10 
p.f.u. per brain In the spleen and serum. SFV was detected from day 2 and titres 
reached a peak o f  IO*p fu  per mouse Following intranasal inoculation with either 
pi3a or p4, SFV titres were reduced by >99% in a similar proportion o f mice as 
expected from the lethality experiments In p4-treated mice, the growth pattern o f 
SFV in brain, olfactory lobes and spleen was similar to that o f  SFV-infected mice, 
but titres declined to low levels (10-100 p fu /m ouse) from day 3 In pl3a-treated 
mice. SFV titres were reduced compared with SFV-treated mice at all time points 
In some mice the levels o f  infedivity in the spleen were similar to that o f untreated 
mice but were reduced in other tissues Notably. Dl virus was not detected in any 
tissue of mice treated with either pi 3a or p4 It it possible that the assay used (an 
RNA synthesis inhibition assay), which detected >I0575 Dl panicles per ml. was 
not sufficiently sensitive
Modulation o f infection by pi3a and p4 was also investigated after intraperitoneal 
inoculation (Barrett and Dimmock, 1984a) Both Dl preparations conferred about 
30% protection but a delay in death (36 hr) was observed after treatment with 
p i 3a
In summary, the work o f Barrett and associates showed that the modulation o f  
infection in vivo by two different preparations of Dl SFV differed in a number o f  
respects, including susceptibility to challenge, tissue distribution o f  SFV and delay 
in death after intraperitoncal inoculation These differences were not due to 
differences in SFV antigen levels or the degree of protection that was conferred 
Furthermore. Barrett and Dimmock (1984b) showed that mouse-protecting ability 
o f Dl SFV preparations was not correlated with passage history Sister stocks o f
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pl .1i and p4 conferred similar levels o f  protection, while daughter stocks differed 
in this respect, reflecting the heterogeneity of the preparations It was concluded 
that the difference in interference properties o f pi3a and p4 was attributable to 
differences in their RN A sequences (Barrett el a i , 1984c)
Finally, the long-term effects of mouse-protection by Dl SFV were investigated 
Atkinson el a! (1986) showed that SFV could persist in the brains o f mice treated 
with p4 or pi3a Virulent SFV was detected in 12*/* of p4-treated mice and 2 4% 
o f pi 3a-treated mice 6 5 months after inoculation In addition. Barrett el a! (1986) 
showed that in protected mice with no detectable infectious virus there were 
changes in the normal levels of certain neurotransmitters The significance o f these 
observations is not clear, but there may be implications for the aetiology o f  certain 
neurological disorders suspected to be associated with viruses
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MATERIALS
fa) Source o f  chemicals
All radioisotopes were obtained from Amer sham International p k  . Aylesbury. 
Bucks All chemicals were o f Analar grade, and were obtained from Sigma London 
Chemical Co Ltd . Poole. Dorset, or BDH Chemicals L td , Poole. Dorset, unless 
otherwise stated Nucleotide triphosphates (NTPa) and deoxynucleotide 
triphosphates (dNTPs) were obtained aa lOOmM aqueous solutions from 
Pharmacia Biosystems L td , Milton Keynes. U K
Tissue culture media and calf serum were purchased from Gibco BRI. Europe Ltd . 
Paisley. Scotland Components o f bacterial media were obtained from Difco 
Laboratories Ltd , E Molesey, Surrey
(h) Sourie o f  enzymes
All enzymes were obtained from Gibco unless otherwise stated Specific buffers for 
restriction enzymes. T4 DNA ligase and T3/T7 RNA polymerases were supplied 
with the enzymes laq  DNA polymerase (AmpliTaq) was obtained from Perkin 
Elmer Cetus, Beaconstield. Bucks
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METHODS
I. TISSUE CULTURE
(a) ( 'allure o f  cells
BHK-21 clone I3-3P was obtained from the European Collection of Animal Cell 
Cultures (CAMR, Porton Down, Wiltshire, U K ) BHK-21 cells were grown as 
monolayers in Glasgow's modification of Eagle's medium (GMEM, Eagle. 1959) 
supplemented with tryptose-phosphate broth (GMEM-BHK) HeLa cells were 
cultured in GMEM supplemented with non-essential amino acids (GMEM-NEAA) 
Cultures of primary chick embryo fibroblasts (CEF) were prepared as described by 
Morser el a! (1973) and were grown in medium 199 For cell growth, media were 
supplemented with 5% (v/v) foetal calf serum (FCS) or new-born calf serum 
(NCS), 4mM glutamine. 100 Units/ml penicillin and 100 tig/ml streptomycin For 
more rapid growth. 10% serum was used All media and solutions used for cell 
culture were sterilised by membrane filtration through 0 2^m 500ml bottle filters 
(Costar UK Ltd . High Wycombe. Bucks )
Cells were incubated at 37«C in flat-bottomed plastic culture vessels (Nundon 
(Gibco)) in an atmosphere o f 5% CO, /  95% air
To prepare for sub-culturing, growth medium was removed by suction and cell 
monolayers were washed once with phosphate-buffered saline (PBS. pH 7 4) Cells 
were detached from the growth vessel with a 4 1 (v/v) mixture o f versene (0 02% 
w/v in PBS) and trypsin (0 25% w/v in Tris-saline pH 7 7) at room temperature
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('ells were pelleted by centrifugation at 200g for 5 min (4°C) and resuspended in 
I Oml growth medium by pipetting ('ells were counted using a Neubauer 
haemocytometer (Sigma) and seeded into fresh flasks
(h) Storage o f  cells
Monolayers were grown to confluency Following trypsinisation and 
centrifugation, cells were resuspended in culture medium containing 10% dimethyl 
sulphoxide (DMSO) and 15% FCS to a concentration o f 3 5 x 10* cells/ml 
Resuspended cells were aliquoted into freezing vials wrapped in cotton wool and 
cooled to  -20°C over 2 hr with shaking every half hour The cells were cooled to 
-70°C overnight and transferred to liquid nitrogen for storage
(c) Vims preparation
For transfection experiments and interference assays. SFV derived from the full- 
length clone pSP6-SFV4 was used (Uiljestrom et a l . 1991) This has similar 
pathogenic properties to the mouse-virulent LIO strain (Glasgow el a l % 1991) For 
all other experiments, a plaque-purified stock o f the virulent ts4 strain o f SFV was 
used (first described by Tan el a l . 1969) This was originally obtained from the 
John Curtin School of Medical Research. Australia National University. Canberra
SFV was propagated in BFIK-21 or Hel-a cell monolayers Cultures were 
inoculated with a multiplicity o f  infection ( m o i )  o f 01  plaque-fomung units 
(p f  u ) per cell, and incubated for 18 hr at 37°C in culture medium containing 2% 
NCS Tissue culture fluid was harvested and clarified by centrifugation at 2000g
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for 10 min <4“C) and Mored al -70"C Slocka o f SFV derived from the full-length 
done pSP6-SFV4 were generated bv traracription and transfection into BHK-21 
cells, as described by Lilicstrom er a/. (1941. see section 7c) The second passage 
alter transfection (designated vSFV4-p2/FIJ) was used in Dl SFV transfection 
experiments
(d) Infeclivity titration
SFV infectivity was determined by plaque assay Virus was serially diluted in 10- 
fold steps in culture medium containing 2% NCS lOOpl samples were added 
centrally to just-confluent monolayers of BHK-21 cells in 5cm dishes (Nunclon 
(Gibco, U K.)) and incubated at room temperature for 30 min Plates were 
overlayed with a I I mixture o f  1% noble agar 2x GMEM-NEAA containing 5% 
NCS, 0 08% DEAE (diethylammoethyl)-dextran. 200 U/ml penicillin and 200pg/ml 
streptomycin Plates were incubated for 2 days at 37°C and live cells stained with 
4 ml neutral red (0 01% (w/v) in PBS) for 2 hr at 37°C
(e) Infectious centre assay
SFV-infected BHK-21 cells were serially diluted in 10-fold steps in GMEM-BHK 
containing 2% NCS lOOpl samples were added centrally to just-confluent 
monolayers o f BHK-21 cells in 5cm dishes and adsorbed for 30 min at room 
temperature Plates were overlayed. incubated and stained as for plaque assays (see 
section Id)
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(f) 1)1 virus preparation
Honed Dl SFV was obtained by transfecting RNA transcribed from cloned Dl 
DNA into SFV-infected BHK-21 monolayers (see section 7). This was 
subsequently passaged at a constant m o i o f 60 at 37° C After 16 hr, sodium 
bicarbonate (5% (w/v) aqueous solution) was added drop-wise until the medium 
became pink in colour Medium was harvested after 24 hr and clarified by 
centrifugation at 2000g for 10 min (4°C).
All other Dl SFV preparations were generated previously by serial passage o f the 
ts* strain o f  SFV in BHK-21 cells at a constant m.o i o f  50
(f0 Ultraviolet (u.v.) irradiation
Infectivity was removed from Dl preparations by the method described by 
Dimmock and Kennedy (1978) I ml samples were placed in 5 cm dishes with 
occasional agitation 10cm below a u.v lamp (254 ran (idman Sciences. 
Northampton, U K ). One log,0 p.f.u. was inactivated in 8s, as determined by 
plaque assay o f u.v -irradiated SFV. To determine loss o f  infectivity, samples were 
titrated on BIIK-21 monolayers and cytopathic effect (c p  e  ) observed after 24hr
(h) Treatment o f  1)1 preparations with ft-propiolactone
To inactivate preparations of Dl vims using ft-propiolactone (BPL., grade II) the 
method described by Barrett el a l ( I984d) was used One tenth volume o f 0 5M 
Tris HCI (pH 7 5) was added to Dl SFV in culture medium 0.01% (v/v) BPl. was
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added and samples incubated on ice for 8 hr To remove BPL., samples were 
dialysed overnight at 4°C against PBS
0 ) Interference away
The interfering activity o f u v - irradiated DI SFV was determined by making serial 
two-fold dilutions in lOOpI medium containing 10 TCIDW (50% tissue culture 
infectious dose) in a 96-well plate (Nunclon) BHK-21 e d it  (2 x I04 in lOOul) 
were added to each well, and plates incubated at 37°C for 24 hr C.p.e was noted 
at 24 hr
2. NUCLEIC ACID PURIFICATION
(a) Phenol extraction
Phenol extraction was used to purity samples of nucleic acid An equal volume o f a 
I I (vAr) mixture o f phenol chloroform was added to aqueous samples in 
Kppendorf tubes (Sarstedt. Walter U K Ltd . l-eicester) Phenol' refers to phenol 
equilibrated with 0 IM Tris HCI (pH * 0 ) containing 0 1% hydroxyqumoline 
'Chloroform' refers to a 24 I (v/v) mixture o f  chloroform isoamyl alcohol Tubes 
were mixed by vortexing and centrifiiged for 15 sec at I5,000g The aqueous layer 
was removed and the extraction process repeated until no pellet was visible at the 
interface Finally, traces o f phenol were removed by repeating the extraction once 
using an equal volume o f chloroform
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(b) Ethanol precipitation
Aqueous samples o f nucleic acid were concentrated by adding one-tenth volume o f 
3M sodium acetate (pH 5.2) and 2 volumes o f  95% ethanol Samples were stored 
at -20°C for at least JO min and centrifuged for 15 min at 15.000g Pelleted nucleic 
acid was resuspended in sterile distilled water
(c) Determination o f  nucleic acid concentration
Nucleic acid was quantitated using spectrophotometry Samples were diluted in 
distilled water and transferred to quartz cuvettes Optical density (OD) was 
measured at 260 and 280 nm 1 ODJft0 was taken as equivalent to 50pg/ml for 
double-stranded ON A. 40pg/ml for single-stranded RNA or 20ug/ml for single- 
stranded DNA The ratio of nucleic acid to protein was determined from ODJfl0 
divided by OD„„ and was used as a measure o f purity For pure preparations, this 
ratio was I 8 (DNA) or 2 0 (RNA)
3. RNA ANALYSIS
(a) bjctraction o f  RNA fro m  tissue culture cells
Total cellular RNA was extracted from tissue culture cells using a modification o f 
the method described by (.1.4m el al (1974) Monolayers of BIIK-21 cells were 
treated for 20 min at room temperature with 4M guanidinium isothiocyanate in 
lOmM Tria.HCI (pH 7.5). CaCI was added to a final concentration o f 0 I5g/ml and 
N-lauroyl-sarcosine to 0  4%  (w/v) Homogenates were layered on one-fifth volume
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5 7M CsCI containing 0. IM EDTA (ethylenediaminc tetraacetic acid, pH 7 0) and 
centrifuged at lOO.OOOg for 20 hr at 20"C Pelleted RNA was resuspended in 
lOmM TrisHCI (pH 8 0), ImM EDTA, 0 1% sodium dodecyl sulphate (SDS), 
extracted with phenol and ethanol-precipitated Purified RNA was resuspended in 
sterile distilled water and stored at -70°C Typically Ipg RNA was obtained from 
10^ cells
(b) Extraction o f  RNA from brain tissue
Adult mice were killed with ether and dissected brains stored at -70°C Thawed 
brains were suspended in guanidinium isothiocyanate lysis buffer (see section 3a) 
and homogenised through a 19-gauge hypodermic syringe needle (Becton- 
Dickinson U K Ltd . Oxford) Homogenates were treated as described in section 
3a Typically, I00^g RNA were obtained from one brain
(c) Extraction o f  RNA from  tissue culture flu id
RNA was extracted from small volumes (typically 75*U) of tissue culture fluid with 
an equal volume o f  10 mM Tris HCI (pH 7 9). 350 mM NaCI, lOmM EDTA, 7M 
urea, 1% (w/v) SDS followed by phenol extraction and ethanol precipitation (after 
A. J Easton, personal communication) RNA was resuspended in distilled water 
and stored at -20°C For analysis by RT-PC'R, RNA was resuspended directly in 
reaction buffer
For larger volumes, virus was pelleted by centrifugation at lOO.OOOg for 3 hr at 
4 T  and resuspended in TNE (0 IM NaCI, lOmM Trie HCI pH 7 5, ImM EDTA
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pH 8 0) Proteinase K was added to 200ng/ml and SDS to  0 1% Samples were 
incubated at 37°C for 30 min and RNA extracted with phenol RNA was 
concentrated by ethanol-precipitation and resuspended in distilled water and stored
at -70°C
(J) Analysis o f  RNA by agarose gel electrophoresis
RNA was resolved on agarose gels after denaturation with glyoxal and dimethyl 
sulphoxide (after McMaster and C armichael, 1977). 5 4|il o f an aqueous solution 
containing up to 20ug RNA was mixed with 5 4MI o f  6M glyoxal. 16^ x1 DMSO and 
3 2ill 0 IM NajHP04 (pH 7.0). The mixture was incubated at 50°C for 60 min and 
3 0(il RNA loading buffer added (50% glycerol. 0 0IM  N a,H P04> 0 4% 
bromophenol blue) A I 0% horizontal agarose gel was prepared as described in 
section 4a. but using 0  0IM NajHP04 as gel and running buffer and no ethidium 
bromide Samples were electrophoresed for 2 hr at 4V/cm Buffer was circulated 
from the anode to the cathode using a peristaltic pump Following electrophoresis. 
RNA was stained for 30 min with lOpg per ml ethidium bromide and the gel was 
subsequently de-stained for 60 min in running huffier Stained RNA was visualised 
on a u.v transilluminator and photographed as for DNA (see section 4a) 
Molecular size was determined by comparison to RNA size markers (RNA ladder 
Gibco)
(e) Northern blot analysis
To analyse SFV RNA by northern blotting, samples were firstly resolved on an 
agarose gel following denaturation with glyoxal (see section 3d) After
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electrophoresis, only the RNA ladder was stained with ethidium bromide, and the 
test samples were transferred to a hybridisation filter (after Southern. 1975) Two 
strips of Whatman 3MM filter paper (Whatman Labs Sales Ltd , Maidstone. Kent) 
were placed on a glass support above a reservoir o f 7 5mM NaOH. with the ends 
o f  the paper submerged in the buffer The gel was placed on the filter paper, and a 
nylon filter (Hybond N: Amersham) on the gel Two squares o f Whatman 3MM 
paper were placed on the nylon filter and paper towels on these A 500g weight 
was placed on the paper towels and transfer allowed to proceed overnight
After transfer, nylon filters were submerged in 30 ml hybridisation buffer (see 
below) for 4 hr at 42°C in a plastic box with constant shaking For hybridisation, 
filters were transferred to 10-15 ml fresh hybridisation buffer pre-heated to 42°C 
and the probe added (see section 3g) Following incubation at 42°C for 16 1», 
unbound probe was removed by washing the filter for 10 min at room temperature 
with 50ml 6 x SSC + 0.5% SDS. 10 min at 37°C with 50 ml 2 x SSC + 0 1% SDS, 
20 min at 42°C with 50 ml I x SSC and 30 min at 60°C with 50 ml I x SSC ♦ 
0 1% SDS Filters were wrapped in clingfilm to  prevent dehydration
Washed filters were transferred to an autoradiography cassette with X-ray film 
(Fuji ( U K )  Photo Film C o . London) and stored at -70°C for 16 hr Film was 
submerged in developer fluid (Kodak Photographic L td . Hemal Hempstead. 
Herts ) for 3 min and transferred to fixative (Kodak) for 3 min Finally, films were 
washed in tap water and dried Where necessary, autoradiography was repeated for 
a longer or shorter period of time
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Note buffers used were as follows -
Hybridisation buffer 6x SSC, I Ox Denhardt's solution. SOpg/ml herring
sperm DNA (boiled for 10 min before use), 
lx SSC : 1.5 M NaCI, 0.015 M sodium citrate pH 7.0
lOOx Denhardt's solution 20g/l Ficoll. 20g/l polyvinylpyrrolidone. 20g/l 
bovine serum albumin (BSA, fraction V)
(f) Dot blot analysis
100 pi RNA samples in TE ( lOmM Tris HCI pH 8 0. ImM EDTA pH 8 0) were 
mixed with an equal volume o f formamide and incubated at 50°C for 15 min 
Samples were transferred to Hybond-N filters by applying under vacuum to a 
Hybn-blot apparatus (Gibco) Each well was washed through with lOOpI TE (pH 
8 0) The filters were dried on Whatman 3MM paper and RNA fixed by u v by 
placing on a transilluminator (254 nm) for 4 min RNA was analysed using labelled 
probes as described in section 3e Autoradiographs were subsequently analysed 
using a scanning densitometer (Molecular Dynamics Ltd., Sevenoaks. Kent)
(f0 Hybridisation probes
Oligonucleotide probes were made by end-labelling synthetic primers (see section 
3h) I Ml primer (0 2 mg/ml) was mixed with I pi I0x linker kinase buffer. 20MCi (y 
-MPJATP, 20 U T4 polynucleotide kinase and diluted to lOpI with distilled water 
The mixture was incubated at 37°C for 30 min and the reaction stopped by adding 
2mI 0 5M EDTA (pH 8 0)
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Nick-translated probes were made using cloned DI SFV (see Chapter 4) Ipg DNA 
was mixed with 5pl lOx nick translation buffer. I til ImM each dNTP, 20pCi (a- 
“ PJdNTP and distilled water to 44^1 The mixture was chilled on ice for 5 min and 
0.5|xl DNAse I (0.1 tig/ml) added S U K coit DNA polymerase I was added, and 
the mixture incubated at I6°C for 60 min The reaction was stopped by adding 2til 
0 5M EDTA (pH 8 0)
RNA probes were made by transcribing cloned Dl SFV (see Chapter 4) 
Transcription was performed as described in section 7a except that 20pCi (a- 
,2PJUTP was included in the reaction
After probes were labelled, unincorporated label was removed Samples were 
diluted to 30|il with TF (pH 8 0) and loaded on a Sml Sephadex 0 5 0  (Pharmacia) 
column equilibrated in TE (pH 8 0 ) 30 I00pl fractions were collected and 
analysed with a Geiger-Muller counter (Mini-Instruments Ltd . Bumham-on-sea. 
Essex) The six fractions with the highest readings and comprising the first peak o f 
radioactivity (usually between fractions 10 and 20) were pooled and stored at 
-20°C
Note: buffers used were as follows -
lOx linker kinase buffer 0 66 M Tris HCl (pH 7 6). lOmM spermidine.
0 I M MgClj, ISO mM dithiothreitol (DTT). 2 
mg/ml BSA
I0k nick translation buffer 0 5 M Tris HCl (pH 7 2). 0 I M MgSO«. ImM 
DTT. SOOug/mJ BSA
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(h) Reverse transcription and polymerase chain reaction (RT-PCR)
The polymerase chain reaction (PCR) was used to amplify cDNA templates (after 
Saiki el a l , 1985) RNA was reverse transcribed and amplified by PCR in 100^1 
reaction buffer (lOmM Tria HCI pH 8 3. 50mM KCI. 0  01% gelatin. 4 5mM 
MgClj, O.SmM each dNTP, 2 U AMV reverse transcriptase (Pharmacia). I S U 
Taq polymerase. 20 pmol each pnmer). and overlayed with I00pl paraffin For 
analysis o f Dl SFV RNA, the primers 5'ShV  and 3'SFV  were used, which were 
homologous to the 5' terminus and complementary to the 3* terminus o f SFV RNA 
respectively For production of DNA for cloning, the promoter for T3 RNA 
polymerase was incorporated on the 5* primer (5 ' STV-T3), and the restriction 
enzyme site for Ncol on the 31 primer (3 ' ShV-Nco) For analysis o f SFV RNA the 
primers Sh V-5i and Sb V-3i were used, which anneal within the nsP2 gene of SFV
Reactions were performed using a thermal cycler (Techne (Cambridge) Ltd , or 
Hybaid L td , Teddington, Middlesex) Primer annealing temperatures were 
determined from an estimate of their melting temperatures (T,, see Chapter 3). 
Typical reaction times were 40 min at 42°C for reverse transcription, followed by 
30 cycles o f 60 s at 94°C. 60 s at (T„-2°C) and 80 s at 72°C A final step of 5 min 
at 72°C was included before cooling to 20°C PCR products were analysed by 
agarose gel electrophoresis (see below) and were stored at -20°C RT-PCR using 
the primers 5'Sh'V-T3 and 3 'ShV-Nco was performed using an annealing 
temperature o f  54°C
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PrimtiM*
5W1 (b u o  1-23) 3'-ATG OCG GAT GTG TOA CAT ACA COA C-3*
J'.VM (base* II442-II4II) S'-GGA AAT ATT AAA AAC CAA TTG CAA AAT AAA
AAT-3*
I----------------- TS--------------1
J'S F V -T J 3-OCA ATT AAC CCT CAC TA A  AGA TOG COG  ATG
TOT GAC ATA CA-3*
I— N col— |
rSFV -N co . 3'-TTC CAT OOG AAA TAT TAA AAA CCA ATT OCA-3*
S H S I (bates I7S0-I7M) 3*-CCC OCA OAC COT OCT CAA 0-3*
Sf-V -Ji (bases 2312-2493) 3*-CCO AGO TTT AAC AAO AOC-V
• Numbers refer to nucleotides o f SFV RNA Primers were made with a DNA 
synthesiser (.3 column. Applied Biosystems. Warrington. Lancs )
(i) In vitro inmsIaiHm
Translation o f RNA transcripts was performed using a rabbit reticulocyte lysate 
translation system (Gibco), and the protocol and reagents supplied with the kit 
Following transcription (see section 7a). the reaction mixture was extracted with 
phenol and ethanol-precipitated RNA was resuspended in 5<Hil DF.PC (diethyl 
pyrocarbonateMreated water 0  5 or I Onl RNA were mixed with 3nl I Ox 
translation mixture. 2 4^1 IM potassium acetate. 25nCi ( ’'Si-methionine. lOpI 
rabbit reticulocyte lysate and DFPT-treated water to 30pl The mixture was 
incubated at 30°C for 60 min and cooled on ice
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lOnl reaction mixture was mixed with IOpl protein sample buffer and incubated at 
100°C for 2 min Denatured translation products were elect rophoresed on vertical 
10-20% gradient SDS-polyacrylamide gels (BioRad Laboratories Inc . Hemel 
Hempstead. Herts ) at lOV/cm in electrode buffer, after the method o f  l-acmmli 
(1970) For size determination, an unlabelled Rainbow marker was used 
(Amersham) Gels were analysed by autoradiography as described in section 3e
Note buffers used for gel electrophoresis were as follows -
Protein sample buffer 3 2ml 5M urea. I 0ml Tris HCI (pH 6 8). 0 8ml glycerol.
I 6ml 10% SDS. 0  7ml 0 5% bromophenol blue. I 2ml 
distilled water
5x electrode buffer 94g/l glycine. 15 Ig/1 Tris base. Sg/1 SDS
4. DNA A N A LY S IS
(a) A/garone /gel elecirophoresi.%
DNA samples were mixed with one-fifth volume marker dye (0 25% (w/v) 
bromophenol blue. 0 25% (w/v) xylene cyanol. 30% glycerol) Samples were 
loaded on horizontal agarose gels (1-2% (w/v) agarose type II, medium EEO) 
submerged in TAE buffer (0 04M Tris-acetate. 0 00IM  EDTA pH 8 0 ) 50ug/ml 
ethidium bromide was included in the gel Electrophoresis was performed at I- 
4V/cm until the marker dye reached two-thirds distance along the gel
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DNA was visualised by placing the gel on a u.v. transilluminator (UV products 
Ltd . Cambridge) and was photographed with black and white film (type 55, 
Polaroid UK L td , St Albans, Herts )
(h) Restriction enzyme analysis
Up to 5ng DNA in distilled water or TE (pH 8 0) was mixed with I 5gl o f  the 
appropriate lOx buffer, 5 Units restriction enzyme and distilled water to 15^1 
Samples were incubated at 37°C for 1-2 hr and analysed by agarose gel 
electrophoresis
(c) Purification o f  DNA resolved on agarose gels
DNA fragments resolved on agarose gels were purified using Geneclean II* (BIO 
101 Inc (Stratech Scientific), Luton, Beds ) and a modification o f the instructions 
supplied with the kit (derived from Vogelstein and Gillespie, 1979) Agarose gel 
containing the DNA o f interest was excised using a scalpel and added to 3 volumes 
6M Nai Agarose was dissolved by incubating at 55°C for 5 min 5pl Glassmilk 
was added and the suspension mixed on ice for 10 min Samples were centrifuged 
at IS.OOOg for 5 s and the supernatant discarded The pellet was washed three 
times with NEW wash (based on NaCI, ethanol, water) and resuspended in 50t*l 
distilled water Samples were incubated at 55°C for 3 min and centrifuged at 
IS.OOOg for 30 s. The supernatant was ethanol-precipitated and purified DNA 
resuspended in the desired volume o f  distilled water
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(d) Southern blot analysts
DNA was resolved on agarose gels and transferred to nylon filters by a 
modification o f the method described by Southern (197$) Following 
electrophoresis, gels were soaked in I $M NaCI and 0  $M NaOII for I hr at room 
temperature The gel was neutralised in IM Tris.HC'l <pH 8 0) and I 5M NaCI for 
I hr at room temperature with constant shaking DNA was transferred from the gel 
to Hybond N filters as described in section 3e. but using I Ox SSC (see section 3e) 
as transfer butter Following overnight transfer. DNA was fixed by placing the 
fiber on a u v  transilluminator (2S4 nm) for 4 min Hybridisation and 
autoradiography was performed as described in section 3e
S. MOLECULAR CLONING
fa) ( 'ell culture
For growing pSP6-SFV4 (see section 5c). fjn h en ch ia  colt (K  colt) strain DH$a 
was used (Stratagene Ltd . Cambridge) For all other plasmids. K  cttlt strain TG2 
was used (obtained from Dr A J Easton)
TG2 cells were grown in LB (Luna-Bert am) medium (I0g/l Bacto-trvptone. 5g/l 
Bacto-yeast extract. lOg NaCI. pH 7 S). DH$a cells were grown in SOB (20g/l 
Bacto-tryptone, $g/l Bacto-yeast extract. 0 5g/l NaCI. 2 5mM KCI. lOmM MgCI,) 
For solid medium. LB-medium was supplemented with I 5% (w/v) Bacto-agar 
(l.B-agar) All media were sterilised by autoclaving
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To culture cells harbouring plasmids, media were cooled to 37°C after autoclaving 
and ampicillin added (sterilised through a 0  2pm filter. Sartorius Ltd . Epsom. 
Surrey) For liquid media, 50pg/ml ampicillin were used, and I00pg/ml ampicillin 
for solid media
Liquid cultures were grown at 37°C and 200 rpm in an orbital incubator (NBS 
Ltd., Hatfield. Herts ) For long-term storage, a single bacterial colony was 
inoculated in 5ml medium and grown overnight 0 85ml was mixed with 0 15ml 
glycerol and transferred to a freezing vial Cells were stored at -70°C.
(h) Rreparation o f  l \  'R products fo r  dow ny
PCR products for subsequent cloning were purified, phosphorylated and end-filled 
DNA derived from lOOpI PCR reaction mixture was purified by phenol extraction, 
concentrated by ethanol precipitation and resuspended in 20pl distilled water This 
was mixed with 20pl linker kinase buffer (see section 3g), I pi ATP (lOOmM), 
20 U T4 polynucleotide kinase and distilled water to lOOpI Samples were 
incubated at 37°C for 30 min, extracted with phenol and ethanol-precipitated
DNA was resuspended in 20pl distilled water and mixed with 2pl 2mM 4x dNTPs, 
5pl nick-translation buffer (see section 3g). 12 U large fragment o f  K.coli DNA 
polymerase I and distilled water to 50pl Samples were incubated at 20°C for 30 
min, phenol-extracted and ethanol-precipitated Finally. DNA was resuspended in 
30pl distilled water lOpI was analysed by agarose gel electrophoresis, lOpI was 
stored at -20°C and I Op! used for ligation
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(c) l ‘reparation o f  vector DNA fo r  d o w n y
The full-length SFV clone pSP6-SFV4 was obtained from Professor P I .iljestrom. 
Department o f Molecular Biology, Karolinska Institute. Huddinge. Sweden
pBluescribe KS* (amj^.)  was obtained from Stratagene pUCI3 (amp*. Yanisch- 
P err an el a l , 1985) was obtained from Dr A J Easton Both vectors have 
polylinkers within the gene for P-galactosidaae permitting blue-white selection of 
recombinants To prepare vectors for ligation. Ipg plasmid DNA was digested 
with the appropriate restriction enzyme, phenol-extracted and ethanol-precipitated 
DNA was resuspended in 20pl distilled water and stored at -20°C For blunt ended 
ligations, the restriction enzyme was Smal
(J) Ijyaiion
For blunt-end ligating modified PCR products into plasmid vectors. lOpI sample 
was mixed with 5pl Smal-digested plasmid DNA (40pg/ml). 4pl ligasc buffer and 
I U T4 DNA ligase Samples were incubated overnight at I6°C and stored at
-20°C
(e) / ‘reparation o f  competent cells and  transformation
A modification of the method described by Mandel and lliga (1970) was used A 
loopful o f bacterial culture was inoculated in 5ml medium and incubated at 37°C 
overnight 2ml culture was diluted in 100ml medium in a conical flask and 
incubated at 37°C and 200 rpm until the OD110 o f the culture reached 0 3 to 0 5
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(usually 2 hr) Cells were collected in Oakridge tubes (Techmate Ltd , Milton 
Keynes) and chilled on ice for 10 min Tubes were centrifuged at 1500g for 4 min 
(4°C) in a swing-out rotor and the supernatant discarded Cells were resuspended 
on ice in 10ml ice-cold lOOmM MgC'l, and centrifuged as above The process was 
repeated using 5ml ice-cold lOOmM CaCI, (the dihydrate form) and finally I 5ml 
lOOmM CaClj Cells were incubated for 1 to 12 hr on ice. after which they were 
considered to be competent to take up DNA
200pl competent cells were added to lOpI ligation mixture Cells were incubated 
on ice for 30 min with shaking Tubes were transferred to a 42°C water bath for 
90 s and returned to ice for 5 min 200pl 2x LB medium were added and the cells 
incubated at 37°C, 200 rpm for 30 min
For blue-white selection o f colonies, transformed cells were inoculated on LB-agar 
containing 50pg/ml ampicillin. 0 005% X-gal (5-bromo-4-chloro-3-indolyl-f)-D- 
galactoside) and 0 ImM IPTG (isopropylthiogalactoside) in 9 cm plastic plates 
Plates were incubated at 37°C overnight, and white colonies selected for further 
analysis
(f) Small-scale plasmid preparation
A modification o f  the method described by Holmes and Quigley (1981) was used 
Bacteria from a single colony were inoculated in 5ml I.-broth containing 50pg/ml 
ampicillin Following overnight incubation at 37°C in an orbital incubator. I 5ml 
samples were taken and centrifuged at I5,000g Bacterial pellets were resuspended 
in 350pl STET (8% (w/v) sucrose. 0  S S  (v/v) Tnton-X-100. 50mM EDTA pH
70
8 0, lOmM Tris.HCI pH 8 0) 20pl fresh lysozyme (12 mg/ml) was added and the 
samples mixed by vortexing Samples were incubated in a boiling water bath for 
40 s and centrifuged at I5,000g for 10 min The pellet was removed with a 
toothpick and 40pl 2 5M sodium acetate and 420pl isopropanol added to the 
supernatant Samples were stored at room temperature for 5 min and centrifuged at 
l$.000g for 10 min (20°C) Pellets were rinsed with 70% ethanol and resuspended 
in lOOpI TE (pH 8 0) Samples were treated with lOpI RNAse A (50pg/ml) for 10 
min at 37*C and phenol-extracted Plasmid DNA was concentrated by ethanol 
precipitation and resuspended in 20pl distilled water
(j0 I  arye-scale plasm id preparation
Plasmid DNA was extracted from large-scale bacterial cultures using a 
modification o f the method described by Bimboim and Doly (1979) A loopful of a 
bacterial culture harbouring the plasmid o f interest was inoculated into 500ml LB 
medium (A.'.co/r TG2) or SOB (K coli DH5a) This was placed in an orbital 
incubator at 37°C for 16 hr Bacteria were harvested by centrifugation at 2000g for 
45 min. resuspended in 8ml Solution I and transferred to an Oakridge tube I ml 
fresh lysozyme (10 mg/ml in lOmM Tria.HCI pH 8 0) and 10ml freshly made 
Solution II was added, and the tubes mixed thoroughly by inversion After 10 min 
at room temperature. 12ml ice-cold Solution III was added and the tubes mixed by 
inversion and stored on ice for 10 min l  ubes were centrifuged at lO.OOOg for 30 
min and the supernatant filtered through 3 layers of muslin 0 6 volumes of 
isopropanol were mixed with the supernatant and the tubes stored at room 
temperature for 15 min To pellet nucleic acids, the tubes were centrifuged at
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1500g for 15 min (20°C) The pellet was rinsed in 70% ethanol, dried by inverting 
the tubes on paper towels and resuspended in 3 ml TE (pH 8 0)
To purity plasmid DNA, the method described by Maniatis el a l (1989) was used 
3 ml ice-cold 5M LiCI was added to the nucleic acid solution and the mixture 
centrifuged at 5,000g for 15 min (4°C) An equal volume of isopropanol was mixed 
with the supernatant and the solution centrifuged at 5.000g for 15 min (20°C) The 
pellet was rinsed with 70% ethanol and resuspended in 500pl TE (pH 8 0) 
containing 2 Op g/ml RNAseA After 30 min at room temperature, the sample was 
mixed with 300pl I 6M NaC'l containing 13% (w/v) polyethylene glycol 6000 and 
centrifuged at 15.000g for 5 min The pellet was dissolved in 400pl TE (pH 8 0) 
and phenol-extracted I00pl I0M ammonium acetate and I ml ethanol were added 
and the samples stored at room temperature for 10 min Plasmid DNA was pelleted 
by centrifugation at I5,000g for 5 min, rinsed with 200pl 70% ethanol and 
dissolved in 500pl TE (pH 8 0)
Note buffers used were as follows -
Solution I 50mM glucose. 25mM Tris HCl (pH 8 0), lOmM EDTA 
Solution I! 0 2N NaOH. 1% (w/v) SDS
60 ml 5M potassium acetate ♦ 11 3 ml glacial acetic acid ♦ 28 5 
ml distilled water
Solution III
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6. DNA SEQUENCING
fa) f*reparation o f  plasmid DNA
Plasmid DNA was prepared as described in section Sf. For sequencing. 4pg DNA 
in 5pl distilled water was used To prepare single-stranded DNA, I5pl 0  27M 
NaOH + 0 27mM EDTA was added and the mixture incubated at room 
temperature for 5 min DNA was precipitated by adding 2pl 3M sodium acetate 
(pH 4.6) and 40pl 95% ethanol The mixture was incubated at -20°C for 10 min 
and centrifuged at I5,000g for 15 min The pellet was washed once with lOOpI 
70% ethanol and centrifuged for a further 2 min The pellet was rinsed with 95% 
ethanol and dried in a vacuum desiccator for 10 min
(b) Sequencing using the chain termination method
Single-stranded plasmid DNA was sequenced using Sequenase* version 2 0  (USB 
(Cambridge Bioscience). Cambridge) and the protocol supplied with the kit (after 
Sanger et a! . 1977) The primers used are listed in Figures 5 I and 5 6 All buffers 
and reagents except label were supplied with the kit
A mixture was prepared o f  2pl reaction buffer. 2pl primer (0 5 pmol/pl) and 6pl 
distilled water This was added to the dried plasmid preparation and incubated at 
65°C for 2 min The sample was cooled to  20°C over a period of 30 min and stored
on ice
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For the labelling reaction, the sample was mixed with I pi 0  IM DTT, 2pl labelling 
mix (diluted 1:5 in distilled water). lOpCi [” £J-dATP 2 5pl each o f the four 
dideoxy-NTPs were pre-heated to 37°C in separate Hppendorf tubes 2pl 
Sequenase 2 0  (diluted 1 8  in enzyme dilution buffer) was added to the DNA 
sample and incubated at room temperature for 3 min 4 x 3 5pl were added to the 
sides o f the tubes containing the ddNTPs and the tubes centrifuged briefly to start 
the reactions The tubes were incubated at 37°C for 5 min 4pl stop solution was 
placed on the side o f  each tube and mixed to  stop the reactions by brief 
centrifugation Samples were stored at -20°C
(c) Cycle sequencing
Some regions o f cloned DNA were sequenced using a thermal cycling method, for 
reasons stated in Chapter 5 For this a A Taq kit (USB) was used and a 
modification o f the protocol supplied with the kit All buffers and reagents except 
label were supplied with the kit
Double-stranded plasmid DNA was labelled by mixing Spg with 0 5pl linker kinase 
buffer (see section 3g), 20pCi [a -’JP]ATP, 20 U T4 polynucleotide kinase and 
distilled water to Spl Samples were incubated at 37°C for 30 min
(.abelled DNA was diluted to 9 5pl with distilled water and mixed with 2pl 
reaction buffer. I pi primer (0 5 pmol/pl) and 2pl la q  polymerase (diluted I 8 in 
enzyme dilution buffer) 4 x 3 8pl o f  the reaction mixture was added to 3 8pl of 
each o f  the four ddNTPs and the samples overlayed with 8pl paraffin
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Samples were incubated on a thermal cycler (Hybaid) and subjected to 15 cycles of 
94°C for 60 s, 60°C for 60 s and 72°C for 80 s Samples were cooled to room 
temperature and 4pl stop solution added
(d) Analysts o f  product \ from sequent tny reactions
Products from sequencing reactions were analysed on vertical polyacrylamide gels 
Gels were prepared by mixing 18 6ml 40% acrylamide N-N'-methylene 
bisacrylamide (19:1 solution. Severn Biotech Ltd . Kidderminster. Gloucs ) with 
63g urea, 15 ml lOx TBE (0 89M Tris-borate, 0 89M boric acid. 0 02 EDTA) and 
distilled water to 150 ml Once the urea had dissolved, the solution was filtered and 
I50j*l TEMED (N.N.N'.N'-tctramethvlencdiaminc) and 0 84 ml 10% (w/v) fresh 
ammonium persulphate was added The mixture was poured between taped glass 
sequencing plates, combs inserted, and the gel set overnight
Gels were placed in a vertical sequencing apparatus (Gibco) with TBE as buffer 
Gels were pre-run at 80W for 30 min Samples were incubated at 80°C for 2 min. 
loaded on the gel and electrophoresed at 80W for up to 4 hr Plates were 
dismantled and fixed in 10% (v/v) glacial acetic acid for 45 min After transfer to 
Whatman 3MM paper, gels were dried at 80°C for I hr using a vacuum drier 
Autoradiography was performed as described in section 3e
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(*) Analysis o f  nm leotidt sequem os
Nucleotide sequences were stored end analysed using a microgenie database For 
secondary structure predictions, data was analysed using a OCG software package 
(University o f Wisconsin. Madison. USA)
7. TRANSFECTION OF RNA INTO TISSUE CULTURE CELLS
(a) RNA transcnpnon
For production o f RNA transcripts. I Mg plasmid DNA was mixed with 5pl lOOmM 
DTT. 2 5pl BSA (2.5 mg/ml). 4 x 2 5p) each 20mM NTP. 10^1 I Ox transcription 
buffer. 25 U human placental RNAse inhibitor. 25 U RNA polymerase (T3 or T7) 
and distilled water to 50pl For production of capped transcripts. I0pl 5mM 
sodium m7G(5,)pppG (Pharmacia) was included in the reaction and the 
concentration o f GTP halved
The reaction mixture was incubated at 37°C for I hr To remove template. 5 U 
RNAse-free DNAse (Promega Ltd , Southampton. Hants ) was added and the 
mixture incubated for a further 10 min Size and integrity o f  RNA was determined 
on agarose gels (see C hapter 6) For transfection experiments. RNA transcripts 
were used on the day o f preparation
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(b) Hypertonic shock
In preliminary experiments, the method o f  hypertonic shock was used to transfect 
RNA transcripts into tissue culture cells CEF or BHK-21 cells were grown as 
monolayers in 5 cm dishes Medium was removed by suction and the monolayers 
washed at room temperature with unbuffered saline
20nl RNA transcription reaction mixture was diluted with I80pl I 5M NaCI. 
lOmM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid. pH 7 2) 
and this was inoculated centrally on the monolayer After incubation at room 
temperature for 10 min, warm medium was added and cells incubated for 10 min at 
room temperature Medium was removed and 10 p f u /c d l  SFV in 3 ml 
medium/plate added Cells were incubated at 37°C fix 24 hr Tissue culture fluid 
was harvested and passaged as described in section Id
(c) hJectroporatnm
In later experiments. RNA transcnpts were transfected into BHK-21 cells using a 
method adapted from LiljestrOm el a/ (1991)
BHK-21 cell monolayers were incubated with 10 p f  u /cell SFV in GMEM-BHK 
at room temperature for 45 min Monolayers were trypsinised and centrifuged as 
described in section la Cells were resuspended in 10 ml GMEM-BHK and 
centrifuged at 200g for 5 min This process was repeated with ice-cold PBS and 
ceils were finally resuspended in PBS (20°C) at a concentration of I07 cella/ml
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0 5 ml cell suspension was transferred to an electroporation cuvette and mixed by 
pipetting with 20pl RNA transcription reaction (approximately 20pg RNA see 
Chapter 6) After the addition o f RNA, cells were immediately subjected to 2 
consecutive pulses at 1 5kV/25pF using a Gene Pulser apparatus (BioRad). with 
the pulse controller unit set at maximum resistance
('ells were diluted in 5 5 ml GMKM-BHK and 2 x 3 ml transferred to 5 cm dishes 
Plates were incubated at 37°C for 18 hr Culture medium was harvested and 
clarified by centrifugation at I500g for 10 min (4°C) Medium was passaged as 
described in section Id
8. MOUSE EXPERIMENTS
fa) Inoculation o f  mice
CFLP mice (ICI strain, outbred) were obtained from Interfauna U K L td , 
Huntingdon. Cambs CD-I random-bred mice were obtained from Charles River 
U K Ltd . Margate. Kent Baib/c mice were obtained from B&K L td . Hull. N 
Humberside Mice were male, and were used at 5 weeks of age Groups o f 7 to  10 
mice were inoculated intranasaJly under light ether anaesthesia with 20pl o f Dl 
SFV in 10 LDy, (1500 p f u  ) SFV, after the method described by Dimmock and 
Kennedy (1978) A single dose was delivered and mice were examined daily until 
the onset o f disease (usually after 4 to  6 days), after which they were examined at 
least twice daily for signs of sickness, paralysis and death until the course o f  the 
disease was over (usually 10 days after infection) Mice were challenged with 100 
LD*, SFV approximately 20 days after the first inoculation to determine their
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immune status All inoculations were performed by Professor N J Dimmock 
(Department of Biological Sciences, University o f Warwick)
(b) Dissection o f  mice
Mice were killed with ether Brains were dissected and snap-frozen with dry-ice 
and transferred to -70°C for storage
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DETECTIO N O F DEFECTIVE RNAm O F S E h iU K ! FOREST VIRUS  
USING TH E POI. YMERASE CHAIN REACTIO N
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INTRODUCTION
This chapter describes the detection o f Dl SFV RNA by reverse transcription and 
amplification using the polymerase chain reaction (RT-PCR) The optimisation of 
these techniques is described and their sensitivity and specificity appraised The 
relative merits o f RT-PCR and northern analysis for the detection o f Dl SFV 
genomes, and their application to  the detection o f Dl SFV genomes in brain tissue 
from mice is described
The primary aim of this project was to isolate and characterise mouse-protecting 
Dl SFV sequences Dl SFV populations are known to be heterogeneous 
(Kaariainen el ai., 1981). and some consist of both protecting and non-protecting 
species (Barrett el a/., 1984a) It was suspected that protection of mice by co- 
administration o f SFV and Dl SFV involved preferential amplification of the 
protecting Dl SFV species From this premise, there was a greater probability that 
Dl genomes isolated in vivo had protecting activity than those isolated in vitro 
Hence it was envisaged that the in vivo system could be used as a filtering 
mechanism for protecting sequences and the initial approach was to attempt to 
isolate Dl SFV genomes from protected mice
Initially it was necessary to  choose a method that was applicable to the detection 
and isolation o f  Dl SFV Previous attempts to detect Dl SFV In vivo have been 
largely unsuccessful The one exception involved an amplification step in tissue 
culture, but this method was too impractical for routine use (Dimmock and 
Kennedy, 1978) Barrett and Dimmock (1981) described an RNA synthesis 
inhibition assay (RSIA), which detected •I057* Dl particles per ml However.
application o f this method to the detection o f Dl SFV lit vivo was unsuccessful It 
was suspected that in protected mice. Dl SFV was present in low concentration 
and this assay was not sufficiently sensitive (Barrett el a / .  1984c) In 1985. Saiki el 
a! reported the development o f  the polymerase chain reaction (PCR) Since then. 
PCR has been used extensively for diagnostic purposes, having high specificity and 
sensitivity, and was therefore an appropriate technique, when coupled with reverse 
transcription, to  use for the detection of Dl SFV RN As m  vivo
The technique o f RT-PCR was optimised before applying it to the detection of Dl 
SFV genomes This optimisation was dependent in part on having an efficient 
method for extracting RNA The RNA extraction methods that were used and their 
relative merits are discussed in this chapter because o f their importance in 
establishing a reliable method for detecting Dl SFV genomes To optimise RT- 
PCR it was necessary to establish a method for determining the sensitivity o f the 
technique and to permit subsequent modifications to be appraised Primers were 
designed that were specific for internal sequences o f  SFV RNA and the sensitivity 
o f the technique assessed from the lowest concentration o f SFV RNA that could be 
detected using these primers It was therefore possible to measure sensitivity in 
terms o f the inactivity titre o f the virus
To extend the technique o f RT-PCR to the detection o f  Dl SFV genomes it was 
necessary to design primers that were specific for these genomes In addition, to 
enable subsequent cloning and characterisation o f Dl SFV genomes, it was 
preferable to use primers that annealed to the termini so that the entire genome 
could be amplified As stated in the (ieneral Introduction, previously sequenced 
genomes o f Dl SFV possessed termini derived from those of the standard RNA
80
81
These termini were conserved in all the DI SFV genomes studied (Ixhtovaara «7 
ai.. 1981, 1982) It was reasonable, therefore, to expect that complete Dl SFV 
genomes would be obtained by RT-PC’R using primers specific for the termini of 
SFV RNA Furthermore, because the genome o f  SFV is 11 4 kb. it was unlikely to 
be amplified under the conditions used for RT-PCR, or in preference to Dl 
genomes
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KtSULTS
I .  Methoda used to investigate D I SKV genomes
(a) RNA extraction methods
In preliminary experiments. RNA was extracted from large volumes (typically 15 
ml) of tissue culture fluid This involved high-speed centrifugation and treatment of 
pelleted virus with SDS and a proteinase to degrade coat proteins, which were 
removed by phenol extraction While this method provided RNA o f adequate 
purity for RT-PCR and sufficient quantities for northern analysis, it was impractical 
for extracting RNA from large numbers of samples The method that was used 
subsequently involved treatment o f tissue culture fluid with SDS and urea before 
extracting RNA with phenol Thia method was applicable to small volumes 
(typically 75|il) o f  tissue culture fluid, and permitted large numbers of samples to 
be handled simultaneously furthermore, this method was rapid by comparison to 
the one described above, hence potential exposure to RNAaes was reduced
For analysis of viral RNAs in tissue culture cells or brain homogenates, total 
cellular RNA was used This analysis was therefore made against a background of 
non-viral RNA It was likely that non-viral RNA represented the majority. but may 
have been beneficial to the process of extraction, serving both to reduce 
degradation o f specific RNA species and to increase the percentage o f the viral 
RNAs that were successfully purified However, as will be discussed later, it was 
likely that these high levels o f background RNA reduced the sensitivity and 
specificity o f the detection o f DI SFV genomes by RT-PCR
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(b ) Northern b lo tting
To detect SFV-derived RNAs by northern blotting, a virus-specific hybridisation 
probe was used In the first experiments, an end-labelled DNA primer was used as 
the probe (3'Sf-V), which was complementary the 3' terminus o f SFV RNA 
However, it was not possible to detect SFV-derived RNAs with this primer, 
suggesting that the labelling was inadequate In later experiments, a probe was 
used that was made by nick-translation o f a DNA clone o f Dl SFV (see Chapter 4) 
While this probe was sufficiently sensitive for the detection o f SFV RNAs. the 
profiles obtained by northern analysis o f  Dl SFV RNA were usually poorly defined 
This was either a consequence o f  RNA degradation, or a reflection o f the 
heterogeneity of the Dl RNA Northern analysis was therefore not used as a 
standard technique for analysing Dl SFV preparations, but was used subsequently 
in the study of homogeneous preparations o f Dl SFV (see Chapter 7)
(c) O ptim isation o f  the  polymerase chain reaction
In preliminary experiments, reverse transcription and PCR were performed as 
independent stages, but more reproducible results were obtained by combining 
these two stages in the same reaction mixture PCR primers were designed that 
were specific for internal sequences o f  SFV RNA these were designated ShV-Si 
(homologous to nucleotides 1780 to 1798 o f SFV RNA) and StV -3t 
(complementary to nucleotides 2312 to 2495 of SFV RNA) SFV RNA was 
prepared from a tissue culture preparation o f SFV. and analysed by RT-PCR using 
these primers A single product o f 0 7 kbp was obtained, which matched the size of
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the region o f SFV RNA expected to be amplified using these primers (for an 
example, see Figure 3 1) Because this analysis was reproducible, the technique of 
RT-PCR was optimised using these primers A number o f  experiments were 
performed in which different parameters o f the RT-PCR protocol were varied 
These included the incubation times and temperatures, and the concentration of 
enzymes, primers and magnesium ions Optimal values for these parameters were 
estimated by visual examination of banded ON A on an agarose gel
These first optimisation experiments established a method that was applicable to 
the detection o f Dl SFV genomes Numerous modifications to the technique were 
made throughout the project to improve sensitivity and specificity (discussed 
below)
(d) Sensitivity and specificity of RT-PCR
The first experiment to determine the sensitivity o f  RT-PCR is shown in Figure 3 I 
RNA was extracted from a tissue culture preparation o f SFV. serially diluted, 
reverse transcribed and subjected to 30 cycles o f  PCR From the infectivity titre of 
the virus preparation, and taking the highest dilution at which there was a visible 
product on an agarose gel as the end-point, it was determined that the sensitivity of 
RT-PCR was equivalent to 4 x 106 p f u  In a later experiment, the virus 
preparation itself was serially diluted and RNA extracted from the dilutions 
Following ethanol precipitation, the RNA was resuspended directly in RT-PCR 
reaction mixture to minimise the potential exposure to RNAses In addition, an 
RNAse inhibitor was included (see Methods) The sensitivity o f RT-PCR using this 
method was equivalent to  I x 10' p f u
85
* i* u rf 3.1 Determination o f the sensitivity o f  RT-PCR
RN A was extracted from a tissue culture preparation of SFV and serially diluted in 
two-fold steps ranging from the equivalent o f  I x 109 p.fu  (lane I) to 2 x 10* 
p f  u (lane 10) The RNA was reverse transcribed and subjected to 30 cycles of 
PCR, using the primers SFV-34 and S t-V S i PC'R products were analysed on a 1% 
agarose gel The highest dilution o f RNA at which the 0 7 kbp product was visible 
by ethidium bromide staining was equivalent to 4 x l ( f  p f  u (lane 9)
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A number of attempt' were made to improve the sensitivity o f  RT-PCR Increasing 
the number o f PC'R cycles had little effect, suggesting that the efficiency o f  the 
reaction was negligible after 30 cycles hxperiments with re-amplification were 
unsuccessful In these, a ten-fold dilution senes o f K 'R  products was made, 
ranging from 1/10 to 1/104 K 'R  amplification of these dilutions yielded 
heterogeneous products, and small DNA products that were undetected after the 
first amplification were preferentially amplified in the second (data not shown)
Specificity was likely to be dependent on a number of factors, including the design 
and concentration o f the K 'R  primers, and the temperature used to anneal the 
primers The melting temperature o f  annealed primers was estimated from their 
base-content, using the formula T .  (°C) -  4 (0  ♦ C) + 2(A ♦ T) (derived from 
Marmur and Doty. 1962) In general, primers were annealed 2 to  5°C below the 
T „  Because the reverse transcription stage was performed at 42°C and the 
estimated melting temperature for most primers was approximately 20°C higher 
than this, non-specific hybridisation was likely to occur during this stage This 
problem arose frequently when RT-PCR was used to amplify from total cellular 
RNA samples, which comprised a high proportion o f non-specific RNAs A 
number of attempts were made to improve the specificity o f primer annealing 
during reverse transcription These included reducing the concentration of primers 
during this stage, adding the homologous primer after reverse transcription, 
reducing the time o f incubation at 42*C and reducing the concentration of reverse 
transcriptase However, these modifications were not beneficial because specificity 
was improved only marginally with a concomitant reduction in sensitivity
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2. Detection o f D l SKY genomes by RT-PCR
(a) Detection o f D l SFV genomes in tissue cu lture  f lu id
For the detection o f  Dl SFV genomes, primers were designed that were specific for 
the termini of SFV RNA These were designated 5SFV and 3' SFV  In preliminary 
experiments, a preparation o f Dl SFV known to interfere in vitro with standard 
virus propagation was used as a parent stock for preparing sufficient quantities of 
tissue culture fluid for analysis by RT-PCR One such preparation, designated p4- 
2/4, was produced by four serial passages o f  this stock in BHK-21 cells Figure 
3 2a shows DNA derived from amplification o f  p4-2/4 RNA by RT-PCR A single 
product of 1 5 kbp was obtained Comparison of this product with those derived 
from non-infected or SFV samples showed that it was unique to the Dl SFV 
sample (data not shown)
Figure 3 2b shows the PCR products derived from tissue culture fluid that was 
produced by serial undiluted passage o f  SFV in BIIK-21 cells Die SFV 
preparation in this experiment was produced by transfection o f  RNA transcripts of 
the full-length SFV clone pSP6-SFV4 into BHK-21 cells (l.iljestrom et a/., IW |) 
The 0 8 kbp product derived from passage v  was not present in those derived from 
passages I and 2. In addition, only passage 9 was shown to have a significant 
interference titre in tissue culture (see Chapter 7) Although at this stage there was 
no proof that these PCR products comprised complete Dl SFV genomes, these 
results suggested that Dl SFV genomes were detected by RT-PCR using the 
primers 3*SFV and 3 ' S/-V  It was reasonable, therefore, to extend the investigation 
to the detection o f Dl SFV In vivo
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(b)
r“*“~i l
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Figure 3.2 Detection o f Dl SFV genomes in tissue culture fluid
RNA w u  extracted from a tissue culture preparations of Dl SFV reverse 
transcribed and subjected to 30 cycles o f PCR using primers to detect SFV RNA 
(SbV-St • SbV-3i) or Dl SFV RNA (5 'ShV  ♦ JSFV ) In (a) the preparation p4- 
2/4 was used (see text for details) A 0 7 kbp product was generated with the 
primers SbV-St * SFV-34, and one o f  I 5 kbp with the primers 5'ShV * 3‘S h V  In
(b) preparations were made by serial passage in BHK-21 o f SF V derived from 
pSP6-SFV4 (Liljestrom el a/., I WI )  After RT-PCR using the primers 5 'S tV  * 
3*SFV, DNA species o f  0 6 kbp were obtained from passages (p) I and 2. and a 
relatively abundant species of 0 8 kbp from passage A 0 7 kbp product was 
obtained from passage I using the primers Sb V-5t * SFV-3!
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<b) I »election o r D l SFV genomes in vivo
For these experiments, a mouse-protecting tissue culture preparation o f Dl SFV 
was used This preparation, designated Dl SFV-p7, was produced by 7 serial 
passages o f SFV in BHK-21 cells In a typical mouse-protection experiment, 
approximately 70% survival was observed after intranasal inoculation of Dl SFV- 
p7 and 10 LDW SFV into adult mice (see Chapter 8) In the experiment shown in 
Figure 3.3, mice were dissected 2 or 4 days after inoculation RT-PCR was 
performed on total cellular RNA that had been extracted from brain tissue, and the 
primer pairs SFV-5i + SFV-U  were used for detecting virus, or 5'Sh'V + 5 ’SFV  for 
detecting Dl virus Virus was detected only in the samples derived from mice 
inoculated with SFV or with 100 LDW SFV + Dl From all samples analysed with 
the primers 5’SFV  + 3'SFV, numerous low molecular weight PCR products were 
obtained, the agarose gel profiles o f which did not vary significantly between 
samples These were therefore suspected to have been generated as a consequence 
of the primers hybridising to mouse-derived RNAs. and Dl genomes had not been 
detected RT-PCR was repeated with a higher primer annealing temperature to 
increase specificity, and although the number of low molecular weight products 
was reduced, there was still no difference between the PC'R products derived from 
the Dl + SFV samples and the others
In Figure 3.4, total brain RNA from the experiment described above was analysed 
by northern blotting The RNA used was derived from mice 2 days after 
inoculation, and was probed with a nick-translated Dl SFV clone (pSFVDI-7 see 
Chapter 4) The profile o f  the sample derived from mice inoculated with 100 LD*, 
SFV + Dl differed from the control samples, with two indistinct bands of
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Figure 3.3 RT-K 'R o f  total RNA derived from mouse brain tissue
Adult mice (male CFLP) were inoculated intranasally. and brains removed 2 or 4 
days afterwards RNA was extracted with guanidimum isothiocyanate and 5pg 
(approximately one twentieth) used in RT-K 'R 30 cycles o f K ’R were performed, 
using the primers SFV-St * StV -Si to detect virus, or 3'SfrV * J'Sh V to detect Dl 
virus (a ) and (b) show K 'R  products derived from brain RNA extracted 2 or 4 
days after inoculation A 0 7 kbp product was obtained from samples derived from 
mice inoculated with SFV alone ( 10 L D ^ )  or D l ♦ IOxSFV (100 LD«,) using the 
virus-specifrc primers Amplification with 5'SFV ♦ 3'Sh\ yielded products o f  0 3 
to 0 6 kbp from all samples
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Figurr 3.4 Northern blot analysis o f total RNA derived from mouse brain tissue
Adult mice (male CFLP) were inoculated intranasally. and brains removed 2 days 
afterward» RNA was extracted with guanidinium isothiocyanate and lOpg 
electrophoresed on a 1% agarose gel after dénaturation with glyoxal Following 
northern blotting. RNA was hybridised with a nick-translated DI SFV clone 
labelled with |a - u P]-dATP (pSFVDI-7 sec Chapter 4) This probe also contained 
sequences derived from the vector, which hybridised to some RNA species o f  the 
unlabelled size marker Two indistinct bands corresponding to 10 and I 5 kb 
(arrowed) were produced by hybridisation of the probe to RNA derived from mice 
inoculated with Dl ♦ IOxSFV (■ 100 LDW)
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approximately I 0  and I 4 kb Because the northern blot was poorly defined, it was 
not possible to make any firm conclusions on the nature o f  this highlighted RNA
(c) Detection o f  D l SFV genomes in mouse-protecting tissue culture 
preparations
Because it was not possible by the methods used to detect Dl SFV genomes m  
vivo, attempts were made to detect Dl genomes in the tissue culture preparations 
that were used as inocula for mouse-protection experiments In preliminary 
experiments, the mouse-protecting preparation Dl SFV-p7 was passaged once in 
CEF cells to generate sufficient quantities o f tissue culture fluid for analysis by RT- 
K 'R  Figure 3 5 shows a P('R product derived from this preparation (designated 
Dl SFV-p8), which contains a predominant DNA species o f  2 I kbp In a similar 
experiment, a different preparation o f Dl SFV was used (Dl SFV-AC) This had 
been made previously by passaging a mouse-protecting Dl SFV preparation in 
BHK-21 cells A single product o f  2.1 kbp was also obtained by RT-PCR 
amplification o f RNA extracted from this preparation
Once the method for extracting RNA from small volumes o f  tissue culture fluid had 
been established (see section la), it was possible to analyse the mouse-protecting 
preparation Dl SFV-p7 itself Figure 3 6 shows the PCR product derived from this 
preparation and a comparison with the one derived from Dl SFV-pH The 
predominant DNA product derived from Dl SFV-p7 was one of I 2 kbp. which 
contrasts with the 2 I kbp product from Dl SFV-pt In addition, while Dl SFV-p7 
protected adult mice against a lethal dose o f SFV, Dl SFV-p8 did not
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Figure 3.5 Detection o f Dl SFV RNA in the tissue culture preparation 1)1 SFV-p8
CEF cells were incubated with medium alone. SFV (ts ' strain) or Dl SFV-p7 + 
SFV Tissue culture fluid was harvested afler 24 hours and RNA extracted, reverse 
transcribed and subjected to 30 cycles o f amplification by K ’R The primers S tV -  
5i * ShV-H  were used to detect virus, or 5'ShV * J'.V M to detect Dl vims A 0 7 
kbp product was obtained from the SFV-alone and Dl SFV-p8 samples using the 
primers SbV-Si ♦ ShV-3! RT-PCR using 5 S h V  ♦ J'.VM yielded a 2 I kbp 
product from Dl SFV-p8
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fig u re  3.6 Comparison o f PCR products derived from 131 SFV-p7 and 131 SFV-p8
131 SFV-pS was produced from the mouse-protecting tissue culture preparation 131 
SFV-p7 by passaging once in BHK-21 cells RNA from both these preparations 
was amplified by RT-PCR using the primers 5 'ShV  * 3'S/-V A predominant 
product o f I 2 kbp was obtained from 131 SFV-p7 (a), and one of 2 I kbp from £31 
SFV-p8 (b)
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DISCUSSION
O f the two methods that were used to extract RNA from tissue culture fluid, the 
one used for small volumes was suspected to be more efficient because a lower 
concentration o f SFV RNA was detected by RT-PCR It was suspected that non- 
viral RNAs represented a large proportion o f the total, and reduced the efficiency 
o f  RT-PCR. In addition, the total amount of RNA that was used in a reaction was 
thought an important determinant of efficiency For example, in Figure 3.1 the 
intensity o f the bands comprising the PCR products was reduced in samples 
derived from the highest amounts of RNA In later experiments, it was shown that 
above RNA concentrations o f 20pg per reaction it was not possible to detect SFV 
RNA, suggesting that RT-PCR was totally inhibited Inhibition o f PCR by non­
specific nucleic acid has been demonstrated before For example. Abbott el a/ 
(1988) used PCR to detect HTLV-1 DNA and found that the limits o f detection of 
the technique were reduced from I ng to 10 ng with the addition o f  l |ig  non­
specific DNA
I'he sensitivity of RT-PCR was determined primarily to permit optimisation of the 
technique Although sensitivity was determined for the detection o f viral RNA, the 
value obtained was not applicable to the detection of Dl SFV genomes, for various 
reasons First, the primers that were used were different, and it was possible they 
had a different affinity for the template In addition, because Dl preparations are 
heterogeneous, it was likely that the primers used to detect Dl virus annealed to a 
variety o f  templates, including the virion RNA While this was unlikely to deplete 
the pool of primers because they were at a sufficiently high concentration, the 
overall efficiency o f RT-PCR may have been reduced Finally, the size o f the
%products were in general larger than the product obtained with the virus-specific 
primers Because smaller templates are amplified preferentially, the sensitivity 
determined using the virus-specific primers was likely to  be greater than that using 
the primers for detecting DI virus
Dl genomes were not detected m  vivo, but it was possible that RT-PCR was not 
sufficiently sensitive The sensitivity o f RT-PCR was determined to be equivalent 
to 105 p f  u virus, and applied to the detection o f DI virus, it was unlikely to be 
more sensitive than methods used previously, for the reasons described above 
Because DI virus is dependent on standard virus for propagation, it was likely that 
in vivo, levels o f  DI SFV were determined by the levels o f  infectivity During 
mouse-protection, it was suspected that the DI virus was present only in amounts 
necessary to prevent the spread of residual infectivity However, by inoculating 
with a high dose o f  SFV to counteract the protecting effect, it was hoped that the 
DI virus would be propagated to levels that would be detected While northern blot 
analysis of these samples suggested DI virus was present in mouse brain, detection 
with RT-PCR was unsuccessful It was suspected that one o f the problems o f this 
analysis was the high proportion of non-viral RNA in the samples that were 
analysed, which was reflected by the many different PCR products that were 
obtained by non-specific hybridisation o f  the PCR primers The proportion o f  non- 
viral RNAs could have been reduced by purifying the polyadcnylated ones, which 
were likely to include putative DI RNAs Alternatively, the sensitivity and 
specificity of RT-PCR could have been improved by using a nested set o f  PCR 
primers However, at the time the nucleotide sequence o f the protecting DI 
genomes, which was required for designing appropriate primers, was not known
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In contrast, it was possible to detect defective RNAs in tissue culture fluid, 
presumably because the ratio of Dl RNA to non-viral RNA was higher It was not 
known at this stage if the RNAs that were amplified by RT-PCR comprised 
complete genomes, or if they contained the sequences responsible for interference 
with standard virus propagation However, the agarose gel profiles o f PC'R 
products derived from different tissue culture preparations concurred with 
differences in biological activity This suggested that these PCR products were 
representative of the components o f the preparations responsible for such activity 
Furthermore, the loss o f mouse-protecting activity on passaging Dl SFV-p7 
coincided with a reduction in levels o f the 12 kbp PC'R product derived from the 
tissue culture fluid This suggested that this DNA species contained nucleotide 
sequences derived from a mouse-protecting Dl virus This PCR product was 
approximately half the size o f  previously cloned Dl SFV genomes (Lehtovaara el 
at., 1981; 1982) It was possible that it comprised a repeated unit o f a larger 
genome, but at this stage o f the project there was no evidence for this
In general, just one product was detected after RT-PCR amplification o f tissue 
culture fluid Because Dl SFV populations are heterogeneous, it was likely that this 
was a consequence o f preferential amplification o f  small or abundant RNAs Most 
Dl SFV genomes studied previously comprise less than 3 kb In later experiments 
with RT-PCR it was possible to amplify sequences o f  3 kb. suggesting that the 
method was applicable to the detection o f most Dl SF V genomes Indeed, defined 
PCR products were generated from every Dl SFV preparation that was examined 
However, for RNA preparations comprising differently sized Dl genomes (for 
example, those from Dl SFV-p7) it was likely that the relative amounts o f  PCR 
products derived from these did not reflect the amounts of the respective RNA
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species It was possible that the use o f primers specific for the termini o f  SFV RN A 
excluded certain RNA species from amplification by RT-PCR However, evidence 
from previously analysed Dl SFV genomes suggested that all retained the termini 
o f SFV RNA (Lehtovaara el cU. 1981, 1982) As a consequence o f these 
limitations o f RT-PCR, it was unlikely that the PCR products were an accurate 
representation of the Dl SFV species in the RNA preparations from which they 
were derived It would have been desirable to develop the technique o f  northern 
blotting for analysis o f all the SFV-denved RNAs in a given preparation, but for 
the purposes o f the project this was unnecessary It was suspected that mouse- 
protecting Dl SFV genomes would comprise a substantial proportion o f  the total 
SFV-denved RNA from tissue culture fluid and therefore would be amplified 
preferentially by RT-PCR A further advantage o f using RT-PCR was that 
sufficient quantities o f DNA were produced to enable cloning and subsequent 
analysis o f  putative Dl SFV genomes
CHAPTER 4
M O t.tC U t^ R  CLONING O F DEFECTIVE GENOM ES OF 
S E M I.Ik l F O REST VIRUS
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INTRO DU CTIO N
This chapter describes the molecular cloning of PC'R products derived from mouse- 
protecting Dl SFV tissue culture preparations Modifications of two o f  these 
clones, pSFVDi-6 and pSFVDI-19, are also discussed In addition, the 
construction o f various sub-clones o f pSFVDI-6 and pSFVDI-19 and the 
construction o f an artificial Dl genome by the internal deletion of the lull-length 
infectious clone pSP6-SFV4 (LiljestrOm el a!., 1991) are described It should be 
noted that this chapter is included to show how the project progressed and 
therefore includes results that were obtained without the benefit of hindsight
The purpose of constructing clones was to permit characterisation o f Dl SFV 
genomes by sequencing, and to enable homogeneous defective virus populations to 
be produced, so that their biological activities could be defined on the basis of 
nucleic acid content To date, only a lew Dl SFV clones have been made 
(discussed in Chapter 5). these are incomplete, lacking the S' termini o f the 
defective genomes (Lehtovaara el a!.. 1981. 1982) Because RT-PCR was used in 
this project to amplify Dl SFV genomes using primers to the termini of SFV RNA, 
the amplification products retained the termini of the defective genome Assuming 
that there were no other sequences either side of the Dl RNA from which the K R  
products were derived, it was reasonable to expect that clones of these PCR 
products would comprise complete Dl SFV genomes and hence that RNA 
transcripts from the clones could be propagated as Dl virus
Initially PCR products were cloned into a transcription vector and RNA 
transcribed from these clones had additional sequences derived from this vector at
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both termini Similar work with Dl Sindbis virus by Levis el al. (1986) showed that 
biologically active RNA transcripts were produced if the promoter for RNA 
polymerase was positioned directly upstream o f  the insert, and the restriction 
enzyme site that permitted run-off transcription directly downstream No work was 
presented on the consequence of having additional non-viral sequences attached to 
the RNA transcripts, but Liljestrdm el a !  (1991) found that the presence of non- 
viral sequences upstream o f the full-length SFV clone was deleterious to 
infectivity For example, the clone pSP6-SFV3 had two extra ('-residues between 
the insert and the transcription start site, the removal o f  which increased infectivity 
1000-fold, to levels comparable to that o f the virion RNA whether these findings 
have any bearing on the propagation as virions o f Dl SFV genomes is not known 
However, it was found that RNA transcripts derived from the first clones that were 
made were not propagated as virions It was not known whether this non­
propagation was due to the presence of additional sequences at both termini or 
because an efficient method for transfecting RNA transcripts into tissue culture 
cells had not been established at this stage o f the project As a precaution, these 
clones were modified so that RNA transcripts produced from them contained only 
SFV-derived sequences
The method for obtaining clones with correctly aligned transcription features was 
based on that used by Makmo el a l (1990) They produced clones o f  defective 
mouse hepatitis virus from PCR products generated using a 5' primer that 
incorporated the promoter for T7 RNA polymerase and a 3' primer containing a 
unique restriction enzyme site Hence the transcription start site o f the clone 
obtained, and the location o f the 3' cleavage site that permitted run-off 
transcription, was determined in the design o f the PCR primers This chapter
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describes the use o f  such primers for the modification o f existing clones and 
describes the cloning o f PCR products obtained from RNA using these primers 
(see Chapter 4)
The second part o f this chapter describes the construction o f various sub-clones of 
two o f  the full-length DI SFV clones that were produced (pSFVDI-6 and pSFVDI- 
19) These sub-clones were made primarily for sequencing purposes (see Chapter 
5) Two internally deleted sub-clones o f  pSFVDI-6 (pSFVDI-IA2 and pSFVDI- 
M2) were used subsequently to investigate regions o f  the Dl genomes that were of 
importance in interference and propagation (Chapter 7).
Finally, attempts were made to construct an artificial Dl SFV genome from the 
full-length SFV done. pSP6-SFV4 (Liljestrom el a/.. 1991) The only previous 
report o f  an artificially constructed Dl genome was for poliovirus (Kaplan and 
Racaniello, 1988, Hagino-Yamagishi and Nomoto. 1989) An infectious DNA 
clone o f  poliovirus was cleaved with an appropriate restriction enzyme such that 
the region encoding capsid proteins was deleted and the non-structural protein 
coding region remained intact RNA transcribed from this clone was capable of 
autonomous replication, but required helper poliovirus for encapsidation Insertion 
o f a 4-base sequence into the clone caused a frame-shift that prevented the RNA 
transcripts from being propagated However, evidence from previously cloned Dl 
SFV and Sindbis genomes suggested that for these viruses it was not important to 
retain protein-coding regions (SFV l.ehtovaara el a l 1981.1982 Sindbis Levis*/ 
al., 1986) For cloned Dl SFV genomes, the regions derived from the termini o f 
the standard virus genome were found to be conserved, as were the regions derived 
from the nsP2 gene o f  SFV (Jalanko and Soderland. 1985) Because it was not
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certain which of' these regions were essential for their propagation as virions, the 
clone described in this chapter (pSFVDI-SBI) was constructed so that only the 
termini o f the SFV-derived sequences o f pSP6-SFV4 were retained The 
propagation in tissue culture o f  RNA transcripts produced from this clone is 
discussed in Chapter 7
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RESULTS
I. (  toning o f l»l SFV-derived PCR product!.
(a) (  to n in g  o f  K  R p ro d u c t!
PCR products derived from tissue culture preparations o f Dl SFV (see Chapter 3) 
were purified by phenol extraction and then modified so that they could be cloned 
Firstly, because the PCR primers used for the amplification of Dl SFV genomes 
lacked the 5’ terminal phosphate group the products were treated with T4 
polynucleotide kinase In addition, it was assumed that the products o f  PCR 
amplification had ragged ends as a consequence o f  the Taq polymerase 
incorporating nucleotides less efficiently at the termini o f the template DNA 
Although the final step o f 5 minutes at 72°C in the protocol used for PCR probably 
helped the terminal incorporation o f nucleotides, products were treated with the 
large fragment o f  E.coU DNA polymerase I to ensure that they were blunt-ended
The initial choice o f vector for cloning was pBluescribe II KS , which has a 
polylinker incorporated into the gene for 0-gaiactosidase. and an ampicillin 
resistance gene for selecting transformed bacteria Colonies harbouring 
recombinants were distinguished from those with just vector DNA by their absence 
o f colour when grown on agar containing IPTCi and X-gal (see Methods) This 
vector contains the promoters for T3 and T7 RNA polymerases, enabling 
transcripts of cloned inserts to be produced For reasons outlined in the 
Introduction, later experiments with PCR used a 5' primer containing the promoter 
for T3 RNA polymerase (5,.V/*T'-7'J). and a 3' primer containing the restriction
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enzyme site Ncol (3'SbV-Nco) The vector chosen for the cloning o f  these PCR 
products and for the majority o f the work described here was pUCl3, which has 
the same selection features as pBluescribe II KS '. and docs not possess promoters 
for RNA polymerases Both the vectors described above possess a site for the 
restriction enzyme Smal within the polylinker region This enzyme cleaves the site 
at the axis o f  dyad symmetry, producing blunt ends Hence PCR products that had 
been blunt-ended were inserted into vector linearised with Smal
(b ) Construction o f  pSFVDI clones 1-8
The previous chapter showed that similarly sized (2 I kbp) products were obtained 
following RT-PCR amplification o f RNA extracted from two different tissue 
culture preparations o f Dl SFV ( Dl SFV-p8 and Dl SFV-AC) Both these 
preparations had biological activity in vitro and were derived from populations that 
had mouse-protecting activity, although they were non-protecting themselves (see 
Chapter 8) At this stage o f the project it seemed worthwhile to clone these PCR 
products because no full-length clones of Dl SFV genomes had been produced 
before, and because it was suspected that the tissue culture preparation from which 
they were derived was heterogeneous and consisted o f  both protecting and non­
protecting Dl virus Initially clones were obtained o f  PCR products derived from 
both the above Dl SFV preparations by blunt-cnd ligation into the Smal site o f 
pBluescribe II KS and transformation into £  colt (TG2) cells In the first cloning 
experiment a recombinant plasmid was isolated containing a 2 I kb insert, which 
was confirmed to be derived from PCR product by Southern blotting using a [y- 
,JP]dATP-labelled PCR primer as probe (data not shown) This clone was 
designated pSFVDI-1
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Figure 4 I . taken from a cloning experiment that used K 'R  product derived from 
Dl SFV-p8, shows a number o f  plasmid preparations from bacteria potentially 
harbouring recombinant DNA The plasmids shown in lanes I, 2, 6 and 9 all 
contained a 2 1 kbp insert which, like pSFVDI-1. was cut once asymmetrically by 
Pvull these were designated pSFVDI-3 to  pSFVDI-6 The other recombinant 
plasmids shown in this figure, containing inserts o f between 0 2 and I 2 kbp in size, 
were either artefacts o f the methodology employed for RT-K 'R and cloning or 
represented Dl sequences smaller than the predominant K 'R  product described 
above One such clone of 0 6 kbp in size was analysed by sequencing and found to 
consist only of the terminal sequences of SFV RNA. suggesting on comparison 
with published Dl SFV genomes that it was unlikely to be a true Dl genome (data 
not shown) These small clones were not investigated further Similar cloning 
experiments not detailed here, using K 'R  products derived from Dl SFV-AC, 
produced the clones that were designated pSFVDI-2, 7 and 8 These plasmids also 
had inserts o f 2 I kbp
(c) Derivation o f pSFVDI inserts
The first indication that the pSFVDI clones had inserts derived from a Dl genome 
was through restriction analysis Figure 4 2a shows examples o f the restriction 
digests that were made The Accl digest produced DNA fragments o f  0 3 and 0 2 
kbp. which were determined from double digests not shown here to be from 
juxtaposed regions in the clones This suggested by comparison to a restriction 
map o f the SFV genome (Figure 4 2c) that the clones contained at least 0 5 kbp 
derived from the 5’ terminus of the SFV genome In addition, three of the sites for 
Accl, Pstl and Pvull were calculated to  lie within approximately 100 bp o f  each
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Figure 4.1 Agarose gel profile o f Pvu 11-digested plasmid preparations from 
putative Dl SFV clones
PCR product derived from Dl SFV-p8 (Chapter 3) was cloned into the Smal site 
o f pBluescribe II KS+ (3 0 Icbp) Plasmid DNA was prepared from bacterial clones 
and cleaved with Pvull. which cuts pBluescribe II KS + either side o f the polylinker 
to  yield fragments o f  2 7 kbp and 0 3 kbp Inserted DNA was thus incorporated on 
the 0 3 kbp fragment Twelve plasmid preparations are shown above In all lanes, 
the 2 7 kbp band corresponds to the size o f the vector-derived fragment, and the 
smaller bands to inserted DNA that includes 0 3 kbp from the vector The inserts 
were calculated to range in size from 0 2 to 2 I kbp Four o f the plasmids (lanes I . 
2. 6. 9) had inserted DNA o f  2 I kbp. corresponding to the size o f the predominant 
PCR product from Dl SFV-p8
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(a)
(c) Semliki forest virus
Figure 4.2 Restriction analysis o f Dl SFV clones
(a) shows examples o f  restriction digests o f pSFVDI-6 (5 I kbp) that were made to 
establish the origin o f the inserted DNA (b) shows six plasmid preparations 
digested with Pst I this enzyme cleaves the vector (pBluescribe II KS+. 3 0 kbp) 
upstream of the Smal site, and cleaves the inserted DNA twice This figure shows 
that the inserted DNA is the same size in all six clones, and for pSFVDI-3, 7 and 8 
is in one orientation within the vector, and for pSFVDI 4. 5 and 6 in the other (c) 
shows a diagram o f  SFV cDNA, with relevant restriction sites indicated Sites 
suspected to have been retained by pSFVDI-6 are boxed
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other This close arrangement of restriction sites also occurs in the nsP2 gene of 
SFV. suggesting that the clones may contain part o f this gene, and therefore that 
the cloned inserts were unlikely to be artefacts o f the methodology used to produce 
them Figure 4 2b shows an analysis o f six o f  the clones digested with the enzyme 
Pstl This and other restriction analyses not shown here suggested that the clones 
pSFVDI - 1 to 8 contained the same insert, either in the 5’-3’ or 3'-S' orientation
(d )  M o d if ic a t io n  o fp S F V  D I-6
pSFVDI-2, 3 and 5 were found by sequence analysis to have lost nucleotides from 
the termini, probably in the process of cloning The other clones had intact termini, 
and from these pSFVDI-6 was chosen for modification Rather than returning to 
the original population o f Dl virus from which pSFVDI-6 was derived, it was 
thought more practical to amplify DNA from the clone itself The primers JW V - 
13 and 3'Sb V-Nco were used in the amplification, and a 2 1 kbp PCR product was 
obtained (see Chapter 3). which was blunt-end ligated into the Smal site o f  pUCI3 
It was necessary to remove the original vector before transforming bacteria by 
digesting with BamHI and fccoRl, which do not cut within the insert Successful 
re-cloning o f the insert in pSFVDI-6 was confirmed initially by restriction analysis 
(data not shown) To ensure the termini of the insert were intact, the plasmid was 
cut with Ncol and transcribed with T3 RNA polymerase (Chapter 6) Sequencing 
provided the final confirmation that the molecule had been successfully re-cloned
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(e ) C o n s tru c tio n  o f  p S K V D I-1 9
RT-K 'R amplification from the preparation Dl SFV-p7 using the primers S'ShV- 
TS and 3'ShV-Nco yielded a product o f I 2 kbp, in addition to one of 2 I kbp (see 
C hapter 3) It was assumed that the 2 I kbp product was the same as that observed 
on amplification from Dl SfV-pS, and hence the same as the insert in pSFVDI-6 
In addition, it was observed that while the passaging o f Dl SFV-p7 once in BHK- 
21 resulted in the loss of the I 2 kbp product and the concomitant loss o f mouse- 
protecting activity (see C hapter 8). the 2 I kbp product was retained It was 
reasonable to suspect, therefore, that the I 2 kbp product comprised all or part of 
the protecting activity o f Dl SFV-p7 and that the 2 I kbp product and therefore the 
insert in pSFVDI-6 had little or no such activity This conclusion assumed that 
mouse-protecting sequences o f Dl SFV-p7 were indeed amplified by R T -K 'R  The 
K 'R  product was transcribed prior to cloning (sec C hapter 6) and the RNA 
transcripts transfected into SFV-infected BHK-21 cells to produce Dl virions (see 
Chapter 7) The observed protecting activity of this Dl SFV preparation in mice on 
coinoculation with a lethal dose o f  SFV (see Chapter 8) confirmed the above 
conclusion
Figure 4 3 shows restriction digests o f three preparations o f  recombinant plasmids 
from a cloning experiment that used the K ’R product obtained from Dl SFV-p7 
The vector used here was pUCI3 (2.7 kbp). and initial analysis o f these 
recombinants by digestion with Pvull showed that two o f these plasmids contained 
a I 2 kbp insert One of these two plasmids could be digested with Ncol. indicating 
that the 3’ terminus of the insert was intact in this case this was analysed further by 
transcription and sequencing Unfortunately, transcription from this plasmid was
n o
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Figure 4.3 Restriction digests o f  plasmid preparations from putative Dl SFV 
clones
I'hree potential D l SFV clones (I, 2 and .1) are examined here These were 
produced by inserting the PCR product derived from Dl SFV-p7 (Chapter 3) into 
the Sinai site o f  pUCI3 (2 7 Icbp) Digestion with Pvull, which cleaves either side 
o f  the pUC 13 polylinker produced vector-derived fragments of 2 4 kbp. and 
fragments that totalled I 8 kbp ( I)  and I 5 kbp (2. 3) in size, these included 0 3 
kbp derived from pUCI3 Plasmids 2 and 3 therefore contained inserted DNA of 
I 2 kbp in size, corresponding to the PCR product o f interest Only plasmids I and 
3 were linearised with Ncol fccoRI. which cleaves pUCI3 once within the 
polylinker, did not cleave within the inserted DNA
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unsuccessful, suggesting that the 5' terminus containing the T3 RNA polymerase 
promoter was not intact It was therefore necessary to re-clone Because o f limited 
starting material, more PCR product was made from the above plasmid, using the 
same primers as before A clone was generated from this PCR product that had 
correct termini, as determined by transcription and sequencing experiments, and 
this was designated pSFVDI-19
( f )  D e r iv a tio n  o fp S F V D I-1 9
Before it was sequenced. pSFVDI-19 was digested with a number of restriction 
enzymes, primarily to confirm the origin o f  the insert by comparison to digests of 
the PCR product from which it was derived, and in an attempt to elucidate the 
regions in the SFV genome from which this putative Dl genome was derived It 
seemed likely from these digests that the pSFVDI-19 insert had derived from the 
12 kbp PCR product and further that it contained part o f the nsP2 gene, for the 
same reasons described above for pSFVDI-6 (data not shown)
< t)  R e s tr ic tio n  m a p p in g  o f  p S F V D I-6  a n d  p S F V D I-1 9
As stated above, restriction sites were determined initially through a senes of 
enzyme digestions Figure 4 4 shows diagrams of pSF VDI-6 and pSFVDI-19, with 
relevant restriction sites included To avoid confusion, the precise locations of 
these sites are shown these were determined by computer analysis after the clones 
had been fully sequenced The inserts o f  both clones are in the 3'-5' orientation and 
have unique Ncol sites at the 3' termini enabling the plasmids to be lineansed 
before transcription Unique restriction sites within the inserts themselves include
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F igure 4.4 Diagrams of pSFVDl-6 and pSFVDI-19
DNA was inserted into the Smal site o f the pUCI3 polylinker M I3m pll Both 
inserts are shown as linear segments, in the S' to  3' orientation, and relevant 
restriction sites are indicated The numbers shown refer to the nucleotides adjacent 
to. and on the 5' side of the points of cleavage The segment shown below the 
dashed lines represents pUC13 DNA the ampicillin resistance gene (Ampr) it 
shown The restriction sites BamHI. Pst I and KcoR] o f  pUCI3 are located within 
the polylinker
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those tor Nhel and HstMl in pSFVDI-6 and Mhil in pSFVDI-19 Unique sites for 
BamHI and HcoRl are contained within the pUCl3 polylinker
2. Creation of sub-clones of pSFVDI-4 and pSFVDI-19
(■) Sub-cloning from pSFVDI-6
Sub-clones were produced from pSFVDI-6 which permitted the sequencing o f  the 
majority o f this clone and hence provided the information needed for primers to be 
designed that could be used to  determine the remainder o f the sequence (see 
Chapter 5) The restriction enzyme Pstl was found to generate the most 
conveniently sized fragments for this sub-cloning (Figure 4.5a). At this stage o f  the 
project, the insert o f  pSFVDI-6 had not been modified (see above) and was in a 
pBluescribe II KS' vector in the 5'-3* orientation The Pstl site in the pBluescribe II 
KS polylinker was upstream o f  the 5' terminus o f the unmodified insert, enabling 
the 5' terminal 0 5 kbp fragment and the internal 0 9 kbp fragment to be isolated 
from the clone The methodology was therefore to digest pSFVDI-6 with Pstl. 
isolate the 0.5 and 0 9 fragments by separation on an agarose gel. purify with 
Geneclean (see Methods), and ligate these into Pstl-digested pBluescribe II KS 
This produced the clones designated pSFVDI-6Pl and pSFVDI-6P2 In addition, 
the digested pSFVDI-6 was religated to produce pSFVDI-6P3. which contained 
only the 3* terminal 0 8 kbp o f the original clone Figure 5 I (Chapter 5) shows 
how these sub-clones were used for sequencing
Two other sub-clones of pSFVDI-6 were made which were subsequently used to 
investigate the sequences required for propagation o f Dl SFV genomes The first.
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Figure 4.5 Diagrams o f sub-clones o f pSFVDI-6
(a) pSFVDI-6* was digested with Pstl and the 451 and «Ml bp fragments inserted 
into pBluescribe II KS+ to give pSFVDI-6PI and pSFVDI-6P2 respectively 
pSFVDI-6P3 was made by religation of Pst I-digested pSFVDI-6*
(b )  pSFVDI-l A2 was made by partially digesting pSFVDI-6* with Accl to delete 
the 919 nucleotide region between Accl 534 and Accl 1453 (boxed) pSFVDI-M2 
was made by excision o f the 465 bp Mlul fragment o f pSFVDI-6
• the original form o f pSFVDI-6 was used here the vector was pBluescribe KS+
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pSFVDl-lA2, is shown diagrammatically in Figure 4 5b. and its profile on an 
agarose gel is shown in Figure 4 6a To create this clone, pSFVDI-6 was partially 
digested by incubating for a brief period (2 minutes) with Accl and then religated 
The Accl sites at .108 and 1248 are compatible, as are the ones at 534 and 1453, so 
the deleted forms o f pSFVDI-6 that were produced lacked either the 940 region 
from 308 and 1248 or the 919 bp one between 534 and 1453 Digestion of 
pSFVDI-IA2 with Pstl, which cleaves within the Accl (1248-1453) fragment of 
pSFVDI-6, showed that this fragment had been deleted (data not shown) Thus the 
0.2 kbp band shown in lane 2 o f Figure 4 6a comprised DNA derived from the 
Accl (308-534) fragment and the deletion in pSFVDI-IA2 comprised the region 
between Accl 534 and Accl 1453 o f pSFVDI-6
Figure 4 6a also shows other sub-clones that were made by the partial digestion of 
pSFVDI-6 with Pstl. and religation Two o f  these clones (shown in lanes 7 and 9) 
lacked the internal 0 9 kbp Pstl fragment o f pSFVDI-6, but because o f their 
similarity to pSFVDI-l A2 they were not used in subsequent experiments
pSFVDI-M2 was created to demonstrate that some function essential to the 
propagation o f RNA transcripts of pSFVDI-6 was located between the two Mlul 
sites (see Chapter 7). This clone was made by the excision o f the 466 bp Mlul 
fragment from pSFVDI-6 (Figure 4 5b) Figure 4 6b shows preparations o f  plasmid 
DNA from transformed bacteria, digested with either Mlul or Pvull Three o f  the 
four preparations shown were cut only once by Mlul. indicating successful excision 
o f  the fragment Further, digestion o f these three with Pvull only gave two 
fragments, suggesting the site located between the two Mlul sites was lost (see 
Figure 4 4) and that the deletion was successful
1 1 6
M l  2 3 4 5 6 7 8 9  10 I I  12 M
l I l l I I I I l l l l I I
kbp
3 1
10
0.5
(b) • M lul ♦ Pvull
i----- 1----- 1 i------1----- 1
M  I 2 3 4 1 2 3 4  M
kbp
4 1
20
Figure 4.6 Agarose gel profiles o f  potential deletion mutants o f pSFVDI-6
(a) pSFVDI-6 was partially digested with Accl or Pstl and transformed into 
bacteria Plasmids from 12 recombinants were digested with Accl (1-6) or Pstl (7- 
12) O f the Accl deletion mutants, all but clone 4 have lost either the 940 fragment 
between Accl 308 and Accl 1248, or the 919 fragment between Accl 534 and 
Accl 1453 (see Figure 4 5) O f the Pstl deletion mutants, clones 7 and 9 have lost 
the internal 0 9 kbp Pstl fragment o f  pSFVDI-6 (see Figure 4 4), clone 8 the 0 5 
and 0 9 kbp fragments, and clones 10. 11 and 12 retained both these fragments
(b) MluI-digested pSFVDI-6 was transformed into bacteria Plasmids from clones 
2, 3 and 4 were cleaved once by Mlul to yield fragments o f  4 4 kbp. and twice by 
Pvull to yield fragments o f 2 I and 2.3 kbp The origin o f clone I is not known
117
(b ) Sub-cloning from  pSFVDI-19
Sub-clones from pSFVDI-19 were made solely for the purposes o f  sequencing 
Three were made, by the same method as described above for pSFVDI-6 using 
Pstl to generate suitable fragments for cloning (Figure 4 7) Unlike the sub-cloning 
from pSFVDI-6, however, the final modified version o f pSFVDI-19 was used in 
the experiment The plasmids that were generated were given the designations 
pSFVDI-l9PI, 2 or 3 The first two were created by inserting the 5' terminal 0 5 
kbp and the internal 0 3 kbp Pstl fragments o f pSFVDI-19 into pBluescribe II KS , 
while pSFVDI-l9P3, which was generated through religating digested pSFVDI- 
19. retained pUCI3 as the vector
3. Creation o f an a rtific ia l D l SFV genome
(a) Strategy
At this stage of the project the sequences required by Dl SFV genomes for 
propagation were not known, and it was suspected that, like Dl Sindbis genomes, 
only the terminal sequences and part o f the nsPI coding region were needed (Levis 
el al., 1986) In order to create an artificial Dl SFV genome, it was therefore 
decided to centrally delete sequences from the full-length infectious clone pSP6- 
SFV4 (I.iljestrOm el al., 1991) to leave the non-coding terminal sequences and the 
5' terminus o f the nsPI gene It was not known if the genome size o f a Dl SFV was 
important for propagation as virions and so it was decided to produce a deleted 
molecule of between 2 0 and 2 5 kbp to match the size of pSFVDI-6 and 
previously cloned Dl SFV genomes (l^ehtovaara el a!., 1982)
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Figure 4.7 Diagrams o f Pstl sub-clones o f pSFVDI-19 used for sequencing
DNA fragments are shown as linear segments, with the position o f the Pstl site of 
pU C IJ indicated with respect to the first nucleotide of the SFV-denved sequences 
o f  the insert pSFVDI-19 was digested with Pstl. and the 488 and 30S bp 
fragments isolated These were cloned into Pstl-digested pBluescribe II KS+ to 
give pSFVDM 9PI and pSFVDM9P2 respectively pSFVDI-l9P3 was made by 
religation o f Pstl-digested pSFVDI-19, and hence retained pUCI3 as the vector
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(b )  D e le tion  o f  pSP6-SFV 4
The restriction map o f pSP6-SFV4 (Figure 4.8) indicated that a suitable internal 
deletion would be generated by using Sail to cleave the clone at the 5' terminus, 
and Bstbll or Ndel to cleave at the 3' terminus Figure 4 9a shows the 
consequence o f single and double digestions with these enzymes Because the Sall- 
Ndel digest did not produce the expected band pattern on an agarose gel. probably 
due to incomplete digestion, and the Sall-BstEII one did. the latter was used as the 
source o f DNA for cloning It was likely, because the cleavage points o f these 
enzymes were known, that the 5.1 kbp band shown in Figure 4 9a comprised the 
sequences o f interest, but it was unnecessary to purify this DNA since none o f the 
others contained sequences capable of replication in bacteria The digested plasmid 
was treated with the large fragment o f  tLcoii DNA polymerase I to fill in the 
cohesive ends that had been generated, and this was religated and transformed into 
h coil (TG2) cells Figure 4 9b shows a plasmid preparation from one clone that 
was obtained Here it was digested with Nhel to give a three-band pattern 
indicating that only the terminal sequences of pSP6-SFV4 had been retained (see 
Figure 4 8) Digestion with Spel ensured that linearisation was still possible this 
enzyme is used to cleave the lull-length clone at the 3' terminus o f  the insert such 
that it can be transcribed Comparison o f digests o f pSFVDI-6 shows that the 
resulting clone, designated pSFVDI-SBI. was o f a similar size, and by calculation 
the insert was 2.2 kbp in length Further evidence that the central regions of pSP6- 
SFV4 had been deleted was indicated by the fact that pSFVDI-SBI was not 
cleaved by EcoRI (data not shown) this enzyme cuts the lull-length clone at four 
sites (see Figure 4 8)
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Kigurr 4.8 Construction o f pSFVDI-SBI from pSP6-SFV4
The diagram o f  pSP6-SFV4 is reproduced from LiljestrOm and Garofr ( 1991b), 
and shows the SFV coding regions contained within an SP6 expression vector 
(pPLH2l 1) and rdevanl restriction sites The vector is also cleaved by Nhcl no 
information was available on the precise location o f  this site To construct 
pSFVDI-SBI. the region between Sail 1658 and BstFII 10920 of pSP6-SFV4 
(boxed) was deleted Sticky ends were filled prior to ligation the position of 
ligation in pSFVDI-SBI is indicated as nucleotide 1662
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Figure 4.9 Restriction analysis o f pSP6-SFV4 (a) and pSFVDI-SBI (b)
pSP6-SFV4 (l.iljestrOm t i  al., 1991) was digested with a number of restriction 
enzymes to discover which gave suitable fragments for cloning The EeoRl digest 
was included to confirm pSP6-SFV4 had not lost sequences during preparation 
this digestion gives a characteristic 4-band pattern on an agarose gel Most 
digestions gave the expected fragments as determined from the restriction map of 
pSP6-SFV4. the Ndel ♦ Sail digestion was partial DNA from the Bsthll ♦  Sail 
digestion was religated and transformed into bacteria A clone was obtained 
(pSFVDI-SBI) o f 5 2 kbp, which corresponded to the expected size o f a Sall- 
BstKII deletion o f pSP6-SFV4 Digestion with Nhcl gave three fragments o f  I 8. 
I I and 0 8 kbp. while Spel cleaved the plasmid once (b) Comparison to 
digestions of pSFVDI-6 showed the plasmids, and by calculation their respective 
SFV-derived sequences were o f a similar size
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DISCUSSION
In a typical cloning experiment using blunt-ended PCR products, less than 1% of 
the colonies that were transformed were found to harbour recombinant plasmids 
This was probably a consequence o f the low efficiency with which the blunt-ended 
DNA ligated into the vector In the cloning experiment shown in Figure 4 I . all the 
putative recombinants had inserted DNA and a quarter had the DNA sequence of 
interest, showing that the selection o f recombinants was accurate and thus it was 
not necessary to find an alternative screening method However, analysis o f the 
termini o f several cloned DNAa by sequencing showed that approximately 50% 
had lost nucleotides This loss may have occurred in the process of ligation, or 
because some o f the PCR products that were cloned did not have intact termini 
The latter would have been possible if the synthetic oligonucleotide preparation 
used for PCR was heterogeneous, with some molecules lacking terminal 
nucleotides Whatever the reason, in retrospect it may have been advantageous to 
design PCR primers that included unique restriction enzyme sites These would 
have enabled the DNA produced on PCR amplification to be ligated using cohesive 
termini, which is more efficient than blunt-ended ligation and permits molecules 
with correct termini to be selected for in the process o f ligation However, in later 
experiments primers were used that incorporated features permitting RNA 
transcription and therefore contained many additional nucleotides It was thought 
that the inclusion o f more non-viral sequences would have reduced the sensitivity 
of reverse transcription and PCR amplification
The first Dl SFV clones that were obtained were found to have inserted DNA of 
2 1 kbp. a size similar to that of previously cloned Dl SFV genomes However.
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because restriction digests o f these clones did not produce fragments of the same 
size, and some enzymes cleaved only once, it was probable that these clones did 
not possess extensive repeat regions (unlike previously cloned genomes) Tentative 
conclusions were made in the Results section o f this chapter on the derivation of 
the cloned molecules from SFV RNA These conclusions were confirmed by 
sequencing (see Chapter 5) and by propagation of RNA transcribed from the 
clones in the form o f virus (sec Chapter 7).
The eight clones designated pSFVDI-l to 8 were all suspected to have the same 
inserted DNA This suggests either that the 2 I kbp PCR product that was cloned 
comprised just one species o f  DNA and hence the method o f PCR amplification 
was selective for particular molecules, or that the Dl SFV preparation from which 
the PCR product was derived was homogeneous The latter is unlikely because Dl 
SFV populations have been shown to  be heterogeneous (K iln linen  el at., 1981, 
Barrett el a/., 1984a) It is likely, therefore, that the reason several identical clones 
were obtained from two separate preparations of Dl SFV was that PCR 
preferentially amplified just one RNA species
The PCR product that was generated from the mouse-protecting preparation Dl 
SFV-p7 was shown in Chapter 3 to differ from that derived from the non- 
protecting Dl SFV-p8 by having an additional 1.2 kbp species Although no Dl 
SFV genomes have been found to date o f  less than 2 kb in size, the evidence 
described in the Results section suggested that this was a true Dl genome For 
reasons described above for pSFVDI-6. the restriction analysis o f the clone that 
was produced from this product (pSFVDI-19) suggested that there were no
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extensive repeat regions, which are characteristic of previously cloned Dl SFV 
genomes.
The modification of the termini of pSFVDI-6 and pSFVDI-19 used the clones 
themselves as templates for PCR amplification, because o f limited starting material 
It would have been desirable to amplify from the original RNA preparation to 
minimise the incorporation of errors into the template during amplification 
However, as discussed in Chapter S, it was unlikely that a few nucleotide 
differences from the RNA from which the clones were derived would be 
deleterious to the biological characteristics o f the Dl genome
The two deletion mutants pSFVDI-!A2 and pSFVDI-M2 were made primarily to 
study interference and propagation of Dl SFV It was not known at the time if Dl 
SFV genomes had a minimum size limit below which they would not be 
encapsidated Fortunately pSFVDI-19, which is smaller than both these clones, was 
found to be propagated as virions, and the sub-clones were thus deemed to be 
suitable for further investigation However, because the primary purpose o f  this 
project was to study mouse-protecting Dl SFV genomes, and because these 
deleted forms o f pSFVDI-6 were suspected to comprise non-protecting sequences, 
they were not investigated extensively
The attempt at producing an artificial Dl genome was made for the reasons 
described in the Introduction, and because it was not possible to propagate RNA 
transcripts of the putative Dl SFV clones in tissue culture at the time There was 
concern that this was a consequence o f the clones not possessing correct termini 
RNA transcripts from the full-length SFV clone, known to be propagated
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efficiently as virus in tissue culture, possess only one non-viral nucleotide on  the 5' 
terminus, and have a 70 base poiyadenylation sequence at the 3' terminus 
(LiljestrOm el aJ., 1991) There was little information on the structure o f  the 
termini o f  DI SFV genomes, but it was probable that deletion of pSP6-SFV4 
would generate a defective genome with termini consistent with those o f  a DI 
genome Hence, if RNA transcribed from this deleted clone (pSFVDI-SBI) was 
not propagated as virions in tissue culture it would probably be because it lacked 
other sequences essential to DI SFV propagation
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INTRODUCTION
The previous chapter described the construction o f a number o f DNA clones 
derived from the mouse-protecting virus preparation, DI SFV-p7 This chapter 
describes the nucleotide sequences of two o f the clones, pSFVDI-6 and pSFVDl- 
19, which were used in subsequent transfection experiments Comparisons are 
made with SFV RNA and with previously published DI SFV genomes
The nucleotide sequences o f  pSFVDI-6 and pSFVDI-19 were determined primarily 
to establish the regions o f  SFV RNA from which they were derived and to learn 
more about the mechanisms involved in their generation The primary structure of 
DI genomes in general contains the information required for replication and 
encapsidation by standard virus proteins, and by definition the information for 
interference and amplification Because DI genomes are only a fraction of the size 
o f the standard genome, these properties reside within a relatively small length of 
nucleic acid By comparing nucleotide sequences of DI and standard virus, regions 
o f  the standard genome can be defined as recognition sites for the propagative 
proteins of the virua The comparisons made in this chapter between the DI SFV 
clones and the SFV genome therefore demonstrate that DI genomes are useful 
tools for studying the molecular biology o f  the virus from which they are derived
As stated previously, little information is available on the nucleotide sequences of 
DI SFV genomes Lehtovaara el a i ( I9 § |, 1982) described the nucleotide 
sequences o f two DI SFV RNAa, DI 301 and DI 309, from which the clones 
pKTH 301 and pKTFI 309 were constructed Because SFV RNA had not been 
completely sequenced at that tune, it was not possible to determine how most of
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the sequences o f  these RNAs had been derived from standard RNA In this 
chapter. Dl 301 and Dl 309 are compared with pSFVDI-6 and pSFVDI-19 in an 
attempt to establish the nucleotide sequence content o f  Dl SFV genomes in 
general
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RESULTS
1. T h r nucleotide sequence o f pSKYDI-6.
(a) Strategy fo r  sequencing pSKVI>l-6.
pSFVDI-6 was sequenced by the chain-termination method (Sanger el al., 1977). 
The sequencing strategy and the synthetic oligonucleotides used are shown in 
Figure 5.1 Sub-clones were made by digesting pSFVDI-6 with the restriction 
enzyme Pstl, which generated fragments of approximately 800 and 900 bp These 
were ligated into pUC13 In addition, the digested pSFVDI-6 was religated, so that 
it contained the 500 nucleotides from the 5' terminus o f the original clone These 
sub-clones permitted the majority o f pSFVDl-6 to be sequenced by primer 
extension from within pUC13 In order to sequence both strands, and the 
remainder o f  the clone, several primers specific to pSFVDl-6 were used Primer 
extension from the oligonucleotide designated '-2000 (Figure 5.1) was only 
possible using a cycle sequencing method, probably because secondary structure in 
the 3' region o f pSFVDI-6 was not removed at the temperature required for the 
standard sequencing method
(b ) The nucleotide sequence o f pSKVDI-6.
The nucleotide sequence o f pSFVDI-6 is presented in Figure 5 2, with differences 
from the sequence of SFV (C.aroff .•/ al.. 1980a, b. Riedel el al.. 1982, Taklunen. 
1986) indicated below the sequence The sequence given is that o f  the clone used 
for transfection experiments The original clone was modified by incorporation o f
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pSFVDI-6
0 200 400 600 800 1000 1200 1400 1600 1800 2000
I---------1--------- 1---------1---------1---------1---------1--------- 1---------h
P * l
(i) Primers annealing to pUC 13
17 ('universal'primer) : 5 ' -  GTTTTCCCAGTCACGAC -  3 ' 
*  ('reverse'primer) : 5 ' -  AACAGCTATGACCATG -  3*
(ti) Primers annealing to pSFVDI-6
+200  : 
- 3 0 0  : 
+ 700  : 
-8 5 0  : 
+900  : 
- 1 1 0 0 : 
+ 1200 : 
+1600: 
-1 7 5 0 :  
+ 1800: 
- 2000 :
5 ' -CGCACCTGGCTACCAAATT-3 '
5 • -CATTCTCCTGGAAGGCGC-3•
5 • -QaaCCQ*CGAOCXaGTG-3 •
5 • - GATCCCGGAACCCCAAAG-3 •
5 ' - C C T C G T G A C C A A A C A C G A T C - 3 •  
5 ' - C C GAGG T  T T AACAAGAGC-3 •
5 * -CATCTGCACTGAAGTATGTC-3 • 
5 ' -CATTCCXCAGGGTAACT- 3 •
5 ' -GCAGTGTCCAGGACAGGC-3 • 
5  ' -GTGGAGCACCATATACCT-3 •
(bases 219-237) 
(bases 304-2S7) 
(bases 684-700) 
(bases 854-837) 
(bases 879-898) 
(bases 1101-1084) 
(bases 1182-1201) 
(bases 1595-1611) 
(bases 1753-1729) 
(bases 1778-1794) 
(bases 2004-1987)
Figure 5.1 Strategy used to sequence pSFVDI-6
pSFVDI-6 was sequenced by the chain-termination method (Sanger el a i , 1977) 
using primer extension from within pUCI3 into the clone or sub-clone (i) or from 
within pSFVDI-6 itself (ii) Sub-clones were made from Pstl-restrictcd fragments 
of pSFVDI-6 Arrows show the approximate number o f  nucleotides determined 
with each primer
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pSFVDI-6 (2146 bases)
10 20  30 40  50 60
ATGGCGGATG TGTGACATAC ACGACGCCAA AAGATTTTGT TCCAGCTCCT GCCACCTCCG
G
70 80 90 100 110 120
CTACGCGAGA GATTAACCAC CCACGATGGC CGCCAAAGTG CATGTTGATA TTGAGGCTGA
130 140 150 160 170 180
CAGCCCATTC ATCAAGTCTT TGCAGAAGGC ATTTCCGTCG TTCGAGGTGG AGTCATTGCA
190 2 00  210 220  230 240
GGTCACACCA AATGACCATG CAAATGCCAG AGCATTTTCG CACCTGGCTA CCAAATTGAT
250 260  270 280  290 300
CGAGCAGGAG ACTGACAAAG ACACACTCAT CTTGGATATC GGCAGTGCGC CTTCCAGGAG
310 320 330 340 350 360
AATGATGTCT ACGCACAAAT ACCACTGCGT ATGCCCTATG CGCAGCGCAG AAGACCCCGA
370 380 390 400 410 420
AAGGCTCGTA TGCTACGCAA AGAAACTGGC AGCGGCCTCC GGGAAGGTGC TGGATAGAGA
AU A
430 440 450 460 470 480
GATCGCAGGG AAAATCACCG ACCTGCAGAC CGTCATGGCT ACGCCAGACG CTGAATCTCC 
A
_____ 490 500 510 520 530 540
TACCTTTTGC CTGCATACAG ACGTCACGTG TCGTACGGCA GCCGAAGTGG CCGTATACCA
550 560 570 580 590 600
GGACGTGTAT GCTGTACATG CACCAACATC GCTGTACCAT CAGGCGATGA AAGGTGTCAG
610 620 630 640 650 660
AACGGCGTAT TGGATTGGGT TTGACACCAC CCCGTTTATG TTTGACGCGC TAGCAGGCGC
670 680 690 700 710 720
GTATCCAACC TACGCCACAA ACTGGGCCGA CGAGCAGGTG TTACAGGCCA GGAACATAGG
730 740 750 760 770 780
ACTGTGTGCA GCATCCTTGA CTGAGGGAAG ACTCGGCAAA CTGTCCATTC TCCGCAAGAA
790 800 810 820 830 840
GCAATTGAAA CCTTGCGACA CAGTCATGTT CTCGGTAAGA CTACAGTAGT AGGAGTCTTT
850 860 870 880 890 900
GGGGTTCCGG GATCAGGCAA GTCTGCTATT ATTAAGAGCC TCGTGACCAA ACACGATCTG
(continued overleaf]
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»10 920 930 940 950 960
GTCACCAGCG GCAAGAAGGA GAATTGCCAG GAAATAGTCA ACGACGTGAA GAAGCACCGC 
C U
970 980 990 1000 1010 1020
GGACTGGACA TCCAGGCAAA AACAGTGGAC TCCATCCTGC TAAACGGGTG TCGTCGTGCC
|--------------------------- 1 x
1030 1040 1050 1060 1070 1080
GTGGACATCC TATATGTGGA CGAGGCTTTC GCTTGCCATT CCGGTACTCT GCTGGCCCTA
1090 1100 1110 1120 1130 1140
ATTGCTCTTG TTAAACCTCG GAGCAAAGTG GTGTTATGCG GAGACCCCAA GCAATGCGGA
1150 1160 1170 1180 1190 1200
TTCTTCAATA TGATGCAGCT TAAGGTGAAC TTCAACCACA ACATCTGCAC TGAAGTATGT
1210 1220 1230 1240 1250 1260
CATAAAAGTA TATCCAGACG TTGCACGCGT CCAGTCACGG CCATCGTGTC TACGTTGCAC
1270 1280 1290 1300 1310 1320
TACGGAGGCA GGATGCGCAC GACCAACCCG TGCAACAAAC CCATAATCAT AGACACCACA
A
1330 1340 1350 1360 1370 1380
GGACAGACCA AGCCCAAGCC AGGAGACATC GTGTTAACAT GCTTCCGAGG CTGGGTAAAG
C
1390 1400 1410 1420 1430 1440
CAGCTGCAGT TGGACTACCG TGGACACGAA GTCATGACAG CAGCAGCATC TCAGGGCCTC
C
1450 1460 1470 1480 1490 1500
ACCCGCAAAG GGTATACGCC GTAAGGCAGA AGGTGAATGA AAATCCCTTG TATGCCCCTG
1510 1520 1530 1540 1550 1560
CGTCGGAGCA CGTGAATGTA CTGCTGACGC GCACTGAGGA TAGGCTGGTG TGGAAAACGC
1570 1580 1590 1600 1610 1620
TGGCCGGCGA TCCCTGGATT AAGGTCCTAT CAAACATTCC ACAGGGTAAC TTTACGGCCA
1630 1640 1650 1660 1670 1680
CATTGGAAGA ATGGCAAGAA GAACACGACA AAATAATGAA GGTGATTGAA GGACCGGCTG
1690 1700 1710 1720 1730 1740
CGCCTGTGGA CGCGTTCCAG AACAAAGCGA ACOTGTGTTG GGCGAAAAGC CTGGTGCCTG
1750 1760 1770 1780 1790 1800
TCCTGGACAC TGCCGGAATC AGATTGACAG CAGAGGAGTG GAGCACCATA TACCTCTATT
1810 1820 1830 1840 1850 1860
ATAATCACTT GAACGAAAAC TGAAAAACAG AAAAAGTTAG GGTAAGCAAT GGCATTAATA
-------------------------- — - |  A U X O G
(continued overleaf)
1 3 2
1870 1880 1890 1900 1910 1920
TAGCAAGAAA ACCGAAAATA GAAAAAGTTA GGGTAGGCAA TGGCATTGAT ATAGCAAGAA 
TT C U X
1930 1940 1950 1960 1970 1980
AATTGAAAAC AGAAAAAGTT AGGGTAAGCA ATGGCATATA ACCATAACTG TATAACTTAT
G
1990 2000 2010 2020 2030 2040
AACAAAGCGC AACAAGACCT GCGCAATTGG CCCCGTGGTC CGCCTCACGA AACTCGGGGC
0
2050 2060 2070 2080 2090 2100
AACTCATATT GACACATTAA TTGGCAATAA TTGGAAGCTT ACATAAGCTT AATTCGACGA
2110 2120 2130 2140
ATAATTGGAT TTTTATTTTA TTTTGCAATT GGTTTTTAAT ATTTCC
Figure 5.2 The nucleotide sequence o f pSFVDI-6
Differences with respect to  SFV RNA are indicated below the sequence tf 
indicates the position o f an additional base in SFV RNA in both cases this is a 
guanine X indicates the absence o f a base in SFV RNA Base substitutions are also 
shown The underlined sequences from 963 to 978 and 1791 to 1814 cannot be 
assigned to SFV RNA The region from 1828 to 1879 is an imperfect repeat o f 
nucleotides 1880 to 1930
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a promoter for T3 RNA polymerase at the 5' terminus and the restriction enzyme 
site Ncol at the 3’ terminus (see Chapter 4) The complete sequence o f the insert in 
pUC 13 has therefore the following additions to the sequence shown -
5' - OCA ATT AAC CCT CAC TAA AG —
— GTA CCT T - 3'
Further, in the original clone there was an additional guanine between nucleotides 
2029 and 2030, which is also contained in the sequence o f SFV, and was lost in 
subsequent manipulations of the clone pSFVDI-6 was one o f eight clones that 
were shown to have inserts o f 2 I kbp. designated pSFVDI-1 to  pSFVDI-8 (see 
Chapter 4) Of these clones, pSFVDI-l.7 and 8 were partly sequenced, and the 300 
nucleotides at each terminus were shown to be identical to those of pSFVDI-6 
This further supported the conclusion that the insert in pSFVDI-6 was derived 
from common sequences in the RNA extracted from tissue culture fluid, and 
therefore from common Dl virus particles
<c) Derivatioa o f  pSFVDI-« from SFV RNA.
The derivation o f pSFVDI-6 from the standard genome is shown in Figure 5 3, and 
is described in detail below Note that some regions o f pSFVDI-6 may have 
insertions or deletions with respect to SFV, and for this reason two regions 
described as homologous may not be exactly the same length There are three 
regions that have extensive homology with SFV RNA The first 817 nucleotides 
are homologous to  the 5' terminus of SFV RNA. and therefore have the potential
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Figure 5.3 Comparison of pSFVDI-6 to  SFV RNA
Arrows indicate the regions o f SFV from which pSFVDI-6 was derived For 
clarity, regions that cannot be assigned to SFV RNA (see Figure 5.2 and 
accompanying text) have been omitted Because of overlapping sequences, the 
numbers shown below pSFVDI-6 refer to the V extents o f  each region of 
homology with SFV RNA
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to encode part of the first non-stmctural protein (nsP l). A protein o f molecular 
weight (M,) 27,000 produced by in vitro translation o f  RNA transcribed from 
pSFVDI-6 is consistent with this conclusion (see C hapter 6) Nucleotides 816 and 
817 also appear in the 147 nucleotide region from 816 to 962 which are 
homologous to 2227 to 2373 o f SFV RNA, so that the junction between the first 
two regions of homology with SFV RNA cannot be determined precisely The 812 
nucleotides from 979 to 1790 are homologous with 2391 to 3202 o f SFV RNA, 
which are within the nsP2 coding region The 16 nucleotides from 963 to 978 
cannot be assigned with any certainty to SFV RNA, and the same is true for the 24 
nucleotides from 1791 to 1814 The derivation of the 13 nucleotides from 1815 to 
1827 is not certain, but is likely to be from nucleotides 11220 to 11232 o f SFV 
RNA which also has the sequence (5'-G-4A-NN-G-5A-3'] The 52 nucleotide 
region from 1828 to 1879 is an imperfect repeat (86% homology) o f nucleotides 
1880 to 1930, which correspond to nucleotides 11176 to  11225 o f  SFV RNA 
Because there is a 28 nucleotide imperfect repeat in SFV RNA itself (11175 to 
11201 and 11225 to II2S2), it is possible that the 28 nucleotides from 1828 to 
1855 of pSFVDI-6 were originally derived from the sequence from 11225 to 
11252 o f SFV RNA, with which they have 100% homology Finally the 267 
nucleotides at the 3' terminus of pSFVDl-6, from 1880 to  2146 correspond to the 
non-coding 3' terminus o f SFV RNA
<d) < omparison of pSFVDI-4 with o ther Ol SFV clones.
Figures 5 4a and 5 4b show comparisons of pSFVDI-6 with Dl 301 and Dl 309 
(Lehtovaara el a/., 1981, 1982) These RNA sequences were determined from the 
DNA clones pKTH 301 and pKTH 309, both of which lacked the 5' termini o f  their
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F ig u re  5.4 Comparison o f  pSFVDI-6 with D1 301 and Dl 309
pSFVDI-6 and the Dl SFV RNAs (Lehtovaara el a!., 1981. 1982) are represented 
as linear sequence blocks Dl 301 and Dl 309 have been simplified to show only 
extensive regions o f  homology with pSFVDI-6, which are labelled a-c in (a) and d- 
g  in (b) Because some regions o f  homology overlap, only the nucleotides at the 3' 
termini of each region o f  the Dl RNAs are numbered Approximately 200 
nucleotides from upstream of the 5* terminus o f Dl 301 have not been determined 
In (a )  the two regions labelled b* are deleted forms o f region b. lacking the 59 
nucleotides which correspond to nucleotides 1447 to 1505 of the pSFVDI-6
genome
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respective RNAs the 5' terminal nucleotides of Dl 309 were determined from 
cDNA Like the Dl RNA from which pSFVDI-6 was derived. Dl 301 and Dl 309 
were extracted from Dl SFV produced by serial undiluted passage o f SFV in BHK- 
21 cells All regions o f both RNAs are contained within pSFVDI-6 and because 
they contain several repeated regions they possess approximately one half o f the 
sequences contained in the pSFVDI-6 genome This suggests that much of 
pSFVDI-6 is unnecessary for propagation in tissue culture analysis o f deletion 
mutants (see Chapter 7) supports this conclusion Dl 301 contains a triplicated 
linear repeat o f  the regions designated a and b Region a' corresponds to the 284 
nucleotide region o f  pSFVDI-6 derived from the 5' terminus o f SFV RNA Not all 
o f the 5' non-coding 85 nucleotides o f  SFV RNA are represented in Dl 301, 
probably because approximately 200 nucleotides from the 5* terminus were not 
determined Region V  is homologous to the 265 nucleotides from 1317 to 1581, 
which correspond to  the nsP2 coding region o f SFV RNA. from nucleotides 2728 
to 2993 o f SFV RNA The two regions designated b* are deleted forms o f region 
b. lacking the 59 nucleotides o f pSFVDI-6 from 1447 to 1505 As noted by 
Lehtovaara el a i  (1981). the deleted nucleotides present in region b have a degree 
o f  inverted complementarity, suggesting that this RNA may form base-paired 
secondary structure in this region Region c' comprises 106 nucleotides from the 3* 
terminus o f pSFVDI-6 This corresponds to the 3' terminus o f SFV RNA. and 
suggests that not all o f  the 3' untranslated region (264 nucleotides) is necessary for 
Dl virus propagation
Dl 309 (Figure 5 4b) is composed o f similar regions o f homology with pSFVDI-6 
and hence SFV RNA Region d' comprises 581 nucleotides adjacent to the 5’ 
terminus o f pSFVDI-6. and has a 26 nucleotide deletion o f this region, from 138 to
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163 o f  pSFVDl-6 (not shown in Figure 5 4b) The 69 nucleotides comprising 
region d’ are also homologous to part o f region d. corresponding to nucleotides 
616 to 684 of pSFVDI-6 The 382 and 329 nucleotide regions designated e and e' 
are homologous to the central region of pSFVDI-6, from nucleotides 1216 to 1597 
and 1323 to 1651 respectively These correspond to part o f  the nsP2 coding region 
o f SFV RNA, from nucleotides 2627 to 3009 and 2734 to  3063 The sequence in 
the 3’ region o f pSFVDI-6 designated 'f  ' is represented twice in D1 309; in both 
cases it is flanked by sequences that are not contiguous with it in the SFV genome
2. The nucleotide sequence o f  pSFVDI-19
(a) Strategy used to sequence pSKVDI-19.
pSFVDI-19 was sequenced by the chain-termination method (Sanger el aJ, 1977) 
The sequencing strategy and the synthetic oligonucleotides used are shown in 
Figure 5.5. Three sub-clones were made pSFVDI-19 was digested with Pstl to 
give fragments o f  approximately 500 and 300 bp. which were ligated into pUC13, 
and the digested pSFVDI-19 was religated so that it contained only the 500 bp 
from the 5' terminus These sub-clones permitted the complete sequence of 
pSFVDI-19 to be obtained by primer extension from within pUCI3 In order to 
sequence both strands, primers specific for pSFVDI-19 were used Primer 
extension from the oligonucleotide designated '-2001/ was only possible using a 
cycle sequencing method, for reasons stated previously for the sequencing of 
pSFVDI-6
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pSFVDI-IV
(i) Primers annealing to pUC 13
U ('universal' primer) : 5  • -GTTTTCCCAGTCACGAC-3 •
R  (’reverse' primer) : 5  • -AACAGCTATGACCATG-3•
(ii) Primers annealing to pSFVDI-19
* 2 0 0  : 5  ' -CGCACCTGGCTACCAAATT-3 ' (bases 219-237) 
-3 0 0  : 5  ' -CATTCTCCTOGAAOOCOC-3 ' (bases 304-287) 
* 1 6 0 0 i  5  ' -CATTCCACAGGGTAACT-3 '  (bases 959-975) 
- 2 0 0 0 :  5  ' -GCGCAGGTCTTGTTGCGC-3 '  (bases 1101-1084)
Figure 5.5 Strategy used to sequence pSFVDI-19
pSFVDI-19 was sequenced by the chain-termination method using pnmer 
extension from within pUCI3 into the clone or subclone (i) or from within 
pSFVDI-19 itself (ii) Subclones were made from Pst I-restricted fragments of 
pSFVDI-19 Arrows show the approximate number o f  nucleotides determined with 
each pnmer Pnmer designations are denved from the approximate position of 
annealing to pSFVDI-6 (see Figure 5 I).
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(b) The nucleotide sequence of pSFVDI-19.
Figure 5.6 shows the nucleotide sequence o f pSFVDI-19 Like pSFVDl-6, the 
original done from which pSFVDI-19 was denved did not possess the promoter 
for T3 RNA polymerase, or a restriction enzyme site to permit run-oft' 
transcription The sequence given is therefore that o f the modified clone, and the 
complete insert in pUC13 has the additional sequences described previously for 
pSFVDI-6 Base 22. given as thymine, was cytosine in the original clone, and 
inadvertently altered in subsequent manipulations o f the done There are open 
reading frames and RNA transcribed from pSFVDI-19 produced a protein o f M, 
25,000 on in vitro translation (see Chapter 6)
<c) Derivation of pSFVDI-19 from SKV RNA.
pSFVDI-19 is composed o f three regions which have extensive homology to 
regions o f  SFV RNA (Figure 5.7) Nucleotides I to 576 correspond to the same 
region o f SFV. the 4 0 1 nucleotides from 576 to 976 with nucleotides 2623 to 3024 
(base 576 is also present in this region o f  homology) and the 268 nucleotides from 
977 to 1244 with 11176 to 11442 o f  SFV RNA The 5’ terminus o f pSFVDI-19 is 
therefore derived from the nsPI coding region o f SFV RNA, and includes the 85 
non-coding nucleotides from the 5‘ terminus of SFV RNA The central region of 
pSFVDI-19 is derived from the nsP2 coding region o f SFV RNA, and the 3’ 
terminus from the non-coding 3* terminus o f SFV RNA, containing all 264 
nucleotides o f this region
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pSFVDI-19 (1244 bases)
10 20 30 40 50 60
ATGGCGGATG TGTGACATAC ATGACGCCAA AAGATTTTGT TCCAGCTCCT GCCACCTCCG 
C G
70 SO 90 100 110 120
CTACGCGAGA GATTAACCAC CCACGATGGC CGCCAAAGTG CATGTTGATA TTGAGGCTGA
130 140 150 160 170 180
CAGCCCATTC ATCAAGTCTT TGCAGAAGGC ATTTCCGTCG TTCGAGGTGG AGTCATTGCA
190 200 210  220  230 240
GGTCACACCA AATGACCATG CAAATGCCAG AGCATTTTCG CACCTGGCTA CCAAATTGAT
250 260 270 280 290 300
CGAGCAGGAG ACTGACAAAG ACACACTCAT CTTGGATATC GGCAGTGCGC CTTCCAGGAG
310 320 330 340 350 360
AATGATGTCT ACGCACAAAT ACCACTGCGT ATGCCCTATG CGCAGCGCAG AAGACCCCGA
370 380 390 400 410 420
AAGGCTCGTA TGCTACGCAA AGAAACTGGC AGCGGCCTCC GGGAAGGTGC TGGATAGAGA 
AT A
<30 440 450 460 470 480
GATCGCAGGG AAAATCACCG ACCTGCAGAC CGTCATGGCT ACGCCAGACG CTGAATCTCC
490 500 510 520 530 540
TACCTTTTGC CTGTATACAG ACGTCACGTG TCGTACGGCA GCCGAAGTGG CCGTATACCA 
C
550 560 570 580 590 600
GGACGTGTAT GCTGTACATG CACCAACATC GCTGTATCCA GACGTTGCAC GCGTCCAGTC
410 620 630 640  650 660
ACGGCCATCG TGTCTACGTT GCACTACGGA GGCAGGATGC GCACGACCAA CCCGTGCAGC
A A
670 680 690 700 710 720
AAACCCATAA TCATAGACAC CACAGGACAG ACCAAGCCCA AGCCAGGAGA CATCGTGTTA
730 740 750  760 770 780
ACATGCTTCC GAGGCTGGGT AAAGCAGCTG CAGTTGGACT ACCGTGGACA CGAAGTCATG
C
790 800 810 820 830 840
ACAGCAGCAG CATCTCAGGG CCTCACCCGC AAAGGGTATA CGCCGTAAGG CAGAAGGTGA
0
850 860 870 880 890 900
ATGAAAATCC CTTGTATGCC CCTGCGTCOG AGCACGTGAA TGTACTGCTG ACGCGCACTG
»10 920 930 940 950 960
AGGATAGGCT GGTGTGGAAA ACGCTGGCCG GCGATCCCTG GATTAAGGTC CTATCAAACA
970 980 990 1000 1010 1020
TTCCACAGGG TAACTTAGAA AAAGTTAGGG TAGGCAATGG CATTGATATA GCAAGAAAAT 
U X
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|continued overleaf)
10J0 1040 1050
TUAAAACAUA AAAAGTTAGG GTAAGCAATG
1090 1100 1110
AAAGCGCAAC AAGACCTGCG CAATTGGCCC
lISO 1160 1170
CTCATATTGA CACGTTAATT GGCAATAATT 
A
1210 1220 1230
AATTGGATTT TTATTTTATT TTGCAATTGG
1060 1070 1060
GCATATAACC ATAACTUTAT AACTTATAAC 
G
1120 1130 1140
CGTGGTCCGC CTCACOGAAA CTCGGGGCAA
1160 1190 1200
UGAAGCTTAC ATAAGCTTAA TTCGACUAAT
1240
TTTTTAATAT TTOC
I* inure 5.6 I he nucleotide sequence of pSKVI>l-IV
Ihtleiences with respect to 8FV RNA are shown below the sequence X 
indicates the absence and V the presence o f  a nucleotide in SFV RNA
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Kigure 5.7 C omparison o f  pSF VDI-19 to SFV RNA
Arrows indicate the regions o f  SFV RNA from which pSFVDI-19 was derived 
The numbers shown below pSFVDI-19 refer to the nucleotides at the 3* terminus 
o f  each region o f homology
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3. C om parison of pSFVDI-6 and pSKVDI-19.
Figure 5 8 shows regions o f  homology between pSFVDI-6 and pSFVDI-19 All 
sequences contained within pSFVDI-19 are represented in pSFVDI-6 Nucleotide 
differences o f pSFVDI-19 with SFV RNA shown in Figure 5.6 are the same as 
those for pSFVDI-6 (Figure 5.2) except for the two nucleotides known to have 
altered as a consequence o f modifications to the two clones The sequence on the 
3' side o f  the junction between the central and 3' region is the same for both cloned 
DNAs While there are no other common sequences on either side o f the junctions, 
the tw o bases 5*- thymine-adenine-i' are located at all the junction points of SFV 
RNA sequences in both pSFVDi-6 and pSFVDI-19. The significance of this is not 
known As mentioned previously, the three regions o f homology with SFV RNA of 
both pSFVDI-6 and pSFVDI-19 are derived from the 5' nsPI coding region, the 
nsP2 coding region, and the 3' non-coding terminus, suggesting that these 1)1 
sequences were generated by a common mechanism The central regions of these 
clones, unlike the terminal regions, were not selected for by the primers used to 
isolate these Dl virus sequences originally It seems likely, therefore, that the 
central regions are necessary for some function of these Dl sequences
4. Secondary structure prediction
The nucleotide sequences o f  pSFVDI-6 and pSFVDI-19 were analysed by 
computer for regions that may be involved in RNA folding However, the results of 
this analysis were ambiguous, to  the extent that it was not considered worthwhile
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to present them here In addition. pSFVDI-6 and pSFVDI-19 were too large to be 
analysed by the computer software in their entirety
1212 1612 HUH 2146
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Figure 5.8 Comparison o f pSFVDI-6 and pSFVDI-19
Arrows indicate regions o f homology between pSFVDI-6 and pSFVDI-19 
Numbers refer to the nucleotides at the 3' termini o f each region o f homology
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DISCUSSION
Initially the justification for sequencing pSFVDI-6 and pSFVDI-19 was based on 
analyses o f insert size and restriction sites (see Chapter 4) This indicated that the 
clones were derived from SFV sequences and were not merely artefacts o f  the 
methodology employed for cloning Because the polymerase chain reaction was 
used for the amplification o f D1 SFV RNA and for modification of the original 
clones, it was possible that errors were introduced into the final DNA copies that 
were cloned Although it would have been necessary to sequence more than one 
clone completely to establish the exact sequence o f  the original RNA template, for 
the purposes o f this project it was more important to know the exact sequence o f 
the DNA used for transcription and subsequent transfection Hence DI virus 
populations generated from the clones could be defined on the basis of sequence 
content
It is possible that the original RNA template from which the clones were derived 
also possessed other sequences not detected by RT-PCR amplification It is known 
that the DI genomes o f SFV are polyadenylated (Kennedy. 1976). In addition, 
three out o f six DI genomes o f Sindbis virus were found to have a structure 
contiguous with their 5' terminus that was almost identical to part (nucleotides IQ- 
75) o f the cellular rat tRNA“’’ (Monroe and Schlesinger. 1983. Tsiang el a/., 
1985) These cellular sequences did not confer a competitive advantage over DI 
genomes without them Whether DI SFV genomes have similar associated 
structures is not known RNA transcripts o f  pSFVDI-6 and pSFVDI-19 proved to 
have all the necessary sequences required for propagation as virions (Chapter 7) 
and it was therefore not important to analyse the original templates further
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The two cloned sequences, pSFVDI-6 and pSFVDI-19 differed from previously 
isolated DI SFV genomes in having no extensive repeats or sequence 
rearrangements However, both were derived from the same regions o f  the SFV 
genome, suggesting a common requirement for these Dl genomes The mismatches 
o f  the Dl genomes with the published SFV sequence may have arisen Jc novo, or 
featured in the SFV RNA from which they were generated The deletions and 
insertions probably arose either during propagation o f the defective RNAs, or in 
subsequent manipulations in vitro because their presence in the virion RNA would 
cause frame-shifts that would be likely to prevent the correct translation required 
for the production essential propagative proteins
Because the entire sequence o f pSFVDI-19 is contained within pSFVDI-6, it is 
possible that the former was derived from the latter However, it is equally likely 
that both molecules were generated Je n o w  from the standard genome The viral 
replicase may have a limited fidelity and jump from one region o f  the standard 
genome to another This jumping may be aided by secondary structure features o f  
the standard genome, such as the circularisation o f the molecule (Hsu et a/ ,  1974, 
Frey el a l , 1979) It is possible that a large range o f molecules are produced by the 
viral replicase, and only those possessing sequences favouring amplification 
become established pSFVDI-6 was shown to have two regions o f  16 and 24 
nucleotides that could not be assigned to SFV RNA These regions may have been 
derived from cellular RNA species, or from an SFV RNA which differed in these 
regions from the published sequence The 52-nucleotide reiterated sequence of 
pSFVDI-6 derived from a region of SFV RNA that is adenine-rich and has the 
potential to base-pair with the thymine-rich 3' terminus This suggests that
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secondary structure may be involved in the generation of this repeated sequence 
from standard RNA
It is clear that the mechanism by which the pSFVDI genomes were generated is 
less complicated than that which produced the repeated and rearranged sequences 
o f  the pKTH clones Both DI SFV sequences described in this chapter were shown 
to  be derived from the same regions o f  SFV RNA as pKTH 301 and pKTH 309 
This suggests further that the minimum requirement of Dl SFV for propagation by 
standard virus is the possession of parts o f the terminal and nsP2 sequences o f SFV 
RNA However, comparison of these clones indicates that approximately 70% o f  
pSFVDI-6 and 45V# o f pSFVDI-19 is superfluous to the sequence requirement o f 
these Dl SFV molecules It it possible that Dl genomes have a minimum size, 
below which they cannot be packaged into virions This implies that in addition to 
the sequences required for replication and encapsidation there need to be spacer 
sequences for viability In the case of the pKTH clones a minimum size limit would 
be achieved by the possession of repeat sequences It may be that while the initial 
structure of these molecules is determined by viral replicase errors, for the Dl 
genomes to achieve sufficient size and hence be propagated as virions, 
polymerisation events must occur However, another reason for the possession o f  
repeated regions could be that they confer some advantage to the Dl genome For 
example, the possession o f multiple replication initiation sites may result in the Dl 
genome being amplified in preference to one with a only a single site
Besides the naP2-3' junction of pSFVDl-6 and pSFVDI-19 which is the same for 
both clones, the sequences at the junction points o f SFV RNA regions of these and 
the pKTH clones are different It is therefore not possible to define a sequence
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motif which could be responsible for a mechanism of D! genome generation It is 
likely, therefore, that the initial putative replicase jumping that results in deletions 
o f the standard genome occurs between juxtaposed secondary structure domains 
rather than between particular sequence motifs
The conservation of a region that is derived from the nsP2 gene o f  SFV in both 
pSFVDI and pKTH clones suggests it has a  <-/.«-acting function necessary for the 
propagation o f the DI RNA The putative base-paired secondary structure within 
this region o f pKTH 301 (designated V  in Figure 5 4a) may be involved in this 
function LiljestrOm and GarofT (1991b) showed that deletion of the majority o f the 
non-structural coding sequences o f the infectious full-length SFV clone. pSP6- 
SFV4, produced a molecule whose RNA transcripts were replicated but not 
encapsidated It seems likely, therefore, that this region o f the nsP2 gene contains a 
recognition signal for capsid proteins Jalenko and Soderiund (1985) replaced the 
late gene region o f SV40 virus with the repeating units of pKTH 301 They 
showed that superinfection o f  monkey kidney cells harbouring the recombinant 
SV40 clone with SFV resulted in a reduction o f  the packaging efficiency of SFV 
RNA They concluded that the terminal regions o f pKTH 301 were required for 
efficient replication and the central repeating units (containing part o f  the nsP2 
gene) for encapsidation
The identification o f regulatory sequences in the Dl genomes o f Sindbis virus 
appears to conflict with the above conclusions on the location o f a packaging 
signal It was shown that only the sequences that comprised the 162 nucleotide 
region at the 5' terminus and the 19 nucleotide region o f  the 3' terminus were 
necessary for replication and packaging o f cloned DI Sindbis genomes (Levis el al.,
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1986) However, more reliable evidence was provided by Weiss el a/. (1989), who 
used capsid protein binding studies to identity a region from nucleotides 746 to 
1226 (within the nsPI gene) o f  Sindbis virus RNA that was required for packaging 
in tissue culture Because Sindbis virus and SFV are closely related, it seems 
unlikely that the location o f the encapsidation region would differ significantly It 
will be necessary to use studies similar to those used by Weiss el a/. (1989) to 
irrefutably define packaging domains o f SFV RNA
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INTRODUCTION
This chapter describes the RNA transcripts generated from the cloned defective 
SFV genomes described in C hapter 4 and directly from PCR products In addition, 
the in vitro translation o f  RNA transcripts from pSFVDI-6 and pSFVDI-19 is 
described
As shown in Chapter 4, the clones pSFVDI-6 and pSFVDI-19 and the sub-clone 
pSFVDI-M2 contained a promoter for T3 RNA polymerase directly upstream of 
their SFV-derived sequences and the restriction enzyme site for Ncol directly 
downstream, permitting run-off transcription Transcripts produced from these 
clones were analysed before transfection into BHK-21 cells to ensure they had not 
degraded and that they matched the size o f  their respective templates It was 
suspected that these RNA transcripts would be propagated more efficiently as 
virions in tissue culture if they possessed V-caps UljestrOm e l al. (1991) showed 
that RNA transcripts o f pSP6-SFV4 that were capped had an infectivity litre in 
BHK-21 cells approximately 100-fold greater than those without It was not 
known if these results were applicable to the propagation as virions o f  defective 
genomes, but as a precaution, the first transfection experiments used capped 
RNAs However, subsequent experiments suggested that uncapped RNA 
transcripts were propagated as virions just as efficiently (data not shown).
In a number o f  experiments RNA transcripts were generated directly from PCR 
products As stated in Chapter 4. it was advantageous to determine if mouse- 
protecting Dl SFV sequences were amplified by RT-PCR before screening 
individual clones for the possession o f  such sequences As a first step to achieving
IS2
this, K 'R  products were generated from Dl SFV-p7 using the primers 5'SbV-T3 
and 3'SFV-Nco Hence a promoter for T3 RNA polymerase promoter was 
incorporated at the 5‘ termini o f these K 'R  products, permitting them to be used as 
templates for RNA transcription Because these primers possessed many non-SFV 
nucleotides, it was necessary to ensure that their use in the amplification from Dl 
SFV RNA generated DNA products similar to those produced using the primers 
5'Sb V and 3 'SFV. This chapter compares the K 'R  products derived from Dl SFV- 
P? using these different primer pairs, and shows the RNA that was transcribed 
from those K 'R  products containing a T3 RNA polymerase promoter
The sub-clone pSFVDI-l A2. which was constructed by deleting internal sequences 
from the unmodified version o f pSFVDI-6, was retained in the pBluescribe II KS* 
vector (see Chapter 4) RNA transcribed from this plasmid also included sequences 
derived from the vector To modify the clone. RT-K 'R was used to copy the Dl 
SFV-derived sequences with the primers 5'SFV-T3 and 3'Sh V-Nco This chapter 
describes the K 'R  products that were generated in this way, and the RNAs that 
were transcribed from them
The final part o f  this chapter consists o f an analysis of the polypeptides produced 
from RNA transcripts o f pSFVDI-6 and pSFVDI-19 by m vitro translation Open 
reading frames o f the two clones were determined from their nucleotide sequences, 
and from these it was possible to speculate on which regions o f  the sequences had 
been translated The nature and significance of these proteins are discussed
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RESULTS
I.  T ranscrip tion o f D l SKV clones
For clarity. RNA transcripts have been given the prefix V (e g ’rSFVDI-IV)
(a) Analysis o f RINA transcripts
Products o f  RNA transcription were treated with either DNAse I or RNAse A to 
ensure that they were indeed RNA Only the product treated with DNAse I was 
undegraded (data not shown) As stated in the Introduction, the first transfection 
experiments used capped RNA transcripts Because these could not be 
distinguished from uncapped transcripts on an agarose gel. the results shown below 
are applicable to both
RNA transcripts were analysed on agarose gels following denaturation with glyoxal 
to determine their sue and integrity, and to permit subsequent northern transfer 
Northern blot analysis o f transcripts was not performed routinely for reasons of 
practicality, but was used for preliminary experiments to determine that the RNA 
transcripts did not contain minor species that were not detected by the usual 
methods o f analysis In most experiments, it was only necessary to determine that 
transcripts were intact before transfection In these cases. RNA transcripts were 
analysed by standard agarose gel electrophoresis, as used for the analysis o f DNA 
RNA migrated at approximately twice the rate o f  DNA in this system, and it was 
therefore possible to estimate size by comparison with DNA markers
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It was deemed unnecessary to quantitate accurately the RNA produced in each 
transcription reaction However, an estimate was made in order to standardise 
subsequent transfection experiments with respect to the quantity o f input RNA 
Each constituent species o f the RNA ladder, in the volume that was 
electrophoresed, comprised approximately 0 5 pg RNA (Gibco BRL, Product 
specifications) Following electrophoresis, a visual comparison was made o f  the 
intensities o f banded RNA transcripts to the banded RNA o f the size marker From 
this rt was estimated that Ipg RNA per I pi was produced from the DNA template 
in a typical transcription reaction There was no difference between the quantity of 
RNA produced in a transcription reaction that included a cap analogue and one 
that did not
(b) Analysis o f RNA transcripts from pSFVDI-6 and pSPVDI-19
Figure 6 I shows an analysis by agarose gel electrophoresis and northern blotting 
of transcripts produced from pSFVDI-6 and pSFVDI-19 with T3 RNA 
polymerase The respective transcripts are 2.1 and 1.2 kb in size, which 
corresponds to the size o f the SFV-denved sequences of the clones In Figure 6  lb. 
the low intensity bands o f 3 9 kbp and 4 8 kbp in lanes I and 2 compose template 
DNA which had not been removed at this stage The origin o f  other low intensity 
bands is not known these do not appear on an agarose gel following denaturation 
with glyoxal (Figure 6 la), but this may be because the RNA is not stained as 
efficiently in this gel system
The northern Not analysis shown in Figure 6 Ic used Ia -J,P)UTP-tebelled RNA 
transcripts as a hybridisation probe These were negative-strand transcripts, which
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Figure 6.1 RNA transcripts from pSFVDI-6 and pSFVDl-19
RNA transcripts were analysed either following denaturation with glyoxal (a) or by 
standard agarose gel electrophoresis <b) In (a), the RNAs transcribed from 
pSFVDI-6 or pSFVDI-19 were 2 I kb and 1.2 kb in size respectively (b )  shows 
that these transcripts migrate at approximately twice the rate o f the DNA size 
marker, and is included because it exemplifies the method that was frequently used 
for estimating the size o f  RNA transcripts and establishing that they were 
undegraded (c) shows a northern blot analysis o f  RNA transcripts produced from 
pSFVDI-6 and pSFVDI-19 By comparison with unlabelled size markers, the 
RNAs were determined to be I 2 kb and 2 I kb m size No other RNA species 
were detected
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were produced from KcoRl-digested pSFVDI-7 using T7 RNA polymerase 
(pSFVDI-7 is described in C hapter 4 it comprises all the sequences o f  pSFVDI-6 
inserted into the Smal site o f  pBluescribc II KS' in the 3-5 ' orientation) Because 
this was a more sensitive technique for detecting RNA than staining with ethidium 
bromide, and since no other RNA species were detected, this analysis confirmed 
that the RNA transcripts were homogeneous with respect to size This also 
suggested that the low intensity bands described above for Figure 6 lb did not 
comprise DI SFV sequences
(c) Analysis o f RNA transcripts from PC'R products
Figure 6 2a shows analyses o f  the PCR products that were obtained from the 
mouse-protecting preparation DI SFV-p7. using the pnmers 5’S tV -1 3  and 3'SFV- 
Nco. Comparison o f  these products with those obtained using the primers S'SFV  
and S'SFV  shows that they are essentially the same, with a predominant DNA 
species o f I 2 kbp in size, and minor species o f 1 6 and 2 I kbp The 0  6 kbp DNA 
present in the PCR product generated with the S'SFV-S'SFV pnmers is not present 
in the other As discussed in C hapter 3. this DNA species was likely to  have 
resulted from non-specific hybridisation by these primers
Figure 6 2b shows an analysis o f DNA produced by PCR amplification o f  pSFVDI- 
IA2 using the pnmers 5SFV-T3  and S'SFV-Nco The sole product is I 3 kbp. 
which corresponds to the size o f the SFV-denved sequences in pSFVDI-l A2 (see 
C hapter 4) As positive controls for PCR. DNA was amplified from pSFVDI-M2 
and pSFVDI-6 In both cases the predominant product corresponds in size to the 
SFV -derived sequences o f  the respective clones
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In (a) RNA was extracted from the mouse-protecting preparation. Dl SFV-p7, and 
amplified by RT-PC’R using the primer pairs 5'SbV  • 3'Sb'V or 5'ShV-T3 + 3'ShV- 
Nco. The main PC’R products in both cases were DNA species o f I 2, I 6 and 2 1 
kbp Amplification with the first primer pair yielded an additional product of 0 6 
kbp
In (b) K 'R  was used to amplify SFV-denved sequences from cloned DNA using 
the primers S ’SbV -13> 3'SbV-Nco The DNA amplified from pSFVDI-IA2. 
pSI VDI-M2 and pSFVDI-6 was I 3, 1.7 and 2 I kbp respectively
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Figure 6 3 shows s comparison o f RNA transcripts derived from the K 'R  products 
described above In Figure 6 3a. RNA transcribed from the <DI SFV-p7Fdenved 
PCR product was shown to consist o f two species, one o f  which co-migrated with 
the 2 I kb RNA from pSFVDI-6. and another that was estimated to be 1 2 kb in 
size Comparison with RNA transenbed from pSFVDI-lv continued that the latter 
was a  1 2  kb species (data not shown) The RNA transcribed from pSFVDI-M2 
was approximately I 7 kb in size and this was conlirmcd by sgarose gel analysis 
afret dcnaturation with glyoxaj (data not shown) Figure 6 3b shows a comparison 
o f  transcripts from pSFVDI-M2 and pSFVDI-l A2 This was included to illustrate 
that there were similar quantities o f RNA in both these preparations, as determined 
from their band intensities By making this comparison, it was possible to ensure 
that similar quantities o f RNA were used in a subsequent transfection experiment 
that compared the propagation o f the two RNAs as virions (see Chapter 7)
Figure b 3c shows a comparison of transcripts from pSFVDI-6 and the artiticiallv- 
constructed clone. pSFVDI-SBI (see Chapter 4) To obtain RNA transcripts. 
pSF V13I-SHI was lincansed with Spel and transenbed wtth SP6 RNA polymerase 
In both cases, the size of the RNA transenpts was 2 I kb. which corresponds to 
those of the respective cloned L>NAs Also, both banded RNA transenpts were of a 
similar intensity suggesting that similar quantities o f  each were produced in the 
transcnption reactions
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Figure 6.3 Further analysis o f RNA transcripts
(a) and (b) show agarose gel profiles o f RNA transcripts produced from PCR 
products In lane 2 o f  fa). RNA is shown that was transcribed from the PCR 
product derived from Dl SFV-p7 (designated rDI7> Two predominant species 
were detected, which were estimated by comparison to a UNA size marker to be 
I 2 and 2 I kb Iranacnption from pSFVDI-M2 and pSFVDI-6 gave products o f 
I 7 and 2 I kb respectively In (b| RNAa o f I 2 kb and I 7 kb transcribed from the 
pSFVDI-l A2 PCR product and pSFVDI-M2 respectively are shown
(e) shows an agarose gel profile of RNA transcriptl, following denaturalion with 
glyoaal RNAs transcribed from pSFVDI-6 and pSFVDI-SBI were both 2 I kb
160
2. In vitro translation of RNA transcripts from pSF VDI-6 and pSFVDI-19
Figure 6 4 shows open reading frames (ORFs) of greater than 200 nucleotides in 
pSFVDI-6 and pSFVDI-19 These were determined from the sequences of these 
two clones, which are described in C hapter 5 Figure 6 5 shows the products of 
translation from the RNA transcripts o f pSF VDI-6 and pSFVUI-19 The protan of 
approximately M, 27.000 from pSFVDI-6 RNA was probably encoded from the 
ORF that extends from nucleotides 86 to 826 in the second reading frame, which 
potentially encodes a protan o f M, 27.000 and is consistent with the reading frame 
used by SFV RNA The product o f approximately M, 25.000 from pSFVDI-19 
RNA may have been derived from the ORF that extends from nucleotides 86 to 
667 in the second reading frame, or from the ORF that extends from 549 to 1055 
in the third However, since the estimated size o f proteins from these two ORFs is 
only 21,000 and 19,000 respectively, it is not clear how this protein was produced
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Figure 6.4 Open reading frames o f  pSFVDI-6 and pSFVDI-19
I he diagram o f  the SFV genome shows the non-coding and coding regions Non- 
structural protans <nsPI-naP4) are translated in the second reading frame, and the 
capsid protans in the third The diagrams o f pSFVDI-b and pSFVDI-19 show the 
nucleotides at the junctions o f  homology with SFV RNA above the sequences, and 
the equivalent nucleotides o f  the clones below Open reading frames of greater than 
200 nucleotides in length are shown below the sequences (labelled ORFI-3)
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Kigtirr 6.5 In  vitro translation products o f pSFVDI-6 and pSFVDI-19 RNA 
transcripts
0 5 or I 0 pg o f  RNA was used in a rabbit reticulocyte lysate translation system 
with | S)-methionine as label Translation products were analysed by SDS-PAGE 
on a 10-20% gradient gel The positions o f unlabelled molecular weight markers 
are indicated on the right The positive control mRNA was chloramphenicol acetyl 
transferase (CAT), which gives a translation product o f  24.000 The main 
translation products o f pSFVDI-19 and pSFVDI-6 RNA transcripts had a M, 
respectively o f  approximately 25.000 and 27.000 (arrowed)
I)IS< I SSIO N
RNA transcripts were shown to be o f  the same size as their respective DNA 
templates and they were produced in sufficient quantities for subsequent 
transfection experiments It was assumed from the high fidelity o f  T3 RNA 
polymerase that these transcripts were copied accurately from their corresponding 
DNAs and that it was unnecessary to investigate them further
One concern was that the additional 5'-guanine residue derived from the promoter 
that was used would be detrimental to the subsequent propagation o f  the RNA 
transcripts as virions In preliminary experiments not described here, a T3 RNA 
polymerase promoter was used which required the same residue at the transcription 
start site as the 5* terminal nucleotide o f the DI SFV genomes RNA transcribed 
using this promoter could not be detected by standard methods, suggesting that the 
promoter was too weak to enable sufficient quantities of RNA to be produced for 
subsequent transfection It was decided to compromise by using a promoter that 
was powerful but required a different residue at the transcription start site from the 
5' terminal nucleotide o f  the cloned D1 SFV genomes LiljestrOm r t a t (1991) 
found that RNA transcribed from the SFV clone pSP6-SFV4. which also included 
a guanine residue at the 3' terminus, had an infectivity titre in tissue culture 
comparable to that o f virion RNA It was likely, therefore, that propagation o f the 
virus was not altered significantly by this extra nucleotide, suggesting that 
propagation o f  defective RNAs, which was likely to involve the same mechanisms 
as those for standard vims, would also proceed satisfactorily
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It is possible that non-viral nucleotides were incorporated at the 3' termini o f  the 
transcribed RNAs Because the substrate for RNA polymerases is double-stranded 
DNA, it was assumed that when the enzyme reached the cleavage site created by 
the restriction enzyme it would not continue to transcribe from the non-viral 
nucleotides comprising the single-stranded portion o f  the digested site It was 
found subsequently that RNA transcripts produced from pSFVDI-6 could be 
propagated as virions, hence putative additional nucleotides were not inhibitory to 
this process (see Chapter 7) It was therefore not considered necessary to 
investigate this further because all the DNA templates that were used, apart from 
pSFVDI-SBI. possessed the same transcriptional features as those o f pSFVDI-6.
Amplification o f Dl SFV-p7 RNAs by RT-PCR has already been discussed 
(Chapter 3) There was concern that the use o f primers with additional non-SFV 
sequences at the 3' termini would prevent the amplification o f Dl SFV genomes 
However, RNA species detected using primers with transcriptional features were, 
with respect to size, the same as those detected using 5 'SH ' and J W .  RNA 
transcribed from these PCR products comprised just two predominant species of 
2 I and I 2 kb It is likely that the process of RT-PCR using Dl SFV-p7 selected 
particular Dl genomes, and that these were further selected for in the process of 
RNA transcription Hence a limited range of putative Dl SFV genomes was 
defined As stated previously, these were screened for mouse-protecting activity to 
determine if they should be cloned
It is possible that errors could be introduced into the nucleotide sequence by 
amplifying from pSFVDI-1A2 using PCR in order to provide a corrected template 
for RNA transcription It is also possible that through non-specific hybridisation of
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the PC'R primers to pSFVDI-1 A2 other species o f  DNA would be produced and 
hence subsequent transcription would yield a heterogeneous preparation o f  RNA 
Minor DNA species were not detected in the PCR product derived from pSFVDI- 
1A2, but it is not known how accurately the SFV-derived sequences o f  the clone 
had been copied In retrospect, it may have been advantageous to reconstruct 
pSFVDM A2 by deletion o f the modified form o f  pSFVDI-6
While both rSFVDI-6 and rSFVDI-19 encoded proteins in an artificial translation 
system, it is not known if such proteins are produced in tissue culture o r in vivo, or 
if these proteins contribute in any way to interference or protection Previously 
cloned Dl SFV genomes do not have extensive open reading frames (ORF) 
(I.ehtovaara el a i ,  1981, 1982) It is probable, therefore, that the production o f 
proteins from DI SFV genomes is not fundamental to the biological activity o f all 
Dl SFV Some Dl genomes o f other viruses, for example Ross River virus and 
influenza virus, encode truncated versions o f standard virus proteins (Martin el a i . 
1979; Penn and Mahy, 1985, reviewed in Nayak el ai., 1989) The contribution, if 
any, o f these proteins to the biological activity o f  the Dl genomes is not known
rSFVDI-6 encoded a protein o f  M, 27,000, which was assigned to an ORF on the 
basis o f the predicted coding potential o f  this region o f sequence Further 
experimentation is needed to confirm the origin and nature o f this protein The 
protein o f M, 25,000 encoded by rSFVDI-19 could not be assigned to any 
particular ORF It is not possible, without further investigation, to resolve the 
discrepancy between the size of the protein produced and the potential o f  rSFVDI- 
19 to encode such a protein It is possible that the protein had an electrophoretic 
mobility that was reduced in relation to the proteins comprising the size marker
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IN TR O D U C TIO N
This chapter describes the transfection o f RNA transcripts produced from clones o f 
defective SFV into tissue culture cells and the detection o f Dl vims derived from 
these transcripts
While infection o f eukaryotic cells by SFV is mediated via receptors for virion 
proteins, there are no known natural receptors for SFV RNA To investigate the 
biological activity o f cloned defective genomes it is therefore necessary to produce 
vims particles by encapsidating the nucleic acid This can be achieved by 
introducing the RNA into cells harbouring infectious vims which thus provide the 
proteins required for replication and encapsidation In order to introduce RNA into 
such cells, the process o f  transfection can be used In this, cells are stimulated by 
chemical or mechanical means to take up foreign nucleic acid.
A number o f methods have been used previously for the transfection o f RNA into 
tissue culture cells These include hypertonic shock and using DEAE-dextran and 
more recently, lipofection and electroporation
To transfect RNAs derived from clones o f  Dl Sindbis vims into tissue culture cells, 
Levis et a! (1986) used the method based on DEAE-dextran This method would 
probably have been applicable to the work described here but LiljestrOm e/ at 
(1991) reported 100% transfection o f RNA transcripts from the lull-length SFV 
clone pSP6-SFV4 by electroporation They also showed that the equivalent 
efficiency using the DEAE-dextran method was only 0 2% under optimal 
conditions Electroporation was therefore used in transfection experiments.
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although attempts were made initially to transfect RNA using the method o f 
hypertonic shock This chapter describes the adaptation o f  the method o f  
electroporation to  the transfection o f  RNA transcripts from defective SFV clones 
The success o f these experiments was determined by analysis o f tissue culture fluid 
Because RT-PCR had been used successfully to  analyse heterogeneous 
preparations o f  DI SFV, the same method was used to detect putative Dl vims 
derived from transfected RNA In addition, tissue culture fluid was analysed for 
interference in BHK-21 cells because such activity would suggest that virions were 
being formed and released and that they contained Dl genomes An analysis in vivo 
for mouse-protecting activity o f these preparations is described in the following 
chapter
To determine the relative concentrations o f  Dl SFV in preparations derived from 
cloned genomes, attempts were made to quantitate SFV-derived RNA extracted 
from tissue culture fluid This chapter describes the adaptation o f dot blot analysis 
for this purpose, and discusses the limitations o f the technique for quantitating Dl 
SFV RNA
This chapter also describes the propagation of deletion mutants o f pSFVDI-6 as 
virus particles In addition, the propagation o f RNA transcripts produced from the 
artificially constructed defective SFV clone. pSFVDI-SBI. is described The 
purpose o f these experiments was to determine if the regions o f  pSFVDI-6 derived 
from the nsP2 gene o f SFV were necessary for propagation as virions and to 
permit speculation on the nucleotide sequences required for the propagation o f Dl 
SFV genomes
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R E S U L T S
I. Transfection of RNA transcrip ts  into BHK-21 cells
As stated in Chapter 6, RNA transcripts derived from clones or PCR products have 
been given the prefix V ( e g  'rSFVDI-19*) For clarity, preparations o f virus 
derived from transfection experiments have been given the prefix V  (e g  'vSFVDl- 
I91) The passage number o f  such virus preparations is indicated after the name 
( e g  vSFVDI-l9/p3) virus in tissue culture fluid harvested following transfection 
is designated passage 1
(a) Methodology
The success o f  transfection was initially determined by using RT-PCR with the 
primers 5  W  and J W T to  detect RNAs in culture medium following transfection 
Such RNA was assumed to have been encapsidated into virions The in vitro 
interference activity o f any Dl SFV present in culture medium was also assayed 
(see section 3a)
In the first experiments, attempts were made to transfect RNA into BHK-21 cells 
using hypertonic shock Following transfection of RNA extracted from a tissue 
culture preparation o f SFV. infectious virus was detected in the tissue culture fluid, 
suggesting that this method was successful However, after transfection o f RNA 
derived from the defective SFV clones using SFV for propagation. Dl SFV was 
not detected in tissue culture fluid harvested from the first and subsequent passages 
by RT-PCR or by interference assay
1 69
In later experiments, the electroporation procedure described by I.iljcstrOm el al 
(1991) was adapted for the transfection o f RNA transcripts derived from clones of 
defective SFV Monolayers o f  BHK-21 cells were infected 45 minutes before 
transfection with 10 p fu /ce il SFV In a typical experiment approximately 20pg 
RNA were used, which equates to 2 x 10* copies per cell, assuming a genome size 
of 2 0 kb After electroporation, cells were incubated for 18-24 hours and tissue 
culture fluid harvested To amplify putative Dl SFV, culture medium was serially 
passaged in BHK-21 cells at least 3 times, with 10 p f  u /cell SFV added each time
The electroporation procedure was assessed for lethal effects upon cells In 
preliminary experiments, the cells that did not attach to the tissue culture flask 
were counted 2 hr after electroporation These comprised less than 1% o f the total 
Assuming that all attached cells were viable, the electroporation procedure was not 
significantly deleterious to cell viability
In preliminary experiments the efficiency of transfection was determined Following 
electroporation with RNA transcripts derived from pSP6-SFV4, an infectious 
centre assay was used to measure the proportion o f  cells harbouring infectious 
RNA In tw o such experiments the average efficiency was 30% While this was 
significantly lower than the transfection efficiency achieved by LiljestrOm el a!  
(1991), it was considered sufficiently high for the purposes o f  establishing 
homogeneous Dl virus populations from defective RNA transcripts following 
transfection
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(b) Control sa.nples
False positive results w ere frequently obtained when RT-PC'R was used to detect 
D1 SFV in culture medium following transfection It was likely that this was a 
consequence o f plasmid DNA contaminating the inoculum RNA transcripts were 
routinely treated with DNAse I before transfection to remove template DNA, but 
this may not have been completely effective It was therefore necessary to routinely 
include appropriate control samples Non-infected cells, transfected with 20pg of 
the RNA under test, w ere used as a negative control A virus-alone control was 
also included to permit analysis o f the generation o f Dl SFV d r novo  To determine 
that PCR products w ere derived from RNA rather than DNA, RT-PCR was 
performed without reverse transcriptase Finally, a positive control for the 
transfection procedure w as included, in which SFV-infected cells were transfected 
with RNA transcripts that had been shown in other experiments to  be propagated 
as vims particles In the  first experiments. RNA derived from pSP6-SFV4 was 
used to determine the success of the procedure
(c) Virus stocks
To create cloned stocks o f  Dl vims, it was desirable to use infectious helper vims 
that was free o f  Dl virus As Dl SFV was not propagated or generated in FleLa 
cells (N.J Dimmock. unpublished data) a HcLa-grown stock o f  SFV was used 
initially However, RT-PCR analysis o f culture medium after transfection of 
rSFVDI-6 using this virus stock suggested that this RNA was not propagated as 
vims particles (data not shown) In subsequent experiments, an SFV stock was 
produced by transfecting rSP6-SFV4 into BHK-21 edit, followed by a single low-
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multiplicity passage This preparation was designated vSFV4-p2/FI3 Transfection 
o f  defective RNA transcripts using vSFV4-p2/F 13 as the source o f  helper virus 
was successful as determined by RT-PCR analysis o f tissue culture fluid All 
transfection experiments described below used this stock of SFV It was found 
subsequently that propagation o f  defective RNA transcripts as virus particles was 
unsuccessful using another stock o f SFV produced in the same way as vSFV4- 
p2/FI3
PCR products derived from transfection experiments using vSFV4-p2/F!3 typically 
contained spurious DNA species o f  0  6 and I I kbp Dl SFV was not detected in 
this virus stock by an interference assay (see Table 7 1). In addition, RNA species 
o f  these sizes were not detected by northern blot analysis (see below) These 
results suggested that these PCR products resulted from the PCR primers 
hybridising to virion RNA non-specifically (this has already been discussed see 
Chapter 3)
(d ) Transfection o f rD I7
RNA transcripts were produced from PC'R products derived from the mouse- 
protecting tissue culture preparation Dl SFV-p7 (rDI7, see Chapter 6) These were 
transfected into BHK-21 cells and the tissue culture fluid serially passaged 5 times 
Analysis by RT-PCR showed that after passages I and 2, a Dl SFV genome of I 2 
kb was present in the tissue culture fluid (Figure 7.1) PCR products derived from 
later passages were heterogeneous and the 1.2 kbp species no longer 
predominated The 12 kbp product was shown by restriction analysis as similar in 
structure to the SFV-derived sequences o f  pSFV DM 9 (data not shown) Figure
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F ig u re  7.1 Transfection o f rDI7 into SFV-infected BIIK-21 cells
RNA was detected in culture medium by RT-PCR with the primers 5‘SF V  • 
3'SFV. In (a), the predominant PCR product from vDI7/p2 is 1.2 kbp (arrowed), 
the same size as that from vSKVDl-19/p2, but in lower quantities In (b ). several 
other products appear on amplification o f  RNA extracted from vDI7/p3 in contrast 
to that from vSFVDM 9/p3 The band o f 0 6 kbp that appears in the amplification 
products of all samples is explained in the text
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7.1 also shows PCR products derived from subsequent RT-PCR analysis of 
vSFVDI-19 In contrast to the PCR products derived from vDI7, these products 
did not vary significantly with passage number
(e) Transfection o f rSFVDI-6
rSFVDI-6 was transfected into SFV-infected BHK-21 cells and culture medium 
serially passaged 9 times in BHK-21 cells Figure 7.2 shows PCR products derived 
from passage 3 A predominant species o f  2 I kbp was detected only in the PCR 
product derived from infected cells transfected with rSFVDI-6 This was the same 
size as the product obtained after amplification from pSFVDI-6 using the same 
primers These results suggested that the RNA had been successfully rescued as 
virus particles The origin of the I I kbp DNA produced by RT-PCR using the 
vSFVDI-6 and virus-alone samples is discussed above
In a restriction analysis of the PCR product derived from vSFVDI-6/p3, the sizes 
o f the fragments obtained after digestion with Haclll corresponded to those 
predicted from the nucleotide sequence o f  pSFVDI-6 This and other restriction 
analyses suggested that the genome structure o f  pSFVDI-6 did not after 
significantly in the processes o f transcription, transfection and serial passage
Figure 7 3 shows PCR products derived from passages I to 9 o f vSFVDI-6 A 
product o f  2 I kbp was detected in all samples Analysis o f these products by 
digestion with Haelll suggested that all contained sequences derived from 
pSFVDI-6 (data not shown)
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Figure 7.2 Transfection o f rW D M  into SFV-infected BHK-21 cells
(a) RNA in culture medium was detected by RT-PCR with the pnmcrs 5 ’SbV  ♦ 
3'ShV. As a negative control. RT-PCR was performed without reverse 
transcriptase As a positive control for PCR, pSFVDI-6 was amplified with the 
primers S'SFV  * 3'SFV. The predominant product o f 2.1 kbp derived from 
vSFVDI-6 matched the size o f the product from the positive control Amplification 
o f  RNA derived from the virus-alone controls yielded a product o f  0 7 kbp using 
the primers S/'V-Si and SFV-3i and one o f I I kbp using the primers 5 W  and 
3 'S tV  The latter matched the size o f  a minor product obtained after amplification 
o f RNA derived from vSFVDI-6/p3
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Kigurr 7.3 detection o f defective SFV RNA in passages I to 9  o f  vSFVDI-6
RNA was extracted from tissue culture fluid, reverse transcribed and amplified by 
PC'R using the primers 3SFV  ♦ 3'SFV. DNA o f 2 I kbp was detected in the P(’R 
products derived from passages (p) I to 9 o f vSFVDI-6
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(0  Transfection o f  rSKVDI-19
Figure 7 4 shows PCR products derived from tissue culture fluid harvested 3 
passages after transfection o f rSFVDI-19 into SFV-infected BHK-21 ceils A I 2 
kbp product was obtained from the vSFVDI-19 sample, which corresponded to the 
size o f  the SFV-derived sequences o f pSFVDl-19 Figure 7 5a shows PCR 
products derived from passages I to 9  o f  vSFVDI-19 In all these, a 1.2 kbp 
product was detected Digestion of these products with Accl produced fragments 
corresponding to those predicted from the restriction map o f pSFVDI-19 (Figure 
7 5b)
( I )  Analysis o f v f f V D U  and vSFVDI-19 by northern M olting
Putative Dl SFV preparations derived from pSFVDI-6 and pSFVDI-19 were 
analysed by northern blotting to determine if they contained RNA species 
undetected by RT-PCR RNA extracted from passage 3 was resolved on an 
agarose gel after denaturation with glyoxal Following transfer to a nylon filter, 
RNA was hybridised to an RNA probe This probe was made by transcribing 
FcoR I-digested pSFVDI-7 (sec Chapter 4) with T7 RNA polymerase to generate 
negative-sense RNAs, which were labelled with (a-^PlU TP A 2 I kb species was 
detected in vSFVDI-6/p3 and three species o f  I 2. 2 4 and 1 6 kb were detected in 
RNA derived from vSFVDM9/pJ (Figure 7 6) It is likely that the RNA derived 
from vSFVDI-l9/p3 had not denatured sufficiently because the sizes of the larger 
RNA species were multiples of the size o f  the cloned genome, suggesting the 
molecule had concatamensed No RNAs other than these were detected.
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Figure 7.4 Transfection o f rSFVDI-19 into SFV-infected BHK-21 cells
RNA was detected in culture medium by RT-PCR with the pnmers S'SI-V ♦ 
J'-SFK The PCR products from vSFVDI-l9/p3 and vSFVDI-6/pl. o f  I 2 and 2 I 
kbp respectively, corresponded to the sizes o f the two cloned molecules
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Figure 7.5 Detection o f defective SFV RNA in passages I to 7 o f  vSFVDI-19
(a) RNA was extracted from tissue culture fluid, reverse transcribed and amplified 
by PCR using the primers 5'SHV • 3’SFV. DNA o f 12 kbp was detected in the 
PCR products derived from passages (p) I to 7 o f vSFVDI-19
(b ) PCR products derived from passages 2 to 7 o f vSFVDI-19 were digested with 
Accl The band patterns produced after agarose gel electrophoresis were the same 
in all samples Digestion of pSFVDI-19 with Accl produced a similar pattern of 
bands the additional 3 0 kbp band comprised vector sequences and included 0 3 
kbp that derived from the 3' terminus o f the clone
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Figure 7.6 Analysis of vSFVDI-6 and vSFVDI-19 by northern blotting
RNA extracted from vSFVDI-6/p3 and vSFV DI-19/p.l was resolved on an agarose 
gel after denaturation with glyoxal Following northern transfer. RNA was 
hybridised to  a [ a - wP|l/TP-labelled RNA probe (rSFVDI-7) Comparison to 
rSFVDI-6 and rSFVDI-19 and to unlabelled size markers showed that a single 
RNA species o f  2 I kb was present in vSFVDI-6. and RNAs of 1.2. 2.4 and 3 6 kb 
were present in vSFVDI-19 (arrowed)
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suggesting that the defective SFV preparations were homogeneous In addition, 
these results suggested that the 0 6 and 1 I kbp PCR products derived from RT- 
PCR amplification of SFV RNA (see above) did not comprise defective SFV 
genomes
2. Assessment o f the propagation as virions o f deletion m utants o f  pSFVDI-6 
and the a rtific ia lly  constructed clone pSFVDI-SBI
Chapter 4 described the construction o f various clones by centrally deleting 
pSFVDI-6 pSFVDI*IA2 was constructed by deleting the region o f  pSFVDI-6 
from Accl (534) to Accl (1453), and pSFVDI-M2 was made by deleting the region 
o f pSFVDI-6 from Mlul (I22S) to Mlul (1690) pSFVDI-SBI was made by 
deleting the full-length SFV clone. pSP6-SFV4. from Sail (1658) to BstFII 
(10920) To determine if these clones retained all the sequences necessary for 
propagation as virions they were transfected into SFV-infected BHK-21 cells and 
tissue culture fluid was subsequently analysed by RT-PCR and interference assay
(a) I rans irrtion  o f  rSFV D I-S B I
RNA transcripts produced from pSFVDI-SBI were transfected by electroporation 
into SFV-infected BHK-21 cells After 3 passages tissue culture fluid was analysed 
by RT-PCR (Figure 7.7) While the positive control sample showed that the 
transfection was successful. RNA corresponding to the size o f the transfected RNA 
(2 1 kb) was not detected, suggesting that rSFVDI-SBI had not been propagated 
as virus particles
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Figurr 7.7 Transfection o f rSFVDI-SBI
rSFVDI-SBI was transfected into SFV-infected BHK-21 cells After 1 passages. 
RT-PCR with the primers 5'ShV  and J'ShV  was used to detect putative 1)1 SFV in 
tissue culture fluid The positive control was rSFVDI-19 RNA o f 12 kbp was 
detected in vSFVDI-19 No RNA that corresponded to  the size o f the SFV-derived 
sequences o f pSFVDI-SBI (2 I kbp) was detected in vSFVDI-SBI
182
(b) Transfect ioa of rSFVDI-l A2 and rSFVDI-M2
Figure 7 8 shows PCR products denved from vSFVDI-l A2 and vSFVDI-M2 The 
positive control sample (vSFVDI-6) showed that the transfection was successful 
RNA corresponding to the size of rSFVDI-M2 was not detected in tissue culture 
fluid An RNA genome o f I I  kb was detected in tissue culture fluid derived from 
transfection with rSFVDl-IA2. However, this was approximately 0.2 kb less than 
the size o f the SFV-derived sequences o f  pSFVDI-IA2 Further investigation is 
needed to determine the nature of this PCR product and to prove whether or not 
rSFVDI-1A2 was successfully propagated as virus particles
3. Q ualitative and quantita tive  assessment o f D l SFV preparations
(a) Assessment o f biological activ ity o f D l SFV preparations in  vitro
Table 7 I shows the relative tissue culture (BHK-21 cell) interference litres o f the 
various Dl SFV preparations Note that the values shown do not take account of 
the quantity o f Dl particles in a given population The estimations o f  the relative 
concentrations o f Dl SFV in the various preparations were made by visual 
examination o f the PCR product on an agarose gel These estimations were made 
assuming that RT-PCR amplified different RNA species with equal efficiency
It is clear from these results and from quantitation o f  total viral RNA by dot 
hybridisation (see below) that vSFVDI-6 was not propagated as efficiently as 
vSFVDI-19 The large quantities o f PCR product from amplification o f  vSFVDI- 
1A2 RNA suggested abundance of an RNA species denved from rSFVDI-IA2 in
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Figure 7.8 Transfection o f  rSFVDI-M2 and rSFVDI-l A2
Following transfection o f rSFVDI-M2 and rSFVDI-lA2 into SFV-infected BIIK- 
21 cells, RT-PCR was used to detect putative Dl SFV genomes in tissue culture 
fluid rSFVDI-6 was included in the experiment as a positive control No DNA 
corresponding to the size o f  pSFVDl-M2 (1.7 kbp) was detected in the PCR 
product derived from vSFVDI-M2 DNA of I I kbp was detected in PCR products 
derived from vSFVDI-1 A2/p I and p.f A 0 6 kbp PCR product was detected in all 
samples derived from SFV-infected cells
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Table 7 .1 Interference Hires o f  1)1 Sb'l' preparations. *
SFV Dl 
preparation t
Dl genome size 
(nucleotides)
Passage
number
Relative 
concentration {
1 /highest dilution 
showing no 
cytopathic effect tj
Dl SFV-p7 NA 7 + 128
vSFVDI-6 2146 3 ++ 16
vSFVDI-19 1244 3 +++ 64
vSFVDI-1 A2 1228 5 ++ 2
vDI7 NA 2 4
virus (p3) NA 3 . 2
vims (p9) NA 7 +++ 64
* BHK-21 cells were used, at a concentration o f 2 x I04 cells per well
t  Each o f the cloned Dl preparations was u v -irradiated for 80 seconds to remove 
infectivity No cytopathic effect (c p  e ) was observed in wells containing Dl SFV 
alone vSFV4-p2/FI3. used in the propagation o f  the cloned Dl RNAs. was 
included as a negative control
X I hese were estimated by visual examination o f the PCR product on an agarose
d d
$ Each Dl vims preparation was assayed in quadruplicate by serial two-fold 
dilution in medium containing 10 TCIDW SFV. c p e  was assessed 24 hours after 
infection
NA -  not applicable
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the cell culture medium As stated previously, it was not proven that rSFVDI-l A2 
had been propagated as vims panicles This population did not interfere 
significantly, suggesting either that rSFVDI-IA2 had not been propagated or that 
some property o f  pSFVDI-6 responsible for interference in cell culture was lost in 
the creation o f this mutant Table 7 I also shows that vDI7 interfered weakly in cell 
culture In addition, low levels of PCR product from amplification o f vDI7 RNA 
suggested that this population was propagated poorly
As stated previously, the generation o f Dl SFV tie novo was assessed by passaging 
the vims used for transfection (vSFV4-p2/FI3) in parallel with the test samples 
Table 7 I shows that after 3 passages o f virus-alone the interfering activity was 
negligible, but this increased to levels similar to that o f  vSFVDI-19 after 9 
passages A 0 8 kb RNA in the tissue culture fluid of passage 9 was suspected to 
be responsible for this interfering activity (see Chapter 3).
(b ) Q uan tita tion  o f  vSFVD I-6  and vSFVDI-19 by dot b lot analysis
To investigate the proportion o f the total vims population that Dl SFV comprised 
in vSFVDI-6 and vSFVDI-19, attempts were made to measure relative quantities 
o f  SFV-derived RNA RT-PCR was used initially for this, but the results were 
ambiguous and were not reproducible Subsequently, total SFV-derived RNA was 
measured by dot blot analysis
vSFVDI-6/p3 and vSFVDM9/p3 were prepared in the same experiment These 
preparations and vSFV4-p2/F13 were diluted to the same infectivity litres (10* 
p f  u /ml), as determined by plaque assay, and RNA was extracted from the diluted
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tissue culture fluid Figure 7 9 shows RNA samples analysed in quadruplicate by 
dot blotting using an |a - wP|-labelled RNA probe (rSFVDI-7 see above) Relative 
quantities o f hybridised RNA were determined using a scanning densitometer 
(Table 7.2). The value obtained for the virus-alone sample was subtracted from the 
test samples, giving values assumed to correspond to RNA derived from Dl virus 
Kstimates o f the proportions o f Dl SFV that comprised vSFVDI-6 and vSFVDI-19 
were made by comparison of these values with that obtained for virus alone fable 
7 2 shows that the relative proportions o f Dl SFV RNA derived from vSFVDI-6 
and vSFVDI-19 was 1:15
For this analysis, the probe was assumed to hybridise to all SFV-derived RNAs 
with equal efficiency In addition, the density values of each blot were assumed to 
be directly proportional to the number o f  SFV-derived RNA molecules However, 
it was known from the analysis shown in fable 7 2 and from repeated experiments 
that the difference in density values between dilutions o f the same sample were not 
necessarily proportional to the dilution factor Because the exposure curve o f X- 
ray film is non-linear, it was likely that measurements made at both the lower and 
upper ranges o f optical density were not directly proportional to the degree of 
hybridisation For these reasons, intermediate density values were assumed to be 
the most precise
(c) Nucleotide sequences required by rSFVDI-6  fo r propagation as v irus 
panicles.
To determine the regions o f  Dl SFV genomes required for propagation, the 
nucleotide sequences o f the defective SFV clones used in the transfection
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SFV — •  W 2 i r - m  *
vSFVDI-6/p3 •  • •  •
vSFVDI-!9/p3 L L##
•  •  
•  •
r # • 
•  •
Figure 7.9 Analysis o f vSFVDI-6/p3 and vSFVDI-l9/p3 by dot blotting
liqual quantities o f rSFVDI-6 and rSFVDI-19 were transfected into SFV-infected 
l i t  IK-21 cells After 3 passages, tissue culture samples vSFVDI-6, vSFVDI-19 and 
the virus-alone control were diluted to 10* p fu  /ml and RNA was extracted from 
the dilutions RNA was transferred to a nylon filter and hybridised with an |a -  
l ,P)UTP-label led RNA probe (rSFVDI-7) Samples were analysed in quadruplicate 
(denoted by brackets), either undiluted or at a dilution o f I in 10 The relative 
densities of each blot were determined using a scanning densitometer (see Table
7 2 )
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Table 7.2 (JuanUtation o f  ShV-derived RNAs hy densitometry •
Virus
preparation
Dilution Integrated 
volume t
Volume
attributable to DI 
SFV RNA X
Ratio o f SFV 
RNA to DI SFV 
RNA §
vSFV4-p2/FI3 Neat 281 0 1 0
1/10 24 0
vSFVDI-6 Neat 611 330 I I
1/10 66 42
vSFVDI-19 Neat 2187 1906
1/10 448 424 1 IS
• The RNA blot shown in Figure 7 9 was used in this analysis
t  The integrated optical density o f each dot blot was determined by computer 
analysis o f the scanned X-ray film Numbers are in arbitrary units
t  The density values determined for the virus-alone samples were subtracted from 
those o f the DI SFV samples The virus-alone sample was assumed to consist 
solely of SFV RNA for this calculation
§ Only intermediate values were used because they were suspected to be more 
precise, for reasons discussed in the text Ratios were determined by division o f the 
values representing DI SFV RNA with that for virus alone
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experiments were compared Table 7 3 summarises the regions o f the clones that 
were derived from the nsP2 gene o f SFV and shows that part o f  this gene is 
essential for propagation o f virus particles pSFVDI-SBI has none o f  the nsP2 
sequence present in pSFVDI-6 and was not propagated as virions In addition, the 
non-propagated pSFVDI-M2 lacked some o f  the sequences o f pSFVDI-6 that 
were derived from the nsP2 gene By subtraction, the sequence required for 
propagation lies with the 466 nucleotides from 1225 to 1690 o f pSFVDI-6. these 
equate to 2637 to  3102 o f  the nsP2 gene o f  the virion If pSFVDI-19, which has 
nucleotides 2623 to 3024 o f  nsP2, is considered in addition, it is possible to define 
a smaller region o f 388 nucleotides, from 2637 to 3024 o f SFV RNA, that are 
needed for propagation o f  virions Table 7.3 also shows that this region is 
conserved in Dl 309 (Lehtovaara el a / .  1982), further supporting the above 
conclusions
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Table 7.3 Analysis o f  the sequence requirement for pnqiayalion o f  1)1 yenomes as 
virus particles.
C lo n e p S F V D I-6 p S F V D I-M 2 p S F V D I-
S B I
p S F V D I - lv D l 3 0 9  x
p ro p a g a tio n ♦ • - ♦ ■f
sequence  
d e riv ed  from  
n sP 2  gene*
2 2 2 7 -3 2 0 2 2 2 2 7 -2 6 3 6
3 1 0 3 -3 2 0 2
none 2 6 2 3 -3 0 2 4 2 6 2 7 -3 0 6 3
sequence  
ab se n t from  
p S F V D I-f tt
N A 2 6 3 7 -3 1 0 2 2 2 2 7 -3 2 0 2 2 2 2 7 -2 6 2 2
3 0 2 5 -3 2 0 2
2 2 2 7 -2 6 2 6
3 0 6 4 -3 2 0 2
* Numbers refer to nucleotide positions in SFV RNA
t  Only pSFVDI-6 sequences derived from the nsP2 coding region o f  SFV RNA are 
considered here
X I ehtovaara eta!., 1982
NA * not applicable
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DISCUSSION
Transfection o f defective RNA transcripts into SFV-infected HHK-21 cells by 
electroporation generated detectable quantities o f defective SFV RNA after a 
single passage RNA transfection by hypertonic shock gave no detectable defective 
RNA, suggesting that the proportion o f cells receiving RNA was not sufficiently 
high to establish a homogeneous Dl SFV population Levis el a t (1986) showed 
that following transfection o f certain defective Sindbis RNA transcripts using the 
DEAE-dextran method, several defective RNA species were detected in the culture 
medium in addition to the RNA of interest It is possible that Dl genomes 
generated Je novo are not competed out by low amounts o f  input RNA transfected 
at low efficiency
Interfering activity was detected in vSFVDI-6 and vSFVDI-19 after 2 passages In 
contrast, this activity was detected in the virus control samples after 4 to 6 
passages In addition, these preparations contained only the Dl RNA that they 
were expected to  have It is reasonable to conclude, therefore, that the defective 
genomes within pSFVDI-6 and pSFVDI-19 possessed sequences required for 
interference in vitro and they could therefore be defined as defective interfering 
genomes Evidence from RT-PC'R and northern blot analyses (discussed below) 
suggested that the cloned Dl SFV preparations were homogeneous It is therefore 
likely that the interfering activity of these preparations was attributable to the 
interfering sequences derived from the cloned genomes From this premise, the 
biological activities o f  the cloned Dl SFV preparations in vitro and in vivo can be 
defined on the basis o f their constituent Dl sequences
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Propagation o f defective RNA transcripts as virions was observed after 
transfection using vSFV4-p2/F13 as helper, but not after transfection using either 
HeLa-grown virus or another preparation o f SFV derived from pSP6-SFV4 There 
is clearly some function of the SFV genome relevant to the propagation o f these 1)1 
clones, which varies between virus preparations This function may be analogous to 
the altered replicase specificity described for a mutant o f  VSV that was resistant to 
DI particles (Sdi mutant Giachetti and Holland, 1988) However, after several 
passages o f each the virus preparations. Dl SFV was detected by interference 
assay, showing that these preparations comprised virus that was not resistant to 
interference by Dl virus A preliminary experiment in which an established 
preparation of vSFVDI-6 was passaged using HeLa-grown virus suggested that 
replication and amplification of the genome was unaffected but the abundance of 
Dl RNA derived from vSFVDI-6 was reduced (data not shown) This suggests that 
the difference in these virus preparations relates to the encapsidative rather than the 
replicative functions It is possible that the non-propagation o f cloned Dl SFV 
genomes in vitro using certain virus preparations is analogous to the in vivo 
system As will be discussed in the following chapter, the degree o f mouse- 
protection by co-administration o f  SFV and Dl SFV is dependent on the 
preparation of SFV used
Once cloned Dl SFV populations were established, they could be maintained 
through at least 9 passages, showing that they were stable and suggesting that they 
prevented the establishment o f Dl genomes Je novo This dominance effect has 
also been seen with Dl VSV and Dl influenza virus (VSV reviewed in Holland. 
1985, influenza virus reviewed in Nayak el a l , 1989) Restriction analysis o f  the 
PCR products derived from different passages suggested that the overall structure
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o f the cloned defective genomes did not alter during their propagation //» vitro The 
stability of cloned defective RNA contrasts with the instability on passage o f the 
heterogeneous mouse-protecting population Dl SFV-p7 (see Chapter 3) The PCR 
profile derived from Dl SFV-p7 changed after a single passage, from exhibiting 
two main products o f 2 I and 1.2 kbp to showing only the 2 I kbp product The 
artificial enrichment o f the I 2 kb species through transcription o f the PCR product 
and subsequent transfection permitted maintenance through two passages (vDI7/pl 
and p2), but it was again lost after the third This could be explained by the 
competing action of minor species o f defective RNAs present in the transcription 
products, and underlines the necessity o f homogeneous transcripts to generate 
homogeneous RNA populations
Although RT-PCR analysis suggested that the cloned Dl genomes were 
successfully propagated as virions, it is possible that other Dl species were present 
but were not detected because o f  the limitations o f  the technique (discussed in 
Chapter 3) The analysis o f vSFVDI-6 using northern transfer suggested that other 
SFV-derived sequences were not present Analysis o f  vSFVDI-19 revealed RNAs 
that were multiples o f the size o f the cloned genome, suggesting the molecule had 
concatamerised As was discussed in Chapter 5, SFV RNA can circularise because 
o f complementary sequences at the termini Because the cloned Dl SFV genomes 
possess both termini o f  the standard virus genome, it is conceivable that 
concatamerisation could occur if the RNA is in a sufficiently high concentration 
Analysis o f the relative quantities o f vSFVDI-6 and vSFVDI-19 by dot blotting 
indicated that the latter was approximately 15 times as abundant Because the same 
volumes of each preparation were used in the northern analysis, more vSFVDI-19 
RNA was used in the analysis than RNA from vSFVDI-6, and it was therefore
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more likely to be incompletely denatured However, further investigation is needed 
to confirm these conclusions
The estimations o f the relative quantities o f  vSFVDI-6 and vSFVDI-19 suggested 
that the latter was propagated in vitro more efficiently It is possible that the 
smaller Dl genome o f pSFVDI-19 was replicated more frequently within the 
infected cell and as a consequence the Dl virus population became established 
more rapidly However, because the dot blot analysis measured relative amounts of 
SFV-derived RNAs and not the absolute numbers o f Dl vims particles, it is not 
possible to make firm conclusions on the relative efficiencies with which the two 
Dl genomes were propagated as virions However, evidence from the u v -target 
size o f  Dl SFV suggested that one genome was packaged per virion (Barrett e t a l , 
1981 ) Whether this is also true o f vSFVDI-19, which consists of a genome that is 
approximately half the size o f previously studied Dl SFV genomes, is not known, 
but there are no reasons to suspect that multiple copies o f this genome would be 
packaged into a single virion Bruton and Kennedy (1976) showed that the buoyant 
density of Dl SFV on a CaCI velocity gradient was greater than that o f standard 
SFV They concluded that this was either a consequence of each vims particle 
packaging multiple copies o f the Dl genome or the Dl SFV particles possessed 
more compact nucleocapsids The latter conclusion is supported by evidence from 
electron microscopy that Dl SFV particles are smaller than those of standard vims 
(Barrett et al., 1984b) It is conceivable, therefore, that particles which package 
single copies o f  Dl SFV genomes can be denser than standard vims particles, 
despite having less RNA
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The methodology used to establish homogeneous populations o f  Dl SFV proved a 
rapid and effective means o f  determining if artificially generated 1)1 genomes could 
be propagated as virus particles Much has still to be done to determine the 
(unctions o f  the various regions o f the cloned Dl SFV genomes, but this aim could 
readily be achieved with the methodology described in this thesis A sequence of 
388 nucleotides, corresponding to 2637 to 3024 within nsP2 of the virion was 
defined, which was necessary for the propagation o f  Dl virions This could contain 
a packaging signal analogous to that identified within nsPI o f Sindbis virus or 
within the polymerase gene o f the coronavirus MHV-4, another positive-strand 
RNA virus (Levis el at., 1986, Makino et a! , 1990) Following transfection of 
rSFVDI-1 A2, an RNA species was detected by RT-PCR in culture medium that 
was approximately 0 2 kb smaller than expected Comparison o f the PCR profile 
obtained from vSFVDI-1A2 with those derived from the control samples suggested 
that this RNA had derived from the transfected genome It is possible that the 
genome altered during its amplification and propagation in vitro, for example 
through recombinational events Interfering activity was not detected in 
vSFVDI-lA2, suggesting that the RNA that was propagated as virions did not 
possess sequences necessary for interference Further investigation is needed to 
resolve these results and determine the nature o f this propagated RNA

1 96
INTRODUCTION
This chapter describes the biological activity of cloned DI SFV preparations m  
vivo Differences in mouse protection by the D1 viruses derived from pSFVDI-6 
and pSFVDI-19 is discussed in relation to the differences in their nucleotide 
sequences
Although by definition all Dl SFV preparations interfere in vitro, only some protect 
in  vivo Barrett and Dimmock (1984b) showed that while the Dl SFV preparations 
p4 and pi3a prevented disease and death from a normally lethal dose o f SFV, Dl 
SFV p5 had no such effect These preparations had similar levels o f  SFV antigen 
and interfered with SFV in vitro to a similar degree It was concluded that there 
was some function o f Dl SFV genomes relevant to their ability to protect in vivo 
However, the Dl SFV preparations used in these experiments were heterogeneous 
and the nucleotide sequences o f the constituent genomes were not known It was 
not possible therefore to determine which Dl SFV genomes were responsible for 
the mouse-protecting activity The previous chapter showed that homogeneous Dl 
SFV populations could be prepared from cloned genomes and these preparations 
could therefore be defined on the basis o f their constituent RNA This chapter 
describes the effects of co-inoculation into mice of these preparations with a lethal 
dose o f SFV, and discusses the regions of the cloned molecules that may be 
responsible for mouse-protection
Mouse experiments were performed using a plaque-purified (ts*) strain o f SFV or 
the cloned strain o f  SFV that had been used in the transfection experiments This
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chapter compares the degree of mouse-protection by Dl SFV against these two 
strains o f SFV
The previous attempts to detect Dl SFV genomes in the brain tissue o f  mice 
inoculated with tissue culture Dl virus were unsuccessful (see Chapter 3). 
Although RT-PCR was used successfully to detect tissue culture Dl SFV. it was 
not known if mouse-protecting Dl SFV genomes in vivo, which were presumably 
propagated in the brain, were small enough to be amplified by RT-PCR, or if their 
nucleotide sequences were complementary to the primers that were used These 
experiments were repeated using cloned Dl SFV. which was known to be amplified 
readily by RT-PCR This chapter describes the attempts made to detect cloned Dl 
SFV in mouse brain following intranasal inoculation with SFV In addition, to 
determine if brain cells supported the propagation o f these Dl SFV preparations, 
mice were inoculated by the intracerebral route and brain RNA analysed by RT-
PCR
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RESULTS
1. Analysis of cloned 1)1 SFV in  vivo 
(a) Methodology
For these experiments. CFLP, CD-I or Balb/c mice were used to  determine strain 
susceptibility to Dl SFV and partly depending on availability All strains were 
equally susceptible to infection by SFV Cloned SFV preparations were analysed in 
mice by intranasal co-inoculation with a lethal dose o f SFV (10 LDM. ■ 1500 p fu  
ts ' strain o f  SFV. or 4000 p.f.u. cloned SFV) Infectivity was removed from the DI 
SFV preparations by u v -irradiation (see Methods) As negative controls, groups 
o f mice were inoculated with u.v -irradiated Dl SFV or culture medium As a 
positive control. Dl SFV-p7 was used, which had been produced by 7 serial 
undiluted passages in BHK-21 cells and typically gave 60-80% protection against 
the ts* strain o f SFV (N J Dimmock. unpublished data) As described in Chapter 3. 
this was the Dl SFV preparation from which the clones pSFVDI-6 and pSFVDI-19 
were derived
It should be noted that in preliminary experiments DI SFV preparations were only 
investigated for mouse-protecting activity and controls for antigen-mediated 
protection were not included In addition, the concentration o f Dl SFV in different 
preparations was not standardised, so it is not possible to  conclude that 
preparations which conferred no protection comprised non-protecting Dl SFV
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(b) K »pertinent s using cloned SFV
In preliminary experiments, SFV derived from the full-length clone pSP6-SFV4 
was used (vSFV4-p2/FI3) This has similar pathogenic properties to the L10 strain 
(Glasgow et at., 1991). Table 8 I shows a comparison o f the ability of different Dl 
SFV preparations to modulate infection o f mice inoculated with a lethal dose of 
SFV These results are compared with the relative concentrations and in vitro 
interference titres o f the DI SFV preparations, which were discussed in Chapter 7 
The estimation o f relative concentrations was based on a subjective assessment of 
quantities o f PCR products derived from tissue culture preparations of Dl SFV. 
and assumed that different Dl RNAs were amplified with equal efficiency
After inoculation with the cloned virus preparation, the mean time o f  death was 4 
days, which was a day less than after inoculation with the ts* strain in CFLP mice 
(see below) In all Dl SFV groups, the mean time o f death did not differ 
significantly from that o f the virus control group
Only 20% protection was observed after inoculation with Dl SFV-p7, which 
contrasts with 60-80% protection observed using the ts4 strain o f SFV The 
greatest degree of protection was observed using vDI7 /p2 As stated previously, 
this preparation was derived from PCR product that had been generated from Dl 
SFV-p7 (see C'hapter 7). This process resulted in the enrichment o f  a 1.2 kb Dl 
SFV genome that was suspected to be the same as that constituting pSFVDI-19 
However, the number o f survivors after inoculation with vSFVDI-l9/p3 was only 
30%. despite evidence from RT-PCR analysis that the I 2 kb Dl SFV genome was 
more abundant in this preparation Further, the in vitro interference titre of
2 0 0
Table 8 .1 Assessment o f  mouse-protecting ability o f  cloned D ! SFV preparations 
using cloned SFV. •
Group Relative 
concentration +
Relative
interference titre X
%  Survival §
virus alone . 2 0
Dl SFV-p7 128 20
vDI7 /p2 + 4 4 0
vSFVDI-19/pl +++ 6 4 30
vSFVDI-19 /p7 +++ 32 20
. S I  \  1 ) 1 - 6 /p 3 ++ 16 0
virus (p‘>) +++ 6 4 0
• All Dl SFV preparations were u.v -irradiated for 80 s; this removed infectivity 
but not interference in cell culture SFV derived from pSP6-SFV4 was used 
(I.iljestrOm el a!., 1991) Male CFLP mice (5 weeks o f age) were coinoculated 
with 10 LDWSFV and 1)1 SFV intranasally, in groups o f 8 or 10 Control groups 
inoculated with medium, or u v -irradiated Dl SFV alone showed no signs of 
clinical disease throughout the course o f  the experiments (10 days)
t  These were determined by visual examination o f  PCR products derived from 
tissue culture Dl SFV preparations on an agarose gel (see Table 7.1).
X The in vitro interference titres were determined by tissue culture assay (see Table 
7.1) Numbers refer to l/highest dilution o f  Dl SFV preventing e p e at 24 hr
§ No mice survived after inoculation with SFV alone and it was therefore not 
necessary to correct these values
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vSFVDI-19 was significantly greater than that o f vDI7 /p2 It is also interesting to 
note that vDI7 /p2 conferred better protection than the positive control (Dl SFV- 
p7) despite having a much lower interference titre
There was no significant difference in protecting activity between passages 3 and 7 
o f  vSFVDI-19 Chapter 7 showed that similar PCR products were generated from 
different passages o f  vSFVDI-19 and the constituent Dl SFV genome was 1.2 kb 
in all samples However, different passages and preparations o f  vSFVDI-19 had 
different interference titres in vitro (data not shown) This variation was suspected 
to b e  a consequence o f slight differences in the conditions used to passage the Dl 
virus and may account for the marginal differences in protection
There was no protection after inoculation with vSFVDI-6 Although the Dl SFV 
concentration in this preparation was not standardised against the positive control, 
the interference litre in vitro was significantly greater than that o f  vDI7 /p2. which 
conferred 40% protection Finally, the vims control used in the transfection 
experiments (passage 9) was included because it had a high interference titre in 
vitro, and thus was a control for putative mouse-protecting Dl SFV generated Ue 
novo  in the transfection experiments No protection was observed after inoculation 
o f  this Dl SFV preparation
(c) Experim ents using the ts4 stra in o f SFV
Table 8 2 shows two mouse-protection experiments using the ts4 strain o f SFV 
The mean time of death was 5 days for CFLP mice and 7 days for Balb/c mice 
These values did not vary significantly between virus-alone and Dl SFV groups
2 0 2
Table 8.2 Assessment o f  mouse-protecting ability o f  cloned D l S h Y  preparations 
using the ts ' strain ofSFV. *
Group Relative Relative %  Survival
concentration t interference titre t (correc
CFLP Balb/c
virus alone - 2 0 0
1)1 SFV-p7 ♦ 128 30 75
vDI7 /p2 + 4 75 nd
vDI7 /p3 + 4 44 nd
vSFVDI-19 /p2 +-M- 64 nd 88
vSFVDI-19 /p3 +++ 64 58 44
vSFVDI-6 /p3 ++ 16 0 nd
• All Dl SFV preparations were u v -irradiated for 80 s, this removed infectivity 
but not interference in cell culture Mice were coinoculated with 10 LDW SFV 
(ts+) and Dl SFV intranasally, in groups o f 7-9 Control groups inoculated with 
medium, or u.v -irradiated Dl SFV alone showed no signs o f  clinical disease 
throughout the course o f the experiments (10 days)
t  These were determined by visual examination of PCR products derived from Dl 
SFV preparations on an agarose gel (see Table 7 1).
X The in vitro interference titres were determined by tissue culture assay (see Table 
7 I ) Numbers refer to l/highest dilution o f Dl SFV preventing e p e  at 24 hr
$ The percentage o f  mice surviving after inoculation with SFV alone was 13% 
(CFLP) or 0% (Balb/c). and was subtracted from those surviving after inoculation 
with SFV ♦ Dl SFV
nd ■ not done
2 0 3
The positive control sample (DI SFV-p7) used in the experiment with CFLP mice 
had been re-frozen and thawed before inoculation This process is likely to have 
damaged some o f the D1 SFV particles, and protecting activity may have been 
reduced compared with the sample used in the experiment with Balb/c mice for this 
reason
As with the experiment described using cloned SFV, both vDI7 and vSFVDl-19 
protected and vSFVDI-6 did not However, the degree o f protection was 
significantly higher using the ts* strain o f  SFV The experiments shown in Table 
8 2 further support the observation that although vD17 conferred a similar degree 
o f protection as vSFVDl-19, the data from RT-PCR and interference assay 
suggested that this preparation contained a lower concentration o f Dl SFV
Different passages o f vDI7 protected to different degrees Chapter 7 showed by 
RT-PCR analysis that passage 2 consisted predominantly o f a 1.2 kb Dl SFV 
genome and passage 3 was heterogeneous This change was reflected in the 
reduction o f mouse-protection from 75% (passage 2) to 45% (passage 3).
(d ) Investigation o f immune-media ted p ro tection  by cloned D l SFV
To investigate the possibility that protection was immune-mediated. mice were 
inoculated with vSFVDl-19 pre-treated with (3-propiolactone (BPL) BPL destroys 
the infectivity o f  viruses by interacting with their nucleic acid and without 
significantly altering the properties o f their proteins (Barrett el a t ,  I984d) For this 
ex pen mem, CD-1 random-bred mice were used at 5 weeks o f age in groups o f 8 or 
10
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Table 8 3 shows that following intranasal inoculation o f  10 LDW SFV + untreated 
vSFVDI-19 (passage 2), 75% mice survived and only 10% survived inoculation 
with SFV alone There was no significant difference between the number o f 
survivors in the virus control group and groups inoculated with 10 LD*, SFV + 
BPI treated vSFVDI-l9/p2
(e) Investigation o f post-infection im m un ity  in mice inocu la ted w ith  SFV + 
cloned D l SFV
Mice that were protected from a normally lethal SFV infection with Dl SFV were 
challenged by intranasal inoculation o f 100 LDW SFV (1.5 x I04 p f u )  to 
determine if they had developed a protective immune response All mice died o f 
clinical disease that followed its normal course In addition, mice that had been 
inoculated with Dl SFV and u v -inactivated SFV were susceptible to challenge
<f) Propagation o f  D l RN A  in  the brains o f mice co-inoculated w ith  SFV and 
cloned D l SFV.
In order to determine if vSFVDI-6 and vSFVDI-19 were propagated in the brain, 
mice were co-inoculated with 100 LDW SFV (ts‘ ) and Dl SFV. by the intranasal or 
intracerebral routes After intranasal inoculation, brains were dissected from mice 
in the advanced stages o f the disease (usually 4-5 days after infection) Following 
intracerebral inoculation, brains were dissected after 1 hour (dO) and then daily 
RT-PCR was used to detect Dl sequences in RNA extracted from brains, with 
primers specific for the termini o f  SFV (5'SI V  ♦ J » V )  It should be noted that in
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Table 8 3 shows that following intranasal inoculation o f 10 LDW SFV + untreated 
vSFVDI-19 (passage 2), 75% mice survived and only 10% survived inoculation 
with SFV alone There was no significant difference between the number o f 
survivors in the virus control group and groups inoculated with 10 LDW SFV + 
BPL
(e) Investigation o f post-infection im m un ity  in  mice inoculated w ith  SFV + 
cloned D l SFV
Mice that were protected from a normally lethal SFV infection with Dl SFV were 
challenged by intranasal inoculation o f 100 LDW SFV (1.5 x I04 p.f.u.) to 
determine if they had developed a protective immune response All mice died o f 
clinical disease that followed its normal course In addition, mice that had been 
inoculated with Dl SFV and u v -inactivated SFV were susceptible to challenge
(0  Propagation o f  D l RNA in the brains o f mice co-inoculated w ith  SFV and 
cloned D l SFV.
In order to determine if vSFVDI-6 and vSFVDI-19 were propagated in the brain, 
mice were co-moculated with 100 LD*, SFV <ts*) and Dl SFV. by the intranasal or 
intracerebral routes After intranasal inoculation, brains were dissected from mice 
in the advanced stages of the disease (usually 4-5 days after infection) Following 
intracerebral inoculation, brains were dissected after I hour (dO) and then daily 
RT-PCR was used to detect Dl sequences in RNA extracted from brains, with 
primers specific for the termini of SFV ♦ 3 •SFV) It should be noted that in
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Table 8.3 ImeMiyahon o f  immune-mediatedprotection by cloned DISFV. *
Group %  Survival
virus alone 10
non-infected 100
vSFVDI-19 alone 100
DI SFV-p7 50
vSFVDI-19 /p2 75
t  BPI -treated vSFVDI I9/p2 0
• All DI SFV preparations were u v -irradiated for 80 s, this removed infectivity 
but not interference in cell culture Adult CD-I mice were co-inoculated 
intranasally with 10 LDW SFV (ts* strain) + DI SFV in groups o f 8
t  vSFVDI-19 was treated with 0 01% (v/v) BPI. to inactivate the nucleic acid
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these experiments the concentration o f vSFVDI-6 was lower than that o f  vSFVDI- 
19 (aee Chapter 7).
When mice were inoculated intranasally, neither vSFVDl-6 or vSFVDI-19 could 
be detected However, after intracerebral inoculation, vSFVDI-19 was detected at
2,3 and 4 days (Figure 8 1) vSFVDI-6 was not detected in brain samples taken up 
to  2 days after inoculation As a control, the same volume o f  vSFVDI-6 as used in 
the inoculum was added to the homogenate o f  one brain from an SFV-infected 
mouse prior to RNA extraction, and this was readily detected by RT-PCR In 
addition, vDI7 /p2 was not detected by RT-PCR in brains dissected up to 2 days 
after infection, although it protected mice to a greater degree than vSFVDI-19 (see 
Tables 8 I and 8 2)
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Figure S. I Investigation o f  the propagation o f  cloned DI SFV in mouse brain
Mice were inoculated intracerebrally with 100 LD*, SFV and Dl SFV in a total 
volume o f approximately 50pl Brains were removed and RNA extracted using 
guanidinium isothiocyanate and analysed by RT-PCR using primers specific for the 
termini o f  SFV RNA (3'Sf-V  * 3'SFV) In (a), a I 2 kbp product was generated 
from samples taken 2, 3 and 4 days (d2. d3, d4) after inoculation with SFV ♦ 
vSFVDI-19 Dl SFV was not detected in samples taken after inoculation with 
SFV-alone or SFV + vDI7 In (b) Dl SFV was not detected in samples taken after 
inoculation with vDI SFV-6 However. vSFVDI-6 (2 1 kb) was detected in the 
inoculum and in a brain homogenate to which 80pl vSFVDI-6 had been added 
before RNA extraction The 0  6 kbp band in all lanes probably derived from non­
specific hybridisation o f the primers to SFV RNA or to mouse RNA
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DISCUSSION
The experiments described in this chapter showed that vSFVDI-19 had mouse- 
protecting activity However, to confirm that vSFVDI-6 was non-protecting it will 
be necessary to standardise the concentration o f Dl SFV in this preparation 
Evidence from dot blot analysis (see Chapter 7) suggested that the concentration of 
Dl SFV in vSFVDI-6 was lower than that o f vSFVDI-19 However, vSFVDI-6 
had a higher interference litre in viirtt than the mouse-protecting preparation vDI7 
(see Table 8 2), suggesting that vSFVDI-6 was indeed non-protecting
The strain o f  SFV was an important determinant o f protection in vivo, and 
protection by certain preparations o f  Dl SFV was lower against SFV derived from 
the full-length clone than against the ts* strain (see Tables 8 I and 8 2) Previous 
work showed that the protection also varied with different plaque-purified 
preparations o f the ts+ strain o f  SFV (N J Dimmock, unpublished data) These 
results suggest that highly specific interactions occur between standard and Dl 
virus in vivo, which can be affected by slight differences in the nucleotide sequence 
o f the standard genome
Different preparations and passages o f vSFVDI-19 protected to different degrees 
It is likely that the concentration o f Dl SFV in these preparations was at a 
threshold required for mouse-protection, and that a slight reduction in this resulted 
in a disproportionate Io s j . o f  mouse-protecting activity In a preliminary 
experiment, a three-fold dilution o f vSFVDI-19 abrogated protection (data not 
shown) Previous work by Barrett and Dimmock (1984c) showed that two-fold 
dilution o f Dl SFV (p4 and p i3a) resulted in a disproportionate loss o f mouse-
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protecting activity They concluded that the ratio of standard to Dl virus was a 
critical factor in protection It will be interesting to determine if the degree of 
protection is increased by concentrating vSFVDI-19 However, this may result in 
sufficiently high quantities o f antigen to elicit immune-mediated protection
Protection was not observed after inoculation with BPL-inactivated vSFVDI-19 
This shows that protection required the participation o f  a biologically active 
genome and was not immune-mediated. supporting evidence from previous work 
which showed that protection in vivo by Dl SFV was independent o f the amount of 
associated antigen (Dimmock and Kennedy, 1978, Barrett and Dimmock, 1984a, b. 
c). Mice protected using vSFVDI-19 were not resistant to  challenge Previous 
work by Barrett and Dimmock (1984b) showed that while mice co-inoculated with 
SFV and some preparations o f Dl SFV were completely immune to subsequent 
lethal challenge with SFV, mice inoculated with SFV and other preparations o f  Dl 
SFV had no immunity whatsoever This was despite o f the fact that SFV multiplied 
in the CNS and systemically to the same extent in all groups o f  mice
Barrett and Dimmock (1984b) also showed that after co-inoculation of Dl SFV 
with encephalomyocarditis (EMC) virus, which is sensitive to interferon (Grcsser el 
a /  , 1976), no modulation o f  EMC virus infection was observed Protection was 
therefore not suspected to  be mediated by non-specific immune responses Similar 
experiments need to be performed with vSFVDI-19 to confirm that protection 
resulted from intracellular interference o f  Dl SFV with standard virus and not from 
non-specific immune responses
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vDI7 /p2 protected mice to the same degree as the positive control (Dl SFV-p7), 
and generally better than vSFVDI-19, despite evidence from an in vitro 
interference assay that the Dl SFV concentration was much lower in this 
preparation (see Tables 8 I and 8 2) However, passage 3 o f  vDI7 had reduced 
protecting activity and this may have been the consequence o f the loss o f a 1.2 kb 
Dl SFV genome (sec Chapter 3). These results support previous conclusions that 
mouse-protection by Dl SFV is mediated by specific Dl RNA sequences (Barrett 
and Dimmock. 1984b)
Evidence from restriction analysis o f  PCR products derived from vDI7 and 
vSFVDI-19 suggested that the 12 kb Dl SFV genome was the same in both (see 
Chapter 7). It is possible that the difference in mouse-protecting activity between 
the preparations lies at the level o f individual nucleotides Such differences would 
not alter the primary structure o f  the genome significantly but may result in 
alteration o f a region o f secondary structure involved in the intracellular 
interactions with standard virus RNA in vivo For example, nucleotide 22 of 
pSFVDI-19 is thymine and in SFV RNA it is cytosine (see Chapter 5). This 
substitution is within a 44 nucleotide region that forms a stem-loop structure and is 
conserved at the 5' termini of different alphaviruses (Ou el a l , 1983) Furthermore, 
Tsiang el a l (1988) showed that by deleting 11 nucleotides in this region o f a Dl 
Sindbis clone (DI-549). this stem-loop structure was disrupted and the genome 
was inactivated T o determine if single nucleotide differences in pSFVDI-19 
resulted in decreased mouse-protecting activity, compared with the genome within 
the original Dl SFV preparation, it would be necessary to re-clone However, 
vSFVDI-19 clearly had mouse-protecting activity and will permit fiiture 
investigation into the sequence-function relationships o f Dl SFV
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Following intracerebral inoculation o f mice with a mixture o f SFV and cloned Dl 
SFV populations, vSFVDI-19 was propagated and vSFVDI-6 was not To confirm 
these conclusions it will be necessary to repeat the experiment using standardised 
concentrations o f Dl SFV and taking samples from mice 3 and 4 days after 
inoculation with vSFVDI-6 However, an explanation as to why vSFVDI-6 did not 
protect against a lethal dose o f SFV and vSFVDI-19 did could be that the former is 
not propagated in vivo The synthesis o f  alphavirus genomic and sub-genomic 
RNAs is believed to require specific t/.v-acting sequences and a combination of 
virus-specific proteins and host cell components that act in irons (Grakoui el a! , 
1989) It is possible, therefore, that vSFVDI-6 is propagated in vitro but not in 
vivo because the replicase complex formed in brain cells differs from the complex 
formed in BlfK-21 cells
Chapter *> showed that pSFVDI-6 possesses all the nucleotide sequences present in 
pSFVDI-19 It is likely, therefore, that the reason vSFVDI-6 had no biological 
activity in vivo compared with vSFVDI-19 was because its additional sequences 
(which comprised 0 9 kb) abrogated protection It is possible that these sequences 
disrupted secondary structure that is involved in intracellular interactions with the 
standard genome or replicase complex in vivo Such interactions may be dependent 
on the sire o f the Dl SFV genome or the length o f sequences separating protein­
binding domains
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This thesis describes the development o f a system that was used to generate 
genetically homogeneous preparations o f  Dl SFV and identify nucleotide 
sequences important for the biological activity o f Dl SFV genomes both in vitro 
and in vivo As specific experimental data have been discussed already, this final 
section will provide an overview o f  the results obtained and speculate on the 
implications o f  this work for future studies
The RT-PC'R technique provided an simple and effective means for isolating Dl 
SFV genomes from heterogeneous tissue culture preparations This technique was 
also useful for studying the progression o f Dl SFV genome populations on serial 
passage For example. Figure 3 6 showed that a I 2 kb Dl genome was replaced by 
a 2.1 kb genome after a single passage with the concomitant loss o f  mouse- 
protecting activity This confirms previous observations that Dl SFV genome 
populations can increase in size on passage (KJUIritiinen el a l . 1981) and suggests 
that smaller D l genomes are not necessarily more competitive It is possible that Dl 
genomes that interfere strongly with standard virus propagation are less successful, 
since a Dl genome that interferes strongly with helper virus will do so at its own 
expense However, this situation is unlikely to arise during passaging at a high- 
multiplicity o f  infection Clearly the replicative advantage o f Dl SFV genomes lies 
with a function o f  the nucleotide sequence but may also be dependent in part on 
other factors, such as the host cell components involved in viral RNA synthesis
Two Dl SFV genomes were cloned and sequenced (pSFVDI-6 and pSFVDI-19) 
Both were essentially unaltered subsets o f  the virion RNA, thus differing from 
previously sequenced Dl SFV genomes which comprised repeated and rearranged 
regions of the standard genome (Lchtovaara el a t . 1981. 1982) These findings
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suggest that different mechanisms are involved in the generation and amplification 
o f Dl SFV genomes However, pSFVDI-6, pSFVDI-19 and the clones described 
by Lehtovaara and associates were all derived from similar regions o f  SFV RNA 
suggesting a common sequence requirement for the production of Dl SFV
It is not possible ffom the sequence data alone to deduce the mechanisms involved 
in the generation o f  the RNA ffom which pSFVDI-6 and pSFVDI-19 were derived 
Both these molecules could have been generated Ue novo ffom the standard 
genome or one was generated ffom the other pSFVDI-6 contains all the sequences 
o f pSFVDI-19 and the latter could therefore have been created through deletion of 
the former However, evidence ffom RT-PCR o f  the tissue culture fluid from 
which the two clones were derived suggested that pSFVDI-19 RNA predominated 
in passage 7, while pSFVDI-6 RNA predominated in passage 8. implying that 
pSFVDI-19 RNA was not generated through sequential deletion events 
Alternatively the RNA ffom which pSFVDI-19 was derived may have been o f a 
structure that favoured recombinational events with the standard RNA, thus 
generating the larger RNA ffom which pSFVDI-6 was derived If this was the case, 
it suggests that the interfering activity o f pSFVDI-19 RNA may result in part from 
some type of recombinational ability that would presumably reduce the 42S RNA 
population in the infected cell However, the stability on serial passage of the 
cloned preparation o f Dl virus derived ffom pSFVDI-19 (discussed below) 
suggests that this is unlikely
It is probable that the secondary structure o f  a Dl genome is important to its 
biological functions As stated previously, SFV RNA can circularise and form 
panhandle structures under the conditions used for electron microscopy (Hsu el a/ .
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1974, Frey r /  a! . 1979) Both pSFVDI-6 and pSFVDI-19 have retained the 
regions from within the termini o f SFV RNA proposed by Ou el a l (1983) to be 
involved in the base-pairing of these panhandles, and may therefore be capable of 
circularising o r concatamerising Indeed, the northern blot analysis o f  RNA derived 
from vSFVDI-19 suggested that at least under certain conditions the molecule can 
form multimers (see Figure 7 6) Although it is difficult to envisage what role 
genomic circularisation may have in the infected cell, it is possible that 
complementary regions within the genome may permit intergenomic base-pairing 
Such an event may cause errors to be made by the viral replicase and hence explain 
how novel D1 genomes can be generated from existing ones Although this is 
speculation, a number o f Dl influenza virus genomes have been shown to contain 
regions derived from different segments o f  the standard genome This suggests that 
the generation o f  Dl genomes can, at least in the case o f  influenza virus, arise 
through intermolecular recombinational events (reviewed in Nayak el a / . 1989)
Clearly there are many regions of the cloned Dl SFV genomes that could be 
involved in secondary structure formation Some o f  these regions may be essential 
to the propagation o f  the Dl genome as virions or to  the replicative advantage of a 
particular Dl genome, while others may only be incidental and have no biological 
function Interference by Dl SFV genomes may be mediated through secondary 
structure interactions with the viral replicase complex or through other 
mechanisms Both pSFVDI-6 and pSFVDI-19 encoded polypeptides in an artificial 
translation system (sec Figure 6 5) Whether such polypeptides are produced in the 
infected cell or contribute to interfering activity remains to  be determined
2 1 5
One o f  the m ore important achievements described in this thesis was the 
development o f  a system that permitted the production o f genetically homogeneous 
preparations o f  Dl virus Transfection o f RNA transcripts from cloned DI SFV 
genomes into SFV-infected BHK-21 cells by electroporation generated detectable 
quantities o f  D l virus after a single passage It is likely that the high efficiency of 
the electroporation procedure prevented the establishment o f  Dl genomes 
generated Je  novo  and may partly explain the stability on passage o f  the cloned Dl 
virus preparations While the transfection procedure was used primarily to generate 
cloned Dl virus populations, it was also used in a preliminary investigation into the 
functional regions o f the cloned Dl genomes A region within the nsP2 gene of 
SFV RNA (nucleotides 2637 to 3024) was tentatively defined as containing a 
packaging signal This region is conserved in pSFVDI-6, pSFVDI-19 and the Dl 
genomes described by l.ehtovaara et a l (1982), and clones which lacked this 
region (pSFVDI-M 2 and pSFVDI-SBI) were not propagated as virions Further 
experiments are needed to resolve the precise function o f this region o f the SFV 
genome, but these experiments underline the usefulness o f Dl genomes for the 
identification o f  viral regulatory elements
With the establishment o f genetically homogeneous preparations o f  Dl SFV it was 
possible to  investigate the relationship between biological activity and genome 
constitution Hvidence from dot blot analysis showed that pSFVDI-6 was not 
propagated in tissue culture as efficiently as pSFVDI-19 For future comparative 
studies it will therefore be necessary to standardise the concentration o f  Dl SFV in 
these tw o preparations
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After intranasal coinoculation o f  the cloned preparations o f DI SFV and 10 LDW 
SFV into adult mice. vSFVDI-19 typically conferred about 75% protection and 
vSFVDI-6 was non-protecting Modulation o f infection was not observed after 
intranasal coinoculation o f  BPL-inactivated vSFVDI-19 with a lethal dose o f SFV, 
showing that protection was independent o f the amount o f  antigen This supports 
previous evidence that protection by Dl SFV is a function conferred by the genome 
and is not mediated through interactions with the host immune system (Dimmock 
and Kennedy. 1978, Barrett and Dimmock, 1984a, b. c; Barrett el a l , 1984c) 
Although the Dl SFV concentration in these preparations was not standardised, the 
tissue culture preparation vDI7-p2 typically conferred about 80% protection, 
despite having a lower interference litre than vSFVDI-6. This provided further 
evidence that vSFVDI-6 was non-protecting, and confirmed previous work which 
showed that only some Dl SFV preparations have mouse-protecting activity 
(Barrett and Dimmock. 1984a, b).
The propagation o f  the two cloned Dl SFV preparations in mice was investigated 
Evidence from PCR analysis o f RNA extracted from the brains o f Dl SFV-treatcd 
mice suggested that only vSFVDI-19 was propagated It will be necessary to 
standardise the concentration o f  Dl SFV in the two preparations to confirm this 
result, but it does provide a simple explanation for why some Dl SFV preparations 
are mouse-protecting and others are not This experiment also suggests that 
interference is dependent in part on host cell factors It is possible that the replicase 
complex formed in brain cells differs from that formed in tissue culture in such a 
way as to prevent certain Dl genomes from being propagated It is also possible 
that only certain types o f cell in the brain are involved with the propagation o f Dl 
SFV It will he interesting to determine if interference only occurs in specific areas
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o f the brain or olfactory lobes after inoculation by the intranasal route, but to do 
this will require the development o f a technique that is sufficiently sensitive and 
specific to detect Dl SFV in vivtt Although RT-PCR failed to  detect Dl SFV in 
mouse brain after intranasal administration, this may have been because the 
protocol used was not sufficiently sensitive It may be possible to increase 
sensitivity and specificity by using a nested PCR technique, which is feasible now 
that a mouse-protecting Dl SFV clone o f  known sequence has been constructed
Finally it is pertinent to ask which regions of a Dl SFV genome are important for 
mouse protection Clearly certain regulatory sequences have to  be retained by the 
Dl genome for viability, but whether other sequences are required for a specific 
interaction with virus replication in vivo is not known pSFVDI-6 contains all the 
sequences of pSFVDI-19 and is apparently non-protecting, suggesting that mouse 
protection is not mediated through interactions with the primary structure o f  the Dl 
genome However, it is possible that the additional sequences o f  pSFVDI-6 are 
involved in secondary structure formation that may mask regions required for 
interference in vivo Alternatively it may be the molecule as a whole that is 
important for mouse protection Hence factors such as size, coding potential, 
distribution o f regulatory elements along the molecule or overall secondary 
structure may be important to interference in vivo Clearly further work is needed 
to  determine which elements o f pSFVDI-19 are required for modulating infection 
in vivt>. and this aim could readily be achieved using the methodology described in 
this thesis
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APPENDIX
NOMENCIA TURE USED FOR MOI.ELVIAR CLONES, 1)1 VIRUS 
ANI) VIRUS PREPARATIONS
2 4 5
LIST O F  M OLECULAR < LONES
Clone Vector Size o f  
insert fkhp)
Derivation
pSFVDI-6 pUCI3 2 1 RT-PCR amplification from Dl 
SFV-p8
pSFVDI-7 pBluescribe KS4 2 1 As pSFVDI-6
pSFVDI-19 pUCI3 12 RT-P('R amplification from Dl 
SFV-p7
pSP6-SFV4 pTZISR 114 SFV cDNA (LiljestrOm el a l , 
1991)
pSFVDI-l A2 pBluescribe K S+ 12 deletion of pSFVDI-6 from 
Accl 534 to Accl 1453
pSFVDI-M2 pUCI3 1.7 deletion of pSFVDI-6 from 
Mlul 122$ to Mlul 1690
pSFVDI-SBI pTZIHR 2 1 deletion o f pSP6-SFV4 from 
Sail 1658 to BstEII 10920
LIST O F  V IR I'S  AND Dl V IR I'S  PREPARATIONS *
Nam* Derivation
Dl SFV-p7 7 serial undiluted passages o f  is* SFV in BHK-21 cells
Dl SFV-p8 I undiluted passage o f Dl SFV-p7 in CEF cells
vDI7-p2 RT-PCR amplification from Dl SFV-p7 using the primers
5'SI'V-T3  * 3'ShY-Nm. followed by transcription, 
transfection and 2 serial undiluted passages in BHK-21 cells
vSFV4-p2/F 13 transfection o f RN A transcribed from pSP6-SFV4 followed
by one senal passage in BHK-21 cells at an m o  i o f  0  01
• tissue culture preparations derived from transfection o f RNA transcribed from 
molecular clones are prefixed V
